¼š议日程... · 2017-05-02 · Palais des Congrès plan 133M132M131M 138M 137M 136M 135M 134M 128M 127M 126M 125M 124M 121M122M123M EXHIBITION HALL LONDON PUB CYBER SPACE ABSTRACT

pocket agenda

Paris 2011

17th-20th May

11T0768_PCRpocket_00_Couv 18/04/11 11:29 Page1

Palais des Congrès plan

133M 132M 131M

138M

137M

136M

135M

134M

128M

127M

126M

125M

124M

121M 122M 123M

EXHIBITION HALL

LONDON PUB

CYBER SPACE ABSTRACTPOSTERS

SINGAPOREFOOD COURT

BAG PICK-UP

MAIN ARENA

EX

HI

BI

TI

ON

EX

HI

BI

TI

ON

103102101

104

111112113

EXHIBITOR SUPPORT CENTRE

MEET WITHTHE TRIALISTS

WC

WC WC

WCWC

WC WC

WC

MEZZANINE MEZZANINE

Level 0

Level 1

ENTRANCE

REGISTRATION AREA

TO LEVEL 1 TO LEVEL 1

CONCIERGE,HOTEL

FACULTYDESKS

TO LEVEL 0,5:

COMPANIES DESK, CLOAKROOM


1

MEZZANINE MEZZANINEPRESS

342AB

341351

353

THEATREBORDEAUX

THEATREHAVANE

TRAININGVILLAGE

INNOVATION INCUBATORWEDNESDAY

303

304

305

302313 301

329M

328M

327M

326M

325M

227M320M

227M321M

227M322M

324M

323M

339M

338M

337M

336M

335M

CASE CORNER

WC

WC WC

WCWC

WC WC

WC

PCRTV

352AB

343

334M

333M 332M

331M

330M

312

314 311

INTERACTIVECASE CORNER

233M 232M 231M

237M

236M

235M

234M

227M

226M

225M

224M

221M 222M 223M

EXHIBITION HALL

243

241251

253

BISTROT MONTMARTRE

PCR FAMILY STAND

PREVIEW

THEATREBLEU

ROOMMAILLOT

MAIN ARENA

204

211213 203202201212

WC

WC WC

WCWC

WC WC

WC

MEZZANINE MEZZANINE

242A

242B

GUESTLOUNGE

252AB

Level 2

Level 3

11T0768_PCRpocket_01_Debut 18/04/11 11:29 Page1

Collaborations

Jean Marco

William Wijns

Patrick W. Serruys

Jean Fajadet

Marie-Claude Morice

Bernard De Bruyne

Alec Vahanian

Marc van Sambeek

Eric Eeckhout

Alberto Cremonesi

Horst Sievert

Dierk Scheinert

Carlos Ruiz

Philipp Bonhoeffer

Tian-Hai Koh

Martyn Thomas

Programme Committee Members

Emanuele Barbato

Andreas Baumbach

Jeroen J. Bax

Siro Buendia

Bernard Chevalier

Thomas Cuisset

Mark de Belder

Peter de Jaegere

Victoria Delgado

Carlo Di Mario

Joel Dunning

Javier Escaned

Gérard Fournial

Martine Gilard

Javier Goicolea

Giulio Guagliumi

A. Pieter Kappetein

Lene Kløvgaard

Ran Kornowski

Marie Leahy

Thierry Lefèvre

Maciej Lesiak

Bela Merkely

Claude Mialhe

Christophe K. Naber

Kari Niemelä

Marko Noc

Giovanni Pedrazzini

Nicolo Piazza

Jan J. Piek

Jose-Luis Pomar

Nicolaus Reifart

Flavio Ribichini

Marco Roffi

Manel Sabate

Antoine Sauguet

Volker Schächinger

David Taggart

Didier Tchétché

Leif Thuesen

Marco Valgimigli

Robbert Vermeulen

Stephan Windecker

Adam Witkowski

Course directors

Alexandre Abizaid

Ibrahim Al-Rashdan

Jorge Belardi

Ted Feldman

Runlin Gao

Morton J. Kern

Spencer B. King III

Steen D. Kristensen

Mitch Krucoff

Alexandra Lansky

Amir Lerman

Yean Leng Lim

Thomas Lüscher

Tom Mabin

Laura Mauri

Ian Meredith

Richard Ng

John Ormiston

Augusto Pichard

Charanjit Rihal

Teguh Santoso

Ron Waksman

John Webb

Alan C.Y. Yeung

Scientific Advisory Committee

2


Live centres

3

Cardiovascular Center Aalst - Aalst, BelgiumOperators: E. Barbato, B. De Bruyne, L. DiSerafino

Cardiovascular Institute and Fu Wai Hospital - Beijing, ChinaOperators: C. Mu, Y. Wu, W. Yang, Y. Yang

Ferrarotto Hospital - Catania, Italy

The National Hospital, The Heart Center - Copenhagen, Denmark

Villa Maria Cecilia Hospital - Cotignola, Italy

Medizinische Klinik I - Darmstadt, GermanyOperators: R. Reifart, G. WernerInvited operator: D. Tchétché

Catharina Ziekenhuis - Eindhoven, The NetherlandsOperators: G. Brueren, P.W. Cuypers, J.A.W. Teijink

Heart Center Essen - Essen, GermanyOperators: M. Farazandeh, D. Lindemann, C.K. Naber, T. Schmitz, C. Wald, A. Wolf

CardioVasculäres Center - St. Katharinen - Frankfurt, GermanyOperator: H. Sievert

Universität Leipzig Herzzentrum - Leipzig, GermanyOperators: S. Bräunlich, A. Schmidt, M. Ulrich

St Thomas Hospital - London, United KingdomOperators: V. Bapat, D. Hildick-Smith, S. Redwood, U. Tevidi, M. Thomas, C. Young

Instituto Cardiovascular / Hospital Clínico San Carlos - Madrid, SpainOperators: F. Alfonso, J. Escaned, R. Hernández , P. Jimenez-Quevedo Invited operator: K. Koch

Hôpital Bichat Claude Bernard - Paris, Bichat, FranceOperators: G. Ducrocq, A. Vahanian

Hôpital Henri Mondor - Paris, Créteil, FranceOperators: P. Desgranges, I. Kobeiter

Institut Cardiovasculaire Paris Sud – Massy - Paris, Massy, FranceOperators: B. Chevalier, O. Darremont, T. Lefèvre, Y. Louvard, M.C. MoriceInvited operators: J. Fajadet, D. Hildick-Smith, G. Stankovic

Erasmus University Medical Center, ThoraxCenter - Rotterdam, The NetherlandsOperators: P. de Jaegere, E. Regar, C. Schultz, W. van der Giessen, R.J. van Geuns, N. Van Mieghem

Chest Hospital, Kuwait Heart Center - Safat, KuwaitOperators: M. Abdel Aziz, A. Al Habashi, I. Al Rashdan, C. Thomas

Clinique Pasteur - Toulouse, FranceOperators: J. Fajadet, B. Farah, D. TchétchéInvited operators: V. Dangoisse, G. Guagliumi, S. Kedev, F. Mauri, B. Merkely, S. Saito

Toyohashi Heart Center - Toyohashi, Japan

Institute of Cardiology - Warsaw, PolandOperators: Z. Chmielak, M. Dabrowski, M. Demkow, T. Deptuch, C. Kepka, K. Kukula, A. Witkowski


Collaborations

TranscatheterValve Symposium (TVS)

EuroPCR is the official meeting of the EuropeanAssociation of Percutaneous Cardiovascular Interventions (EAPCI)

European Association for Cardio-Thoracic Surgery (EACTS)

The scientific programme is the result of close collaboration withthe following European and international societies:

EuroPCR collaborates with the following organisations:

EBAC AccreditationEuroPCR 2011 is accredited by the European Board for Accredi-tation in Cardiology (EBAC) for 18 hours of External CME Cred-its. EBAC works in cooperation with the Europan AccreditationCouncil for Continuing Medical Education (EACCME), which isan institution of the Europan Union of Medical Specialists(UEMS).

US CME AccreditationThe American Medical Association (AMA) has an agreementof mutual recognition of continuing medical education (CME)credit with the European Union of Medical Specialties (UEMS).Under the terms of this agreement, the AMA will convert CMEcredit certified by the European Accreditation Council for Con-tinuing Medical Education (EACCME), the accrediting arm ofthe UEMS, to AMA PRA Category 1 Credit™.Physicians may apply to convert EACCME credit into AMA PRACategory 1 Credit™ by submitting a form and attaching an EACCME credit certificate. Download the form onhttp://www.ama-assn.org/

Dutch AccreditationIn 2011 EuroPCR is accredited by the Association of Surgeonsof The Netherlands.

Swedish Society for Vascular SurgeryIn 2011 EuroPCR is officially endorsed by the Swedish Societyfor Vascular Surgery.

Course accreditation

4

Stent for Life

g CCT g CIT

g ICI g SOLACI

Together we achieve more


Z Arbeitsgruppe Interventionelle Kardiologie – Deutsche Gesellschaft für Kardiologie

Z Association of Interventional Cardiology of Hungary

Z Association of Interventional Cardiology of Romania

Z Austrian Working Group on Interventional Cardiology

Z Belgian Society for Vascular Surgery (BSVS)

Z Belgian Working Group of Interventional Cardiology

Z British Cardiovascular Intervention Society (BCIS)

Z Bulgarian Working Group on Interventional Cardiology

Z Danish Working Group of Interventional Cardiology

Z Dutch Working Group of Interventional Cardiology

Z Egyptian Working Group of Interventional Cardiology (EWGIC)

Z Euro CTO Club

Z European Bifurcation Club

Z French Group of Interventional Cardiology (GACI)

Z German Working Group of Interventional Cardiology

Z Interventional Cardiology Working Group of the Czech Society of Cardiology

Z Iranian Society of Interventional Cardiology

Z Israeli Working Group on Interventional Cardiology

Z Italian Society of Invasive Cardiology (GISE)

Z Lebanese Working Group of Interventional Cardiology

Z Polish Association of Cardiovascular Interventions

Z Portuguese Association of Interventional Cardiology

Z Russian Society of Interventional Cardioangiology

Z Saudi Arabia Cardiology Interventional Group (SACIG)

Z Scottish Cardiac Society

Z Siberian Association of Interventional Cardioangiologists

Z Slovenian Working Group of Invasive and Interventional Cardiology

Z South African Society of Cardiovascular Intervention (SASCI)

Z Taiwan Society of Cardiology

Z Turkish Working Group of Interventional Cardiology

Z Vascular Surgery Society of Southern Africa (VASSA)

Z Working Group for Interventional Cardiology of the Cyprus Society of Cardiology

Z Working Group of Hemodynamics and Intervention of the Hellenic Cardiological Society

Z Working Group of Interventional Cardiology of the Croatian Cardiac Society

Z Working Group on Interventional Cardiology and Acute Coronary Syndrome of the Swiss Society of Cardiology

Z Working Group on Interventional Cardiology of Latvian Society of Cardiology

Z Working Group on Interventional Cardiology of the Cardiology Society of Serbia

Z Working Group on Interventional Cardiology of the Estonian Society of Cardiology

Z Working Group on PCI of the Danish Society of Cardiology

Z Working Group on PCI of the Norwegian Society of Cardiology

Z Working Group on PCI of the Spanish Society of Cardiology

Z Working Group on PCI of the Swedish Society of Cardiology

Scientific Societies and National Working Groups

5


Sessions types

Main sessions - 100% revampedThese completely revamped sessions concentrate on one major topicfor four hours. The most popular sessions at EuroPCR are now a part ofthese main sessions - including How should I treat?, Complications,Keynote lectures and live demonstrations. They will be open to thelargest audiences, held in the larger rooms such as the Main Arena.

All you need to knowDesigned to provide a comprehensive, structured update on keyclinical topics and an up-to-date reflection on a specific field. Thesesessions will be immediately transferred to PCRonline and will serve asthe core of a key topic section. Cases will be available on pcronline.comas well as links to the curriculum and web related content.

LTT (Learning the techniques)The renowned LTT sessions are always a success. This year, they will beclassified into one of the following categories: How to treat a patient,How to use or perform a technique. During these highly interactivesessions, audience participation is strongly encouraged. LTT includesLive in-a-box® cases.

Glimpse into the futureLearn about which tools, techniques or technologies may make theirway into tomorrow’s mainstream practice. With live demonstrations.

Innovation dayInnovation is one of the pillars of EuroPCR. This year, you’ll have a fullday to dive into the future. Best of ICI@EuroPCR session will highlightthe best of the Innovations in Cardiovascular Interventions meeting(ICI). Cardiovascular Innovation Pipeline@EuroPCR present innovativecompanies and their latest technologies. The Innovation incubator willshow highly innovative concepts and technologies in cardiovascularinterventions. Last but not least, the new session "ABC for inventors"will end the day. Chaired by Philipp Bonhoeffer, who performed thefirst human transcatheter heart valve implantation, in 2000, thisunique session aims to give young inventors a greater understandingof what it takes to bring their innovation forward.

“Call for” based sessionsAbstracts, Complications, Clinical cases. Your daily practice is that ofmany others. You are a major source of education. That's why this year,EuroPCR proposes >80 abstract sessions and >50 forum based onclinical cases and complications.Beside the sessions, cases submitted for EuroPCR will be displayed at theCase corner (Level 3) and open to all for online consultation.In the same area, the Interactive case corner will allow presenters andattendees to discuss the cases throughout the day.

Participants will exchange in a friendly environment, without any timeconstraints.Check the programme in the Daily!

How should I treat?Based on the EuroIntervention concept, these dynamic sessions bringtogether two experts to discuss the different treatment strategies fora case, and compare this with how the case was actually treated. Theyare the result of a fruitful collaboration between Scientific Societiesfrom all over the globe.

Hot linesThese sessions are reserved for first presentations of recentlycompleted clinical trials and new data or analysis of trials presented atprevious meetings. The Meet with the trialists session covers the best of Hot line sessionsand provides the opportunity to interact directly with the presenters.

Supported by the industry

Tech News & Trends (TNT)Tech News & Trends sessions address innovations, problems anddifficulties in daily practice or more challenging situations. 90 minutesare dedicated to live case transmissions which are the core of thesesessions. Designed to encourage audience interactivity (spot lectures,a limited number of slides), these sessions aim at helping the audiencefind an answer on how to simplify their practice. There are noacademic lectures, only cognitive teaching techniques are used.

SymposiaSymposia aim to develop themes through state-of-the-art lecturesand present clear syntheses of studies and trials. These sessionsshould allow attendees to leave with practical solutions topatient/lesion problems.

How should I treat?Based on the EuroIntervention concept, these dynamic sessions bringtogether two experts to discuss the different treatment strategies fora case, and compare this with how the case was actually treated.

Training villageTraining sessions are specific hands-on workshops with the aim ofimproving not only device knowledge, but also the manipulation skillsof the attendees, through a “coaching” style of teaching. Thesesessions offer a select number of attendees the possibility to gainexperience in a coached environment.

6


Participants will exchange in a friendly environment, without any timeconstraints.Check the programme in the Daily!

How should I treat?Based on the EuroIntervention concept, these dynamic sessions bringtogether two experts to discuss the different treatment strategies fora case, and compare this with how the case was actually treated. Theyare the result of a fruitful collaboration between Scientific Societiesfrom all over the globe.

Hot linesThese sessions are reserved for first presentations of recentlycompleted clinical trials and new data or analysis of trials presented atprevious meetings. The Meet with the trialists session covers the best of Hot line sessionsand provides the opportunity to interact directly with the presenters.

Supported by the industry

Tech News & Trends (TNT)Tech News & Trends sessions address innovations, problems anddifficulties in daily practice or more challenging situations. 90 minutesare dedicated to live case transmissions which are the core of thesesessions. Designed to encourage audience interactivity (spot lectures,a limited number of slides), these sessions aim at helping the audiencefind an answer on how to simplify their practice. There are noacademic lectures, only cognitive teaching techniques are used.

SymposiaSymposia aim to develop themes through state-of-the-art lecturesand present clear syntheses of studies and trials. These sessionsshould allow attendees to leave with practical solutions topatient/lesion problems.

How should I treat?Based on the EuroIntervention concept, these dynamic sessions bringtogether two experts to discuss the different treatment strategies fora case, and compare this with how the case was actually treated.

Training villageTraining sessions are specific hands-on workshops with the aim ofimproving not only device knowledge, but also the manipulation skillsof the attendees, through a “coaching” style of teaching. Thesesessions offer a select number of attendees the possibility to gainexperience in a coached environment.

7


8

NEW! Case corner

At EuroPCR we value your work and participation.

On Level 3, a new place has been created where all attendees canreview and discuss the cases that were submitted this year.

In between sessions? Taking a break? Stop by the Case corner: it’sopen all day long!

You will find it on level 3, between the Bordeaux and Havanetheatres. You will know you are in the right place when you reachthe purple carpet. The area is divided into 2 rooms: on one side youwill see the Case corner and on the other the Interactive casecorner.

The Case corner: Look over the complication and clinical cases in a welcoming and user-friendly environment

We believe that all cases submitted have an educational value, sothis year over 350 presentations are displayed via an easy-to-useapplication on 6 different computers.

The Interactive case corner:Take part in case-based exchanges!

In this space participants will discuss, share and learn with theircolleagues in a convivial and open atmosphere.

Facilitators will animate each session to encourage communication.The submitter will present his case and you will be free to askquestions and add your opinion. Receive on the spot feedback totake straight back to the cathlab with you.

Don’t forget to look out for the case discussion that interests youon the schedule available in the Daily.

MUST SEE!

Countries meet EuroPCRThese case-based discussion sessions are designed to act asplatforms for the country involved: China, India, Taiwan, SouthKorea and Russia.See Thursday and Friday programmes for more information!

ForumTalk about your experience: the Forum are peer-led sessionscreated to share, exchange and learn from each other. Everybody isencouraged to take the microphone and make a comment.


MUST SEE!

Endovascular Programme for interventional cardiologists: follow the “How to” sessions trackIn response to last year’s success the endovascular programmehas strengthened. In 2011 you’ll find more! Sessions, additional Livedemonstrations & increased sessions built from submissions. This programme is for interventional cardiologists who would liketo expand their current practice to endovascular/peripheral field.This tailor-made programme is a real “How to” and covers allperipheral vasculature, with live demonstration as the centrallearning tool.

Innovation incubatorWednesday is dedicated to innovation! Just outside theinnovation session rooms, find the innovation incubator. Grab abite to eat at the buffet table and chat with representatives from12 innovative companies to learn about their latest technology.This space is open to everyone, all day long on Level 3.

PostersFor the second year at EuroPCR, posters will be displayed. Over 160abstracts will be posted on Level 1. Don’t miss the interactiveposter sessions Wednesday and Thursday from 12:00 to 13:30.

Training village Head up to Level 3 and take a look at the training villageprogramme, where you can also sign up for sessions. Rememberplaces are limited to ensure participants spend the maximum oftime practicing themselves.See page 22 for the Training programme at a glance.

EAPCI General Assembly The EAPCI General Assembly will be held Tuesday evening in theMain arena. Besides a welcome by the President, Carlo Di Mario,and an update of EAPCI activities, questions submitted bymembers will be answered at the end of the assembly.

Meet with the trialists Put your questions to the principal investigators of trialspresented in the Late breaking trial sessions. This unique sessionallows participants to engage in in-depth exchange on the latestpioneering studies.Thursday 19th May, 14:00-16:00 - Level 1, room 101/102/103.

9


How to get the most out of EuroPCR

Once the Board of Directors, the Programme Committee

Members and the Scientific Advisory Board have finalised

a great scientific programme, covering all the hot topics,

with great speakers and world experts sharing their skills

and knowledge, there is still one thing missing…

YOU!As an attendee, you have an important role in the successof EuroPCR. To do this, we ask that you do three things:

. Ask questions! Raise your hand, ask that question and add to

the interactivity of the sessions. By doing so you’ll ensure that

EuroPCR is the best learning forum for you and your colleagues.

. Share your experience! Your personal experience as a practitio-

ner is a source of education in itself. Make sure you share it with

other attendees by picking up the microphone and being an ac-

tive attendee.

. Disagree! You don’t agree with what’s being said – then let us

know! You do things differently in your cathlab? Local constraints

have lead you to find another solution? Share it with us and help

grow the collective intelligence of the community.

Thanks for being an active participant!

10


11

Coronary & structural heart disease

The coronary and structural heart disease programme is colour-coded in blue.

4 coronary gateways4 categories that mirror the life-cycle of a device, moving from

innovation to the techniques that can be applied to the technology,

onto clinical studies, and finally evidence which often leads us to

establishing guidelines.

They are: Innovation, Technique, Clinic, Evidence.

C InnovationAs a springboard for innovation, EuroPCR puts you in contact with the

latest devices and the best innovations in the field.

The Innovation category helps you keep up to date with the latest

inventions and abreast of this fast-paced industry.

C TechniqueLearn it here and take it back to the cathlab!

The Technique category enables you to get your head - and your hands

around new techniques, as well as fine-tuning the ones you use as

part of your daily practice.

C ClinicFocusing largely on case-based learning, the Clinic category connects

technical know-how with in-depth clinical judgement.

It will help you see the trees from the woods, and ensure you make the

right decision for each individual patient.

C EvidenceWhat data matters?

The Evidence category tries to answer this question. EuroPCR unites a

community that covers over 90 countries, with a variation in local

constraints that is mind boggling to say the least.

How to get the most out of EuroPCR


Endovascular programme

The endovascular sessions are colour-coded in orange

In response to last year’s success the endovascular programme

has strengthened. It is divided in two, targeting both interventional

cardiologists and peripheral practitioners.

“How to” sessionsA programme for interventional cardiologists wishing to expand

their current practice to endovascular/peripheral. This tailor-made

programme of 7 sessions covers all peripheral vasculature, with

live case demonstration as the central learning tool.

Horst Sievert says, “Attendees can learn almost everything they

need to perform these procedures within 4 days. It starts with

basics on Tuesday and on the other days each session is dedicated

to one vessel area.”

Follow the How to… label. See page 188

“Break-out” programmeFor all those interested working in the endovascular field, these 8

sessions will bring you up-to-speed with the latest techniques,

technology and current controversies, with debate and discussion

in an interactive format.

Follow the Break-out label. See page 187

Don’t miss Carotid revascularisation: Live it!A live comparison of the clinical practice of interventional

cardiologists and cardiac surgeons.

Parallel live transmissions will be broadcast on two screens

showing both the cathlab and operating room, the sound will be

connected alternately from one room to another. The session will

be constructed so there is a real simultaneity between the 2

procedures.

12

.Opening session with continuous live demonstrationand Endovascular Late Breaking Trials

.Live demonstrations from: Frankfurt, Leipzig, Cotignola,London & Paris

.8 Abstract sessions

.6 Forum

.Innovation session in collaboration with CardiovascularInnovation Pipeline: Peripheral vascular disease andstructural heart disease

Highlights


13

Nurse and technician programme

Follow the Nurse & technician programme colour-coded ingreen

Non-sponsored programme. 7 nurse & technician scientific sessions

Constructing the scientific session programme, Siro Buendía, Lene

Kløvgaard, Marie Leahy and Robbert Vermeulen created a

programme that covers the main topics of interest for nurses and

technicians while ensuring the programme is coherent with the

rest of the EuroPCR programme.

. LTT session “Scrubbing-in for bifurcation PCI”

For the first time, one of the most popular session formats has

been adapted to the nurses & technicians point of view. Interactive

and 100% educative. With Live in-a-box® from Paris, Massy.

. A new forum session

Join the Forum on the treatment of STEMI, Thursday 19th May,

14:00. This original session format will allow you to listen to

different European countries’ perspectives and then participate in

1 hour of open discussion. Express yourself!

Sponsored programme.More than 19 training sessions

The Training village proposed by companies offers practical

education, with a number of sessions specifically for nurses and

technicians.

The number of participants for each session is limited in order to

ensure that each attendee spends the session practicing and not

waiting in line. Sign up on Level 3. See page 22 for the Training

programme at a glance.

Network!The nurses & technicians sessions are all programmed in Room 241.

It’s your place @ EuroPCR.

Meet, share, discuss and network in this dedicated nurses & technicians

room. To make networking with colleagues even easier, you will be

provided with coffee and lunch in the room.

“We must keep working together for the future improvement of

our profession and to offer the best possible patient care.”

Siro Buendia, nurse, Programme Committee Member.

Missed the 2011 call for submissions? Nurse & technician abstract

submissions will open for 2012 this August.


Main arena

Theatre Bleu

Theatre Bordeaux

Theatre Havane

Room

Maillot

Room

241

Room

242A

Room

242B

Room

243

Room

251

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

Welcome & Live from

Frankfurt

p. 26

Opening: PCR Family

p. 26

The Great Debate

Med

tronic

Left

main in 201

1 - p

. 27

Live from

Toulouse

p. 32

Late breaking trials

p. 34

EAPCI General Assem

bly

p. 47

Abstracts - Carotid

p. 187

Abstracts - TAVI

p. 36

How should I treat?

Iran - Turkey

p. 42

Abstracts - TAVI

p. 27

Abstracts - DES

p. 36

Abstracts - Devices

p. 43

Forum - Multivessel disease

p. 28

Forum - Dissection

p. 37

Forum - Below the knee

p. 189

All you need to know about...

Pharmacology during PCI

p. 28

Forum - Left main (Part I)

p. 37

Forum - Left main (Part II)

p. 44

What's new in endovascular interventions?

p. 187

How to do

endovascu

lar interve

ntion

s: imaging

,vascu

lar access and e

quipm

ent sele

ction

p. 188

How to do

endovascu

lar interve

ntion

s: carotid and supra-aortic

intervention

sp. 189

Percutaneous revascularisation of CTO: a largely

disregarded alternative to surgery

p. 32

Symposium

Ab

bott

Vascular

PCI S

afety - p

. 47

TNT

Terumo

Left

main/

Multiv

essel d

isease - p

. 35

Symposium

As

traZe

neca

Antip

latelet t

herapy

in ACS

- p. 48

LTT - How to select m

aterial and equipment

for PCI

p. 34

Nurse research from

daily cathlab

practice

p. 217

How should I treat?

Iroko

Cardio

PCI for ACS

- p. 41

How should I treat?

Cordis

Radial vs femoral -

p. 48

Tuesday 17

thLEVEL 1: M

ain Aren

a / LEVEL 2:

Thea

tre Bleu, ro

om M

aillo

t, room

s 24

1 to 253

LEVEL 3:

Thea

tre Hav

ane & Bo

rdea

ux, roo

ms 34

1 to 353

, Training villa

geCo

rona

ry and

stru

ctural hea

rt disease

Endo

vascular

Nurses & te

chnician

sWith

Live

L

LL

LL

L

L

L

11T0768_PCRpocket_02_Glance 18/04/11 11:28 Page14

Room

252AB

Room

253

Room

341

Room

342AB

Room

351

Room

352AB

Room

353

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

Tuesday 17

th

Forum - Structural heart

interventions

p. 29

Forum - Complications

(Part I)

p. 38

Forum - Stent throm

bosis

p. 44

Abstracts - STEMI

p. 29

Abstracts - ACS

p. 38

Abstracts - TAVI

p. 45

Abstracts - CIN (Part I)

p. 30

Abstracts - CIN (Part II)

p. 39

Forum - TAVI

p. 46

Abstracts - Imaging

p. 31

Abstracts - PFO

p. 40

Abstracts - TAVI

p. 46

Symposium

Eurocor

DEB - p

. 30

Stent for Life @ EuroPCR 2011

p. 40

How should I treat?

Med

tronic

Critical lim

b isc

hemia -

p. 190

Forum - Devices

p. 33

Forum - AAA

p. 188

Abstracts - STEMI

p. 44

Symposium

Med

tronic

Corona

ry to

rena

l arte

ries - p

. 33

Symposium

St. Jud

e Med

ical

FFR - p

. 49

SOLACI@EuroPCR

p. 42

Training village at a glance, see page 22


Wednesday 18th

LEVEL 1: M

ain Aren

a / LEVEL 2:

Thea

tre Bleu, ro

om M

aillo

t, room

s 24

1 to 253

LEVEL 3:

Thea

tre Hav

ane & Bo

rdea

ux, roo

ms 34

1 to 353

, Training villa

geCo

rona

ry and

stru

ctural hea

rt disease

Endo

vascular

Nurses & te

chnician

sWith

Live

L

Main arena

Theatre Bleu

Theatre Bordeaux

Theatre Havane

Room

Maillot

Room

241

Room

242A

Room

242B

Room

243

Room

251

8h

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

Revascularisation in patients with com

plex left main stenosis

p. 50

Forum - TAVI

p. 50

Complication forum

p. 52

Forum - Dissection

p. 52

Abstracts

Endothelial function

p. 53

New generation DES

(ESC-EACTS revascularisation guidelines)

p. 59

LTT - How to treat a patient with high-risk non ST-segment

elevation acute coronary syndrom

ep. 60

TNT

Med

tronic

TAVI -

p. 69

Percutaneous intervention for m

itral regurgitation

p. 79

TNT

Abbo

tt Va

scular

Mitral -

p. 93

Symposium

Cordis

DAPT -

p. 70

Symposium

Boston

Scien

tific

CAD/

SHD - p

. 71

Symposium

Terumo

Prim

ay PCI -

p. 71

How should I treat?

Med

tronic

MVD

in Asia

Pacific - p

. 72

Abstracts - Diabetics

p. 73

How should I treat?

IHT - C

ordy

namic

Prim

ary PC

I - p. 7

4

Symposium

Bios

enso

rs In

ternationa

lDE

S - p

. 94

Symposium

Eli L

illy

ACS/

PCI - p. 9

4

How should I treat?

Med

tronic

Prim

ary PC

I - p. 9

6

Abstracts - Devices

p. 103

Revascularisation in patients with stable angina and com

plex

multivessel disease

p. 78

L

Secondary revascularisation - Part I - Restenosis in drug-eluting stents

p. 51

L

L

L

L

How to do endovascular interventions:

femoro-popliteal interventions

p. 192

Acute stroke interventions

p. 192


Carotid artery stenting

p. 194

Forum - Carotid

p. 195


Bleeding / access site

p. 78

Forum - Dissection

p. 88

How should I treat?

Belgium - South Africa

p. 193

How should I treat?

Bulgaria - Siberia

p. 63

Abstracts - STEMI

p. 65

Structural heart disease interventions

p. 218

Coronary clinical cases from

a nursing perspective

p. 218

Lunch

Networking

LTT - Scrubbing-in for bifurcation PCI

p. 219

Forum - Neurology

p. 56

Forum - STEMI

p. 56

Abstracts - Bifurcation

p. 60

Percutan

eous treatment of uncom

mon

structural heart disease disorde

rsp. 64

L

L

Secondary revascularisation - Part II - Revascularisation of

saphenous vein graft attrition

p. 80

L

LTT - How to treat a patient with STEMI caused

by a large thrombus

p. 81

How should I treat?

Egypt - Saudi Arabia

p. 81

Abstracts - Imaging

p. 82

Abstracts - Left m

ain

p. 83

Abstracts - CTO

p. 89

Abstracts - STEMI

p. 90

Abstracts - TAVI

p. 97

Abstracts - Imaging

p. 97


Bifurcation stenting

p. 98

How should I treat?

Hungary - Rom

ania - Scotland

p. 88

L


aorto-iliac interventions

p. 198

L

L

Symposium

B. Braun

& M

edrad

DEB - p

. 95/

200

Symposium

Hexa

cath

ACS - p

. 72/

197


Room

252AB

Room

253

Room

341

Room

342AB

Room

343

Room

351

Room

352AB

Room

353

Near Theatre Bordeaux

and P

CRTV studio

8h

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

Forum - Left main

p. 53

Abstracts

Dissection

p. 53

Abstracts - Devices

p. 54

Abstracts - Devices

p. 54

How should I treat?

Estonia - Latvia - Russia

p. 57

How should I treat?

Denm

ark - Norway - Sweden

p. 58

Glimpse into the future - Future treatment decision-making based

on intracoronary lesion assessment

p. 55

Abstracts - Access site

p. 61

Abstracts - Multivessel disease

p. 62

Abstracts - Mitral valve

p. 62

Forum - Access site

p. 63

Forum - TAVI

p. 69

Abstracts - Left atrial

appendage

p. 66

Abstracts - Critical limb

ischemia

p. 195

Late breaking first-in-Hum

antrials

p. 66

Abstracts - Devices

p. 67

How should I treat?

Czech Republic - Germany

p. 68

How should I treat?

Minva

sys

Bifurcation - p

. 74

Symposium

Baye

r Hea

lthcare

CIN

- p. 7

6

Abstracts - Fem

oro-popliteal

p. 196

How should I treat?

Abbo

tt Va

scular

CTO - p

. 76

Symposium

St. Jud

e Med

ical

OCT - p

. 77

How should I treat?

Cook

Med

ical

SFA - p

. 198

Critical limb ischemia

p. 199

Best of ICI Technoparade

p. 84

Forum - Plug it

p. 84


p. 85

How should I treat?

Austria - U.K. - Netherlands - Slovenia

p. 85

Glimpse into the future - TAVI: what lays ahead and how to

improve procedural outcomes

p. 86

How should I treat?

France - South Africa

p. 87

Forum - STEMI

p. 92

LTT - How to perform

transseptal catheterisation

p. 61

LTT - How to perform manual

thrombus aspiration in STEMI

p. 65

L

L

L

LTT - How to use rotablator

p. 83

L

LTT - How to perform PCI via

transradial access

p. 90

Abstracts - Devices

p. 90

Cardiovascular Innovation Pipeline

Coronary artery disease

p. 91

Renal denervation therapy

p. 199

Abstracts - TAVI

p. 92

Forum - Multivessel

disease

p. 93

How should I treat?

Terumo

Bifurcation an

d CTO - p

. 99

How should I treat?

Maq

uet C

ardiov

ascu

lar

AMI - p. 1

00

ABC for inventors

p. 101

Symposium

Sano

fi Av

entis

ACS - p

. 102

How should I treat?

Tryton

Med

ical

Bifurcation - p

. 102

Symposium

Volca

noIm

aging - p

. 103

How should I treat?

Hexa

cath

SFA / Re

nal a

rtery -

p. 201

Abstracts - Carotid

p. 200

L

Wednesday 18th

Innovation Incubator Space - Level 3

p. 59 /1

93


Cardiovascular Innovation Pipeline -

Peripheral vascular disease and SHD

p. 75/

196


Thursday 19th

LEVEL 1: M

ain Aren

a, ro

om 101

/102

/103

/ LEVEL 2:Th

eatre

Bleu, ro

om M

aillo

t, room

s 24

1 to 253

LEVEL 3:

Thea

tre Hav

ane & Bo

rdea

ux, roo

ms 34

1 to 353

, Training villa

geCo

rona

ry and

stru

ctural hea

rt disease

Endo

vascular

Nurses & te

chnician

sWith

Live

L

Main arena

Theatre Bleu

Theatre Bordeaux

Theatre Havane

Room

Maillot

Room

101/102/103

Room

241

Room

242A

Room

242B

Room

243

8h

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

Meet w

ith the trialists

p. 140

Current challenges with transcatheter aortic valve im

plantation

for severe aortic stenosis

p. 104

Symposium

Edwards

Life

sciences

TAVI -

p. 124

Symposium

The Med

icines Com

pany

High

-risk

PCI -

p. 125

Symposium

Abbo

tt Va

scular

STEM

I - p. 1

26

Symposium

Orbu

sNeich

DAPT -

p. 126

Forum - India

meets EuroPCR

p. 127

Forum - Taiwan meets EuroPCR

p. 131

EuroIntervention / European

Heart Journal @ EuroPCR

p. 141

How to write a paper?

p. 146

Forum - Thoracic

aorta

p. 209

LPrimary PCI in STEMI - towards optimal results in com

plex lesions

p. 131

L

Glimpse into the future - Bioresorbable scaffolds:

a new era in clinical interventional cardiology

p. 105

TNT

Terumo

Bifurcation/

CTO - p

. 124

L

Complex coronary chronic total occlusion interventions: live from

Toyohashi Heart Center, Japan and CCT meeting@

EuroPCR

p. 106

L

LTT - How to treat a patient

with multivessel coronary disease

p. 112


below the knee interventions

p. 202

New developments in the

modern cathlab

p. 220

The miscellaneous abstract

session

p. 220

Lunch

Networking

The treatment of STEMI from a cathlab

managem

ent perspective

p. 221

Forum - SVG

p. 106 How should I treat?

Denm

ark - Lebanon

p. 111

Forum - SVG

p. 107

Abstracts - Imaging

p. 107


p. 112

Abstracts - TAVI

p. 120

Abstracts - STEMI

p. 127

Abstracts - Cell regeneration

p. 135

Abstracts - CTO

p. 142

Abstracts - TAVI

p. 150

Computed tomography:

interactive case reading

p. 112

Forum - China meets EuroPCR

p. 119

How should I treat?

Iran - Turkey

p. 203

Forum - Carotid

p. 203

How should I treat?

Portugal - Spain

p. 134

How should I treat?

Italy - Switzerland

p. 142

Forum - CTO

p. 149

L

L

Complication forum

p. 140

Where cardiologists and cardiac surgeons can meet: the

beginning of a great future

p. 132

LTT - How to treat a patient with

coronary bifurcation lesions

p. 133

LTNT

Edwards

Life

sciences

TAVI -

p. 147

Symposium

Daiichi San

kyo & Eli L

illy

ACS/

PCI - p. 1

47

Symposium

CID

DES - p

. 148

L

L


renal and visceral interventions

p. 206

LSymposium

Med

tronic

DEB - p

. 149

/208


Room

243

Room

251

Room

252AB

Room

253

Room

341

Room

342AB

Room

343

Room

351

Room

352AB

Room

353

8h

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

Abstracts - Imaging

p. 107

Forum - Aneurysms

p. 108

Forum - Bifurcation

p. 108

Abstracts - Devices

p. 109

Abstracts

Endothelial function

p. 109

Abstracts - Devices

p. 110

Forum - Dissection

p. 110

Abstracts - Devices

p. 110

Multilevel vascular disease

p. 202

All you need to know about…

Gender differences in PCI

p. 113

Forum - STEMI

p. 114


p. 114

Abstracts - TAVI

p. 115

Abstracts - Devices

p. 117

Late breaking science

p. 120

LTT - How to perform OCT

imaging

p. 121

Abstracts - Adjunctive

pharmacotherapy

p. 121

Abstracts - FFR

p. 121

Abstracts - Multivessel disease

p. 122

How should I treat?

Croatia - Cyprus - Greece - Serbia

p. 118

Forum - Mitral valve

p. 117

Abstracts - Im

aging

p. 118

Forum - STEMI

p. 123

Abstracts - STEMI

p. 123

Invasive strategies for STEMI initially treated with fibrinolysis:

a case-based discussion

p. 116

How should I treat?

Boston

Scien

tific

Infra

ingu

inal cha

lleng

es -

p. 204

How should I treat?

Biotronik

Femoral

and inf

rapo

pliteal

- p. 2

04

Abstracts - Endothelial

function

p. 128

Abstracts - Elderly

p. 128

Symposium

Sten

tys

STEM

I - p. 1

29

Abstracts - Devices

p. 205

How should I treat?

Med

tronic

TAVI -

p. 129

Symposium

Minva

sys

Bifurcation - p

. 130

Abstracts - OCT

p. 131


Intracoronary im

aging

p. 135

LTT - How to use

pressure-derived FFR

p. 136


p. 136

Abstracts - Secondary

revascularisation

p. 137

Cathete

r-based managem

ent of

massive intravascu

lar throm

bosis

p. 206

Abstracts - TAVI

p. 137

Best of AsiaPCR/SingLive 2011

p. 138

Glimpse into the future - Novel approaches to treatment of

mitral valve disease

p. 138 Abstracts - M

ultilevel vascular

disease

p. 207

Abstracts - SVG

p. 139

Forum - Devices

p. 144

Abstracts - Adjunctive

pharmacotherapy

p. 144

Abstracts - Devices

p. 145

Abstracts - TAVI

p. 145

Imaging valvular disease: clinical

and pathologic correlates

p. 146

Hybrid approach for the treatment of

the thoracic aortic disease

p. 207


Percutaneous assist-devices

p. 143

How should I treat?

Terumo

STEM

I - p. 1

50

Abstracts - Imaging

p. 151

Abstracts - ACS

p. 152

How should I treat?

Abbo

tt Va

scular

LM/B

ifurcations

- p. 152

Abstracts - Devices

p. 153

Symposium

Med

tronic Ardian

Rena

l den

erva

tion tre

atmen

t - p. 2

08

Abstracts - Stent thrombosis

p. 155

Intera

ctive meeting w

ith the p

rincipal investigato

rsof essential on

going

or future clinical trials

p. 154


p. 112

Abstracts - TAVI

p. 120

Abstracts - STEMI

p. 127

Abstracts - Cell regeneration

p. 135

Abstracts - CTO

p. 142

Abstracts - TAVI

p. 150

L

L

Thursday 19th



Friday 20th

LEVEL 1: M

ain Aren

a / LEVEL 2:

Thea

tre Bleu, ro

om M

aillo

t, room

s 24

1 to 253

LEVEL 3:

Thea

tre Hav

ane & Bo

rdea

ux, roo

ms 34

1 to 353

, Training villa

geCo

rona

ry and

stru

ctural hea

rt disease

Endo

vascular

Nurses & te

chnician

sWith

Live

L

Main arena

Theatre Bleu

Theatre Havane

Room

Maillot

Room

241

Room

242A

Room

242B

Room

243

Room

251

Room

252AB

8h

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

Cardiovascular interventions: intercontinental crossfire

With LIVE from Asia-Pacific & Ethica award

p. 156

Complication forum

p. 157

LTT - How to treat a patient with coronary chronic total occlusion

p. 157

Carotid revascularisation: Live it! Great news:

carotid stenting is Class I recommendation

p. 210

Abstracts - Thoracic aorta

p. 211

Abstracts - Imaging

p. 160

Abstracts - Fem

oro-popliteal

p. 212

2010 ESC - EACTS guidelines on

myocardial revascularisation

p. 159

Abstracts - M

itral valve

p. 165

LAw

ards and closing

ceremony

p. 169

L L

Forum - India meets

EuroPCR

p. 160

Forum - South Korea

meets EuroPCR

p. 165

Forum - Russia meets

EuroPCR

p. 169

Abstracts - Clinical trials

p. 165

Abstracts - Specific patient

subsets

p. 160

How to do endovascular interventions: abdom

inal aortic

aneurysm treatment in the cathlab

p. 211Forum - Aneurysms

p. 166

Forum - Spasms

p. 169

L


Room

253

Room

341

Room

342AB

Room

343

Room

351

Room

352AB

Room

353

8h

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

Friday 20th

Room

252AB

Abstracts - STEMI

p. 161

Abstracts - Stent thrombosis

p. 166

Cardiogenic shock: an update

p. 162

Forum - Left main

p. 163

Forum - CTO

p. 162

Forum - CTO

p. 167

Late breaking registries and trial updates

p. 158

Abstracts - Devices

p. 167

Forum - Imaging

p. 168

Forum - Aorto-iliac

p. 212

Forum - TAVI

p. 168

Forum - Secondary

revascularisation

p. 164

Forum - Devices

p. 164



Training villag

e - Lev

el 3

Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

s

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Vascular closure

p. 173

Bifurcation lesions

p. 173

Tuesday 17

th

CORDIS CARDIAC

& VASCULAR INSTITU

TE

CROSSROADS, The Abbott

Vascular Education Network

EDWA

RDS LIFESCIEN

CES

MEDTRONIC A

CADEMIA

ST. JUDE M

EDICA

L

Radial approach

p. 173

AMI for nurses

p. 227

Bifurcation lesions

p. 174

Transcatheter heart valves

p. 174


p. 174

MVD

p. 174

Hemostasis

managem

ent

p. 175

Hemostasis

managem

ent for

nurses

p. 227

Hemostasis

managem

ent

for nurses

p. 227

Hemostasis

managem

ent for

nurses

p. 227

Training villag

e - Lev

el 3


Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

sTraining villag

e - Lev

el 3

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Vascular closure

p. 175

Radial approach

p. 175

Wednesday 18th

CORDIS CARDIAC

& VASCULAR INSTITU

TE



EDWA

RDS LIFESCIEN

CES

MEDTRONIC A

CADEMIA

ST. JUDE M

EDICA

L

Bifurcation lesions

p. 176

Intracardiac echocardiography in TAVI

p. 176

Vascular closure

p. 175

AMI for nurses

p. 228

CTO

p. 177


p. 177


p. 177

MVD

p. 178

FFR for physicians

p. 178

STEMI

p. 176


p. 177


p. 177


p. 177

Bifurcation lesions

p. 177

MVD

p. 178

MVD for nurses

p. 228

AMI for nurses

p. 228

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for physicians

p. 178

FFR for physicians

p. 178

FFR for physicians

p. 178

FFR for physicians

p. 178


9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

TAVI

p. 183

Friday 20th

MEDTRONIC A

CADEMIA

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Radial approach

p. 179

FFR for nurses

p. 229

AMI

p. 180

CORDIS CARDIAC

& VASCULAR INSTITU

TE



EDWA

RDS LIFESCIEN

CES

MEDTRONIC A

CADEMIA

ST. JUDE M

EDICA

L

Vascular closure

p. 179

Intracardiac echocardiography

in TAVI

p. 179

Radial approach

p. 180

CTO

p. 180

Bifurcation lesions

p. 181

AMI

p. 180


p. 181


p. 181


p. 181


p. 181

TAVI

p. 182

TAVI

p. 182

TAVI

p. 182

TAVI

p. 182

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

OCT for physicians

p. 182

OCT for physicians

p. 182

OCT for physicians

p. 182

OCT for physicians

p. 182

OCT for physicians

p. 182

Training villag

e - Lev

el 3

Thursday 19th

Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

s


scientific programme

Coronary and structural heart

disease programme

PART I

11T0768_PCRpocket_03_coro 18/04/11 12:10 Page25

10:00-11:00 Main arena Innovation

Main session

Welcome and live demonstration from Frankfurt

Chairperson: W. Wijns

Panellists: A. Cremonesi, T. Lüscher, C. Rihal, C. Ruiz, P.W. Serruys,

R. Whitbourn

With continuous live demonstration from CardioVascular Center Frankfurt -

Germany

▸ Introduction - W. Wijns

▸ Renal denervation: a new treatment option in hypertension and beyond?

T. Lüscher

11:00-12:30 Main arena

Main session

PCR Family: Innovation in education at work


Panellists: E. Eeckhout, J. Ge, T.H. Koh, J. Marco, M.C. Morice, R. Ng,

P.W. Serruys, M. Thomas, A. Vahanian


European Society of Cardiology: a word from the President - M. Komajda

PCR courses

▸ EuroPCR - W. Wijns

▸ AsiaPCR/SingLive - T.H. Koh

▸ PCR London Valves - M. Thomas

PCR communications

▸ PCRonline - A. Vahanian

▸ PCR Publishing: impact factors in the digital era - P.W. Serruys

▸ Percutaneous interventional cardiovascular medicine. The PCR-EAPCI

textbook - E. Eeckhout

PCR educative solutions - J. Marco

PCR trials - P.W. Serruys

EAPCI: vision of the future - J. Fajadet, EAPCI President-Elect 2011-2013

and the EAPCI President-Elect 2013-2015

Tuesday 17th

26

Don’t forget to check the Training programme, page 170.


Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease

Coronary and structural heart disease


Symposium

The Great Debate - Left main in 2011: CABG or PCI?

With an unrestricted educational grant from MEDTRONIC

Chairperson: G. Wimmer-Greinecker

Panellists: A. Erglis, V. Falk, D. Hildick-Smith, M.C. Morice,

D. Taggart, L. Torracca

Objectives:

▸ To provide the audience with expert commentary on the efficacy and

safety of left main treatment options

▸ To provide physicians with the factual information they need to help

patients make informed decisions about their treatment options

▸ To comment on the data and evidence currently available and outline what

is being done to improve our understanding

13:30-15:00 Room 242B Clinic

Abstract session

Results of TAVI: evaluation by echocardiography

Session comprising selected EuroPCR 2011 abstract submissions

Chairpersons: H. Eltchaninoff, D. Messika-Zeitoun, O. Bodea

▸ Introduction - H. Eltchaninoff

▸ Early hemodynamic changes and myocardial injury after transfemoral TAVI

R. Dworakowski

▸ Left ventricular mass regression one year after TAVI - A. Tzikas

▸ Hemodynamic performance of transcatheter self-expandable aortic

bioprosthesis: immediate results and long-term echocardiographic

follow-up - C. Fraccaro

▸ Serial echocardiographic follow-up of the CoreValve bioprosthesis: 1-year

results of 400 patients from the Italian registry - M. De Carlo

▸ Intracardiac echocardiography: an ideal guiding tool for TAVI in an

extremely high-risk population - T. Bartel

▸ Intracardiac echocardiography is an accurate and safe technique for

guidance during TAVI - J. Kefer

▸ Take-home message - D. Messika-Zeitoun

27


13:30-15:00 Room 243 Technique

Forum

PCI in complex multivessel disease

Session comprising selected EuroPCR 2011 clinical case submissions

Chairpersons: P. MacCarthy, P. Ruygrok

▸ Introduction - P. MacCarthy

▸ Complete revascularisation in multivessel coronary artery disease in high

risk patient - W.J. Chung

▸ Transradial PCI for left main and multivessel coronary artery disease

W.J. Chung

▸ Double occlusion PCI: elective chronic occlusion and unexpected subacute

stent thrombosis - F. Hernandez

▸ A challenging case of successful complete revascularisation by antegrade

and retrograde PCI - H. Watanabe

▸ Angiography is not enough for decision making on revascularisation in

patients with borderline coronary lesions - J. Legutko

▸ Take-home message - P. Ruygrok

13:30-15:00 Room 251 Evidence

All you need to know about adjunctive pharmacology

during PCI

Chairpersons: M. Valgimigli, A. Baumbach

Objective:

▸ At the end of this 90-minute ‘All you need to know about...’ session the

audience should have an up to date knowledge of the field, relevant for

their clinical practice. They should be familiar with the current evidence

base, existing guidelines and have an understanding of the open questions

that need addressing in the near future

▸ Introduction and objectives - A. Baumbach

▸ Background - Anti-thrombotics in PCI: pathophysiological considerations

for the interventional cardiologist - D. Ardissino

▸ Clinical data - Conventional and new anti-thrombotics in PCI: practical

implications for optimal use in 2011? - D. Angiolillo

▸ Issues and clinical practice - Anti-thrombotic treatment dosing: how to

best use the available drugs - T. Cuisset

▸ Guidelines - F. Weidinger

▸ Unresolved issues - Risk scores and point-of care testing in 2011 - J. Mehilli

▸ Question & answer - M. Valgimigli

Tuesday 17th

28


Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease


13:30-15:00 Room 252AB Clinic

Forum

Challenging structural heart interventions

Session comprising selected EuroPCR 2011 clinical case & complication

submissions

Chairperson: P. Bonhoeffer

▸ Introduction - P. Bonhoeffer

▸ Isolated interventricular septal diverticulum presented as unstable angina

A case report - Y.C. Huang

▸ A pressing matter - idiopathic mediastinal fibrosis with severe

compression of the pulmonary arteries - M. Spence

▸ Rupture of the left-coronary sinus of valsalva aneurysm - another

syndrome mimicking acute STEMI - F. Cuculi

▸ Percutanous retrievement of Amplazer migrated in left pulmonary artery

after initial success of post-surgical ventricular septal defect - I. Sheiban

▸ Percutaneous rescue of left ventricular embolised amplatzer septal

occluder device - R. Parma

▸ Take-home message - P. Bonhoeffer

13:30-15:00 Room 341 Clinic

Abstract session

Primary PCI in STEMI patients: where is the challenge?


Chairpersons: V. Schächinger, M. Degertekin, S. Hardas

▸ Introduction - V. Schächinger

▸ Real picture of reperfusion map with coronary angioplasty in patients with

acute myocardial infarction in Spain - the RACIMO multicentre experience

A. Iniguez

▸ PCI and acute myocardial infarction: temporal changes in presentation,

management and in-hospital mortality - K. Jansen

▸ Analysis of subset of patients who undergo delayed primary PCI

P. Rubartelli

▸ Early hospital discharge at 48 hours following primary PCI for myocardial

infarction is both safe and feasible - E.C. Sammut

▸ Comparative analysis of DES vs. bare metal stents for the treatment of

STEMI - acute and mid-term outcomes - V. Esteves

▸ Take-home message - M. Degertekin

29


13:30-15:00 Room 351 Clinic

Abstract session

Be careful! Contrast induced nephropathy is a real issue in daily

practice - Part I


Chairpersons: C. Rihal, A. Bartorelli

▸ Introduction - C. Rihal

▸ Keynote lecture - R. Mehran

▸ Prevalence of renal insufficiency in Chinese patients who undergo

coronary angiography or PCI: an observational study - Y. Chen

▸ Variations in the risk of contrast induced nephropathy in patients

undergoing PCI - R. Jabara

▸ A randomised, double-blinded comparison of Iopromide and Iodixanol in

renally impaired patients undergoing cardia catheterisation (DIRECT

study) - Y. Chen

▸ Sodium bicarbonate plus N-acetylcysteine to prevent contrast induced

nephropathy in the setting of primary PCI (BIcarbonato e N-Acetil-cisteina

nell'infaRto mIocardico acutO, the BINARIO study, NCT01218178)

A.M. Leone

▸ The effect of renal dysfunction on periprocedural outcome in patients

undergoing elective PCI: an open-label multicentre registry - A. Ntalianis

▸ Take-home message - A. Bartorelli

13:30-15:00 Room 352AB

Symposium

Drug-eluting balloons: current practice and future perspectives

With an unrestricted educational grant from EUROCOR

Chairpersons: A. Serra, S. Silber

Objectives:

▸ To understand the drug-eluting balloon family of products: Dior and Freeway

▸ To present the recent data in clinical research obtained with the second

generation coating of drug-eluting balloon

▸ To understand the clinical data and benefits of this drug-eluting balloon in

further indications

Tuesday 17th

30



Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Current role and indications for drug-eluting balloons - S. Silber

▸ The VALENTINES trial; highlighting the creation of the biggest database on

treatment of in-stent restenosis so far - P. Stella

▸ Practical input and Spanish registry: global and subgroup results (in-stent

restenosis, small vessels) - A. Serra

▸ Acute myocardial infarction in India - P. Chandra

▸ Diabetic disease, progress in the Argentinean experience - A. Rodriguez

▸ Periphery, a glimpse on first experiences, comment on Columbian results,

announcement of activation and first results of randomised studies

K.L. Schulte

▸ Discussion

▸ Take-home message - H. Tan


Abstract session

Novel imaging techniques for assessment of PCI


Chairpersons: M. Gilard, M. Kimura

▸ Introduction - M. Gilard

▸ Mechanisms of non-fatal stent related myocardial infarction late following

coronary stenting with DES and bare metal stents: insights from optical

coherence tomography - P. Davlouros

▸ Comparison of neointimal coverage between zotarolimus-eluting stent and

everolimus-eluting stent using optical coherence tomography - Y.S. Jang

▸ Early detection of stent tissue coverage and apposition after primary

angioplasty: an optical coherence tomographic study of chromium

cobaltum and first generation DES - F. Prati

▸ Usefulness of a trans-stent fractional flow reserve gradient for assessing

the results of DES implantation - S.J. Tahk

▸ A six-month analysis of quantitative echogenicity of the second generation

everolimus-eluting bioresorbable vascular scaffold in relationship with

baseline greyscale intravascular ultrasound morphology of the scaffolded

plaque - S. Brugaletta

▸ Quantitative multi-modality imaging analysis of a fully bioresorbable

scaffold: a head-to-head comparison between quantitative coronary

angiography, intravascular ultrasound and optical coherence tomography

J.L. Gutiérrez-Chico

▸ Take-home message - M. Kimura

31



Main session

Live demonstration from Toulouse

Chairpersons: G. Wimmer-Greinecker, M.J. Kern

Panellists: A. Erglis, V. Falk, D. Hildick-Smith, M.C. Morice, D. Taggart,

L. Torracca

With continuous live demonstration from Clinique Pasteur, Toulouse -

France

14:00-17:00 Theatre Bordeaux Clinic

Plenary session

Percutaneous revascularisation of coronary chronic total

occlusion: a largely disregarded alternative to surgery

Chairpersons: N. Reifart, O. Katoh

Panellists : N. Boudou, G. Cassel, J. Escaned, A. Gershlick,

F. Hellig, T. Lefèvre, Y. Louvard, J. McKibbin, E. Tsuchikane, P.T. Tsui,

G. Werner

Objectives:

▸ To review evidence on the clinical benefit of coronary chronic total

occlusion recanalisation

▸ To identify good candidates for coronary chronic total occlusion recanalisation

▸ To understand the various procedural techniques and their outcomes

▸ Introduction and objectives - N. Reifart

▸ Essentials of ante and retrograde techniques - O. Katoh

14:15-15:00 Live demonstration from Ferrarotto Hospital, Catania - Italy

▸ Keynote lecture - Reflect together on how to balance benefit and risk when

considering opening a coronary chronic total occlusion - G. Werner

▸ How should I treat – Under the auspices of French Group of Interventional

Cardiology and South African Society of Cardiovascular Intervention

- Case presentation - N. Boudou

- How would I treat? - Y. Louvard

- How would I treat? - F. Hellig

- How did I treat? - N. Boudou

- Discussion and consensus

▸ Complication case - A tale of “three ventricles” - S. Fairley

▸ Complication case - Double distal coronary perforation - S. Mansour

16:10-16:50 Live demonstration from Ferrarotto Hospital, Catania - Italy

▸ Final key remarks - O. Katoh

Tuesday 17th

32


Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease



Forum

Stent malapposition


Chairpersons: G. Guagliumi, T. Johnson

▸ Introduction - G. Guagliumi

▸ The late stent malapposition develops also after paclitaxel-balloon

predilatation before bare metal stent implantation - T. Kovarnik

▸ Vulnerability of late-acquired stent malapposition after Sirorimus-eluting

stent implantation detected by serial coronary angioscopy - N. Takaharu

▸ A case of peri-stent contrast staining after sirolimus-eluting stent

implantation - T. Satoh

▸ Take-home message - T. Johnson

14:00-15:30 Room 342AB

Symposium

The role of the interventional cardiologist from the coronary to the renal

arteries


Chairperson: C. Lotan

Objectives:

▸ To share the body of scientific evidence for Resolute and the role of

Resolute Integrity in daily clinical practice

▸ To present Medtronic's cardiovascular pipeline in particular focusing on

the drug filled stent concept, drug-eluting balloon concept and the

radiofrequency ablation concept in resistant arterial hypertension

▸ Introduction and objectives - C. Lotan

▸ One additional step forward in clinical evidence: Resolute - S. Windecker

▸ Discussion

▸ DES in complex patients: Resolute Integrity - Two case presentations

- Case 1 - F. Burzotta

- Case 2 - C. Von Birgelen

▸ Discussion

▸ Drug-eluting balloons: value in interventional cardiology - G.M. Sangiorgi

▸ Drug-filled stent: a glimpse into the future - J. Wilcox

▸ Radiofrequency ablation in resistant arterial hypertension: the role of the

interventional cardiologist - R. Whitbourn

▸ Discussion

▸ Take-home message - C. Lotan

33


14:30-17:00 Theatre Havane Technique

LTT - How to select material and equipment for PCI

Facilitators: E. Barbato, F. Mauri, J. Marco

Panellists: M. Awata, F. D'Ascenzi, P. Davlouros, L.W. Tam

Media driver: L.A. Malek

Live in-a-box®

15:00-17:00 Main arena Evidence

Hot Line session

Late breaking trials

Chairpersons: P.W. Serruys, T. Lüscher

Panellists: P. Agostoni, R. Byrne, M.J. Kern, L. Mauri, G. Montalescot

▸ Randomised comparison of manual compression and use of Femoseal

vascular closure device for closure after femoral artery access coronary

angiography. The closure devices used in everyday practice (CLOSE-UP

study) - N.R. Holm

▸ Discussion - P. Agostoni

▸ Panel discussion

▸ High residual platelet reactivity after clopidogrel loading and long-term

thrombotic events in patients with acute coronary syndrome undergoing

invasive treatment: the RECLOSE 2-ACS trial - D. Antoniucci

▸ Discussion - G. Montalescot


▸ A prospective, randomised and multicentre trial comparing Titan-2 BAS

and Xience-V stent: the BASE-ACS trial - P. Karjalainen

▸ XAMI: randomised multicentre trial comparing first generation Sirolimus

with second generation Everolimus DES in acute myocardial infarction

S.H. Hofma

▸ Discussion - L. Mauri


▸ The first randomised trial comparing the reservoir-based polymer-free

CRE8 DES to Taxus Liberté: the NEXT study - D. Carrié

▸ NOYA I: a prospective randomised trial of NOYA Sirolimus-eluting stent

with biodegradable coating compared to Firebird 2 Sirolimus-eluting stent

with durable coating in patients with coronary artery disease - 9-month

angiographic and 12-month clinical results - R. Gao

▸ Discussion - P.W. Serruys


Tuesday 17th

34



Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ The ECO-PLEASANT trial: comparison of efficacy between two different

paclitaxel-eluting stents: Coroflex Please and Taxus Liberté stent in Korea

H.S. Kim

▸ Discussion - R. Byrne


▸ A randomised, double-blinded comparison of Iopromide and Iodixanol in

renal impaired patients undergoing cardiac catheterisation (DIRECT

study) - Y. Chen

▸ Discussion - M.J. Kern


15:00-18:00 Theatre Bleu

Tech News & Trends (TNT) session

Left main and multivessel disease

With an unrestricted educational grant from TERUMO

Chairpersons: A. Baumbach, J. Fajadet

Panellists: I.C. Hsieh, M.A. Rosli

Objectives:

▸ To understand how to build the decision making process in order to

propose the best treatment option for one individual patient

▸ To provide a better understanding on the best strategy and technique in

patients with left main and/or complex multivessel disease undergoing PCI

▸ To share knowledge on the Nobori DES results in patients with left main

and/or multivessel disease

▸ Introduction and objectives - A. Baumbach

15:05-15:50 Live demonstration from Clinique Pasteur, Toulouse - France

▸ Proper patient selection: surgeon's view - A.P. Kappetein

▸ Proper patient selection: interventionalist's view - A. Protopopov


▸ Clinical outcomes of Nobori DES in left main and multivessel disease

J. Mehilli

▸ Myocardial revascularisation in Bangladesh - F. Malik


▸ Take-home message - A. Baumbach

35


15:00-16:30 Room 242A Technique

Abstract session

Valve in valve: TAVI for treatment of degenerative bioprosthesis


Chairpersons: J. Webb, L. Torracca, R. Moreno

▸ Introduction - J. Webb

▸ Transcatheter valve-in-valve implantation using CoreValve Revalving

System in high risk patients with failed aortic bioprosthesis: a multi-

centre experience - M.L. Laudisa

▸ Valve-in-valve procedure with the Edwards transcatheter heart valve to treat

bioprosthetic valve degeneration in high-risk surgical patients - A. Ielasi

▸ Transaortic transcatheter aortic valve implantation within a previous

bioprostic aortic valve replacement - J. Cockburn

▸ Impact of 20mm transcatheter aortic valves on valve-in-valve

hemodynamics for small degenerated bioprostheses - E. Tseng

▸ Impact of patient prosthesis mismatch after transcatheter aortic valve-in-

valve implantation in degenerated bioprostheses - M. Seiffert

▸ Impact of transcatheter aortic valve orientation on valve-in-valve

hemodynamics - E. Tseng

▸ Take-home message - L. Torracca

15:00-16:30 Room 242B Technique

Abstract session

DES in special lesions and patient subsets


Chairpersons: H.M. Mardikar, M. Lesiak, N. Melikian

▸ Introduction - H.M. Mardikar

▸ Effect of PCI with Paclitaxel-eluting stent in hemodialysis patients:

comparison with Sirolimus-eluting stent - H. Takimura

▸ Clinical outcomes after PCI with DES in patients with chronic kidney

disease - H. Takimura

▸ Small coronary vessels stenting in the DES era: very long-term (>3 years)

clinical outcomes - I. Sheiban

▸ DES improve long-term outcomes compared to bare metal stents (BMS)

for the treatment of isolated proximal left anterior descending (LAD)

coronary artery - O. Guttmann

▸ Clinical benefit from drug-eluting vs. bare metal stents after rotational

atherectomy for the treatment of calcified coronary lesions: results from a

single-centre registry - F. Mangiacapra

▸ Comparison of Everolimus- vs. first generation DES in left main coronary

artery lesions: the HSR-EMO experience - A. Ielasi

▸ Take-home message - M. Lesiak

Tuesday 17th

36


Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease



Forum

Coronary and aortic dissection during PCI

Session comprising selected EuroPCR 2011 complication submissions

Chairpersons: F. Eberli, F. Tomai

▸ Introduction - F. Eberli

▸ Iatrogenic aorto-coronary dissection: oops! - S. Bagga

▸ Left main dissection during coronary angiography for unstable angina in a

38 year-old female - D. Alexopoulos

▸ Aortic and coronary dissection during elective PCI - G.B. Danzi

▸ Aortic dissection during coronary chronic total occlusion case

A. Ghofraniha

▸ Successful recovery from large iatrogenic aortic dissection by stenting to

left main trunk entry site - H. Matsuo

▸ Take-home message - F. Tomai


Forum

Complications encountered during left main interventions - Part I


Chairpersons: T. Mabin, M. Sousa Uva

▸ Introduction - T. Mabin

▸ Treatment of left main coronary artery dissection with culotte technique as

a complication of percutaneous intervention - O. Celik

▸ A not so noble complication - P. Scott

▸ Migration: not just for the birds! - S. Mansour

▸ Left main stem PCI: now you see it, now you don't - M. Williams

▸ Stent lost: an interventional cardiologist nightmare - R.A. Parisi

▸ Take-home message - M. Sousa Uva

37



Forum

Unusual PCI complications - Part I


Chairpersons: E. Eeckhout, G. Heyndrickx

▸ Introduction - E. Eeckhout

▸ An accumulation of complications - K. Onsea

▸ A case of PCI procedure successfully bailed out from multiple

complications - Y. Kawamura

▸ Challenging complication of routine PCI - A. Qasim

▸ Retrieving the trapped buddy - E. Wong

▸ Inadvertent removal of fully deployed stent during retrieval of another

dislodged stent in the right coronary artery with goose-neck snare

M. Celik

▸ Take-home message - G. Heyndrickx

15:00-16:30 Room 341 Clinic

Abstract session

Biomarkers in stable and unstable coronary syndromes


Chairpersons: I. Meredith, P. Cervinka

▸ Introduction - I. Meredith

▸ The role of micro RNAs involved in the psychological stress-induced

cardiac disorders in rats - Y. Wang

▸ ADAMTS13 antigen levels are associated with increasing atherosclerotic

burden in patients with stable coronary artery disease - A.J. Peace

▸ Early and long-term changes in serum concentration of high-sensitive

C-reactive protein and fibrinogen after implantation of sirolimus-eluting

coronary stents - S. Provatorov

▸ Preprocedural elevated white cell count and eosinophilia predict outcome

in primary PCI - K.S. Rathod

▸ Soluble Fms-like Tyrosine Kinase-1 (sFLT1) and its role in post-PCI

myocardial infarction (Type 4a MI) - M. Möckel

▸ Low hdl cholesterol levels are an independent predictor of coronary artery

disease in patients with aortic aneurysms - S. Aso

▸ Take-home message - P. Cervinka

Tuesday 17th

38



Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease


15:00-16:30 Room 351 Clinic

Abstract session

Be careful! Contrast induced nephropathy is a real issue in daily

practice - Part II


Chairpersons: E. Esplugas, Y. Chen

▸ Introduction - E. Esplugas

▸ Invasive renal hemodynamics after left ventricular and coronary

angiography with randomised use of different contrast media - M. Möckel

▸ Hypersensitive c-reactive protein and the risk of contrast induced acute

kidney injury in patients undergoing PCI - F. Gao

▸ Serum NGAL identifies contrast nephropathy early in patients with

diabetes mellitus and chronic kidney disease undergoing coronary

angiography and angioplasty - A. Qureshi

▸ Possible association between admission hyperglycemia and contrast

medium induced nephropathy in patients undergoing primary PCI

S. Fukuzawa

▸ Preliminary results from a randomised trial on the role of Glucose-Insulin-

Potassium and N-Acetyl-Cysteine for prevention of contrast induced

nephropathy in high-risk patients undergoing PCI - A. Nusca

▸ A comparison between serum creatinine and cystatin-C for the early

diagnosis of contrast induced nephropathy after coronary angiography

and interventions - F. Ribichini

▸ Take-home message - R. Mehran

39



Plenary session

Stent for Life @ EuroPCR 2011 - How do we optimise

the delivery and quality of primary PCI?

Chairpersons: S.D. Kristensen, P. Widimsky

Panellists: D. Deleanu, O. Goktekin, J. Jorgova, C. Vrints

Objectives:

▸ To understand the causes of treatment delay and how to reduce it

▸ To review options for optimal medical therapy during patient transportation

▸ To identify the conditions for a successful STEMI network

▸ Introduction and objectives - S.D. Kristensen

▸ Reduction in patient and system delay is the key to improvement - M. Sabate

▸ Discussion

▸ Can we optimise diagnosis and therapy during transport to primary PCI?

A. Van't Hof

▸ Discussion

▸ Major challenges in setting up STEMI centres - G. Guagliumi

▸ Discussion

▸ A remarquable case story - M. Ostojic

▸ Discussion

▸ Stent for Life: what have we achieved and what is the future? - S.D. Kristensen

▸ Take-home message - P. Widimsky

15:00-16:30 Room 353 Clinic

Abstract session

PFO: clinical experience and new devices


Chairpersons: P. Bonhoeffer, G. Manoharan

▸ Introduction - P. Bonhoeffer

▸ Percutaneous closure of patent foramen ovale: experience from Sydney,

Australia - K. Liou

▸ Percutaneous transcatheter closure of interatrial septal defect in adults:

procedural outcome and long-term results - J. Kefer

▸ Amplatzer patent foramen ovale occluder vs. bioabsorbable device biostar

for patent foramen ovale closure. safety and efficacy at 12-month follow

up - A. Giardina

▸ Application of Cardio-O - fix occluders for transcatheter percutaneous

closure of undesirables shunts - preliminary experience - M. Knop

▸ Take-home message - G. Manoharan

STENT

FOR LIFE

Tuesday 17th

40


Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease


15:30-17:00 Room 241

How should I treat?

PCI for acute coronary syndrome: from trial data on triple

antiplatelet therapy into clinical practice

With an unrestricted educational grant from IROKO CARDIO

Chairperson: C. Hamm

Objectives:

▸ To understand the importance of accurate risk stratification and

assessment of bleeding risk

▸ To learn how to tailor antiplatelet therapy to improve patient outcomes,

balancing major adverse cardiac events reduction and safety

▸ To understand options for combining antiplatelet therapies with

complementary modes of action to optimise platelet inhibition

▸ Introduction and objectives - C. Hamm

▸ A NSTEMI diabetic patient: the challenge continues

- Case presentation - L. Holmvang

- How would I treat? - M. Valgimigli

- How would I treat? - M. Noc

- How did I treat? - L. Holmvang

- Discussion

- Consensus - C. Hamm

▸ A young STEMI patient: high-risk requires higher protection

- Case presentation - J.P. Collet

- How would I treat? - M. Valgimigli

- How would I treat? - M. Noc

- How did I treat? - J.P. Collet

- Discussion

- Consensus - C. Hamm

▸ Take-home message - C. Hamm

STENT

FOR LIFE

41



Plenary session

SOLACI@EuroPCR - How to deal with complex interventions:

the Latin American vision

Chairpersons: D. Echeverri, C. Ruiz

Objectives:

▸ To provide practical recommendations for selection of patients candidate

for complex PCI

▸ To review tips & tricks for complex interventions and prevention of

complications

▸ Introduction - D. Echeverri

▸ PCI in multivessel disease - Strategies to identify risk - A. Abizaid

▸ My worst complication - PCI in multivessel disease case presentation

J. Gaspar

▸ TAVI - Latino American experience - J. Belardi

▸ My worst complication - TAVI case presentation - O. Mendiz

▸ Complex congenital interventions - Technical concepts that should be kept

in mind - C. Zabal

▸ Discussion - C. Ruiz

16:30-18:02 Room 242A

How should I treat?

Challenging coronary artery intervention

Under the auspices of the Iranian Society of Interventional Cardiology

and the Turkish Working Group of Interventional Cardiology

Chairpersons: M. Hashemian, M. Degertekin

Objective:

▸ To learn how to prevent and treat one of the undesired complications of

the rapid-growing TAVI technique

▸ Welcome - W. Wijns

▸ Introduction and objectives - M. Hashemian

▸ Total occlusion of left main coronary artery during TAVI

- Case presentation - S. Abdi

- How would I treat? - M. Maadani

- How would I treat? - E. Atalar

- How did I treat? - S. Abdi

- Discussion

- Consensus - M. Hashemian

Tuesday 17th

42



Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Treatment of left main coronary artery disease in patients with acute

coronary syndrome

- Case presentation - E. Ilkay

- How would I treat? - E. Atalar

- How would I treat? - M. Maadani

- How did I treat? - E. Ilkay

- Discussion

- Consensus - M. Degertekin

▸ Take-home message - M. Degertekin

16:30-18:00 Room 242B Innovation

Abstract session

Innovations in catheter and stent design


Chairpersons: R. Kornowski, F. Schiele, G. Van Langenhove

▸ Introduction - R. Kornowski

▸ Comparison of novel slender 6.5 french ('Virtual 4 French') sheathless

guiding catheter vs. 5 french guiding catheter for transradial coronary

intervention

▸ Stent boost performed only with a guide wire with double distal marker as

surrogate of conventional stent boost for procedural cost saving

C. G. Landaluce

▸ Plaque sealing and passivation with a mechanical self-expanding low

outward force nitinol VShield device for the treatment of intravascular

ultrasound and optical coherence tomography-derived thin cap

fibroatheromas (TCFAS) in native coronary arteries - J. Wykrzykowska

▸ Preliminary experience with Acrobat Svelte stent-on-a-wire system in

complex coronary interventions - A. Rezq

▸ Treatment of coronary artery aneurysm with a novel covered stent

S. Tondi

▸ Efficacy of 4F inner catheter as a distal stent delivery device - T. Ashikaga

▸ Take-home message - F. Schiele

43



Forum

Complications encountered during left main interventions - Part II


Chairpersons: J.L. Pomar, T. Santoso

▸ Introduction - J.L. Pomar

▸ Emergency stenting of unprotected left main coronary artery after acute

catheter induced occlusive dissection - D. Melehi

▸ Left main dissection - W. Kadro

▸ Catheter-induced left main dissection requiring complex trifurcation PCI

F. De Vroey

▸ A left main nightmare - R. Leung

▸ Left main trunk perforation sealed with 90-second perfusion balloon

inflation - A. Endo

▸ Take-home message - T. Santoso

16:30-18:00 Room 252AB Technique

Forum

Stent thrombosis


submissions

Chairpersons: T. Cuisset, A.M. Kayani

▸ Introduction - T. Cuisset

▸ Stent thrombosis due to a combination of reasons: modern issues added

to old knowledge - G. Tsigkas

▸ BK stent thrombosis - R. Chawla

▸ Rheolytic thrombectomy of the left main and left anterior descending

coronary arteries - V. Zeienin

▸ Delayed stent thrombosis of covered stent - S. Munwar

▸ A case of very late stent thrombosis caused by stent malapposition and

stent fracture following Sirolimus-eluting stent implantation - A. Miyoshi

▸ Take-home message - A.M. Kayani

16:30-18:00 Room 253 Clinic

Abstract session

Biomarkers should be routinely measured after PCI


Chairpersons: P. Vranckx, M. Sousa Uva

Tuesday 17th

44


Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction - M. Sousa Uva

▸ Periprocedural myocardial infarction following stent implantation:

comparison between first and second generation DES - K. Tandjung

▸ Insights on the mechanisms of periprocedural myocardial infarction after

PCI - X. Muschaert

▸ Six-month follow-up of the prevention of cardiac and vascular

periprocedural complications in patients undergoing coronary

angiography or angioplasty: intracoronary Adenosine administration to

prevent periprocedural myonecrosis in elective coronary angioplasty - A

prospective double-blind randomised trial (PREVENT-ICARUS trial)

G.G. Secco

▸ Routine vs. ad hoc measurement of serum creatine Kinase after PCI:

a long-term prognostic comparison - R. Lim

▸ Closing lecture and take-home message - P. Vranckx

16:30-18:00 Room 341 Clinic

Abstract session

Predictors of clinical outcome after TAVI


Chairpersons: M. Thomas, P. Kala

▸ Introduction - M. Thomas

▸ Gender differences in patients undergoing TAVI with the Medtronic

CoreValve system - Y. Elhmidi

▸ Incidence, predictors and prognostic value of major hemorrhagic

complications following TAVI procedure - N. Amabile

▸ The impact of peripheral arterial disease on outcome after TAVI: results

from the German TAVI registry - J.M. Sinning

▸ The impact of preprocedural renal function on outcome after TAVI

J.M. Sinning

▸ Stroke within 30 days predicts all-cause mortality after percutaneous

aortic valve implantation: long-term results from the corevalve 18F safety

and efficacy study - C.K. Naber

▸ The influence of a systemic inflammatory response syndrome on

prognosis after TAVI - J.M. Sinning

▸ Take-home message - P. Kala

45


16:30-18:00 Room 351 Clinic

Forum

TAVI cases - Part I


submissions

Chairpersons: R. Lange, N. Piazza

▸ Introduction - R. Lange

▸ TAVI via femoral and transapical routes in one single patient - J. Brito

▸ Corevalve dislodgment while retrieving the delivery catheter - N. Van Mieghem

▸ An unusual scenario - M. Abdel-Wahab

▸ Severe valvular aortic regurgitation late after Edwards Sapien TAVI

J. Newton

▸ Combined transcatheter aortic and mitral valve-in-valve implantation in a

patient with degenerated bioprostheses and high surgical risk - M. Seiffert

▸ Take-home message - N. Piazza

16:30-18:00 Room 353 Clinic

Abstract session

Quality of life and neurocognitive function after TAVI


Chairpersons: M. Gilard, G. Manoharan, H. Rickli

▸ Introduction - M. Gilard

▸ Neurocognitive function after transfemoral aortic valve implantation - a

diffusion-weighted magnetic resonance imaging study - A. Ghanem

▸ Quality of life in patients undergoing percutaneous aortic valve

implantation - S. Stortecky

▸ Health-related quality of life shows sustained improvement with

transcatheter aortic valve - R. Bonan

▸ Durability of quality of life improvement in elderly patients after TAVI

M. Barbanti

▸ Percutaneous aortic valve implantation improves quality of life in a

geriatric patient population - R. Bekeredjian

▸ TAVI improves quality of life in high surgical risk patients with severe

symptomatic aortic stenosis - S. Salizzoni

▸ Take-home message - G. Manoharan

Tuesday 17th

46



Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease



Main session

EAPCI General AssemblyChairperson: C. Di Mario - EAPCI President 2009-2011

▸ Welcome - C. Di Mario

▸ EAPCI: the second biggest association within the ESC - V. Schaechinger

▸ EAPCI Board election results - W. Wijns

▸ Stent for Life: promoting primary angioplasty in Europe - S.D. Kristensen

▸ Practical examples of online certification platform - L. Gonçalves

▸ Cardiovascular Interventions in Europe 2009/2010 - S. Cook

▸ Interventional sessions during ESC Congress 2011 - D. Dudek

▸ EAPCI 2010-2011 Budget Update - K. Niemela

▸ ESC Transcatheter Valve Registry - C. Di Mario

▸ Questions & answers

17:00-18:30 Theatre Bordeaux

Symposium

PCI safety: a resolved issue or a never-ending target for theinterventional cardiologist?With an unrestricted educational grant from ABBOTT VASCULAR andCROSSROADS, the Abbott Vascular Education NetworkChairperson: A. Bartorelli

Objectives:▸ To understand the importance of DES safety and the impact of it for other

medical specialities

▸ To understand the different parameters which have an impact on DESsafety

▸ To discuss how patient's safety could be increased

▸ Introduction and objectives - A. Bartorelli

▸ Are DES a nightmare for the non-cardiac surgeons? - A. D'Hoore, F. Rocco

▸ From bare metal stent to DES: safety remains important - M. Valgimigli

▸ Bioresorbable vascular scaffold: the impact of resorption on safetyA. Abizaid

▸ Improving safety in the cathlab and beyond - C. Dubois

▸ Discussion

▸ Take-home message - A. Bartorelli

47


17:00-18:30 Theatre Havane

Symposium

Antiplatelet therapy in acute coronary syndromes: managing patientsacross the spectrum of riskWith an unrestricted educational grant from ASTRAZENECAChairpersons: C. Hamm, P.G. Steg

Objectives:▸ To recognise the growing evidence base for newer treatment options for

patients with acute coronary syndromes

▸ To understand the range of patient risk profiles presenting with acutecoronary syndromes and contemporary best practice for treatment

▸ To consider the importance of improving long-term outcomes for patientswith acute coronary syndromes

▸ Introduction and objectives - C. Hamm

▸ Long-term outcomes following acute coronary syndromes - M. Claeys

▸ Antiplatelet therapy for PCI: balancing the risks and benefits - S. Rao

▸ Antiplatelet strategies in acute coronary syndromes: 'ready to wear' or'bespoke therapy' - P.G. Steg

▸ Moderated cases: considering the options in the variety of patients withacute coronary syndromes - S. James

▸ Take-home message - P.G. Steg

17:00-18:30 Room 241

How should I treat?

Radial versus femoral in complex proceduresWith an unrestricted educational grant from CORDIS CARDIAC & VASCULAR INSTITUTEChairperson: M. Sabate

Objectives:▸ To understand the impact of bleeding complications due to dual

antiplatelet therapy or antithrombotic drugs and how to reduce these bychoosing the right vessel access

▸ To be able to discuss the available evidence associated with the percutaneoustreatment of complex coronary artery disease

▸ To recognise which patient should be referred to femoral or radial approach

▸ Introduction and objectives - M. Sabate

▸ Radial or femoral approach in a STEMI case

- Case presentation - D. Fraser

- How would I treat? - F.J. Neumann

- How would I treat? - O. Varenne

- How did I treat? - D. Fraser

- Discussion

- Consensus - M. Sabate

Tuesday 17th

48


Tue

sday 1

7th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Femoral or radial approach in a patient with aortic aneurysm

- Case presentation - E. Stabile

- How would I treat? - F.J. Neumann

- How would I treat? - O. Varenne

- How did I treat? - E. Stabile

- Discussion

- Consensus - M. Sabate

▸ Take-home message - M. Sabate

17:00-18:30 Room 342AB

Symposium

Fractional flow reserve to simplify: improving outcomes in multiple

patient subsets

With an unrestricted educational grant from ST. JUDE MEDICAL

Chairpersons: J. Escaned, S.J. Park

Objectives:

▸ To highlight the complementary value of intracoronary imaging and

physiology in the cathlab

▸ To review current evidence for improved clinical outcomes in fractional

flow reserve-guided interventions

▸ To discuss the use and value of fractional flow reserve in patients with

acute coronary syndromes

▸ Introduction and objectives - J. Escaned

▸ Fractional flow reserve and the vulnerable plaque: closer links than

commonly thought - B. De Bruyne

▸ Morphology and/or function: trials and tribulations of an IVUS-man

A. Pichard

▸ Clinical outcome after fractional flow reserve-guided decisions - N.H. Pijls

▸ What is the place of fractional flow reserve in acute coronary syndromes?

K.G. Oldroyd

▸ Discussion

▸ Take-home message - S.J. Park

49


08:00-12:00 Main arena Clinic

Main session

Revascularisation in patients with complex left main stenosisChairpersons: M.C. Morice, P. SergeantPanellists : A. Chieffo, M. de Belder, M. Lesiak, T. Majwal, D. Pagano, J.L. Pomar, K. Prathap, T. Santoso, V. Schächinger, M. Sobhy, P. Widimsky

Objectives:▸ To understand which patients with bifurcation left main disease with

or without other coronary lesions could be candidate for PCI

▸ To understand the best PCI techniques in order to achieve the best long-term outcomes

▸ Introduction and objectives - M.C. Morice

08:05-08:55 Live demonstration from Chest Hospital, Kuwait Heart Center,Safat - Kuwait

▸ Keynote lecture - Reflect together on the strategy for the best treatment ofa patient with complex left main stenosis - J.L. Pomar

09:10-10:00 Live demonstration from Institute of Cardiology, Warsaw - Poland

▸ How should I treat - Under the auspices of the InterventionalCardiology Working Group of the Czech Society of Cardiology and theGerman Working Group of Interventional Cardiology

- Introduction and objectives - V. Schächinger

- Case presentation - P. Widimsky

- How would I treat? - P. Kala

- How would I treat? - H. Mudra

- How did I treat? - P. Widimsky

- Discussion & consensus - V. Schächinger

10:50-11:45 Live demonstration from Chest Hospital, Kuwait HeartCenter, Safat - Kuwait

▸ Final key remarks - P. Sergeant

08:00-09:00 Theatre Bleu Clinic

Forum

TAVI complications - Part I

Chairpersons: S. Redwood, P. Nataf

▸ Introduction - S. Redwood

▸ Catastropic obstruction of a patent left internal mammary artery duringsubclavian CoreValve TAVI - C. Eftychiou

▸ Post-implantation repositioning of the CoreValve percutaneous aortic valvecomplicated by ischemic stroke - R. Parma

▸ Multiple TAVI for severe aortic regurgitation in true porcelain aorta - B. Reimers

▸ Take-home message - P. Nataf

Wednesday 18th

50


We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease



Plenary session

Secondary revascularisation - Part IRestenosis in DES: an unfrequent but complex diagnostic and therapeutic problemChairpersons: J. Escaned, L. ThuesenPanellists: F. Alfonso, R. Byrne, H.M. Garcia-Garcia, A. Kastrati, V. Legrand,R. Mehran, S.J. Park, B. Scheller, A. Seth, M. Sousa Uva, P. Stella, G. Van Langenhove, R. Virmani, D.O. Williams, A. Witkowski

Objectives:▸ To review updated evidence on the epidemiology, causes and prognosis of

restenosis in DES

▸ To highlight the importance of invasive and non-invasive diagnostic techniquesin assessing the mechanisms of DES restenosis and its functional impact

▸ To understand the modalities and technical aspects of DES restenosistreatment and how to optimise its results

▸ Introduction and objectives - Scope of the problem: epidemiology of in-stent restenosis in DES - J. Escaned

08:05-08:55 Live demonstration from Instituto Cardiovascular / HospitalClínico San Carlos, Madrid - Spain

▸ Keynote lecture - Reflect together on how to optimise outcomes inpatients with restenosis in DES - A. Kastrati

09:10-10:00 Live in-a-box® from Instituto Cardiovascular / HospitalClínico San Carlos, Madrid - Spain

▸ How should I treat - Under the auspices of the Belgian Working Group onInterventional Cardiology

- Introduction and objectives - G. Van Langenhove

- Case presentation - T. Adriaenssens

- How would I treat? - C. Van Mieghem

- How would I treat? - A. Guedes

- How did I treat? - T. Adriaenssens

- Discussion & consensus - V. Legrand

10:50-11:45 Live demonstration from Instituto Cardiovascular / HospitalClínico San Carlos, Madrid - Spain

- Final key remarks - L. Thuesen

51



Forum

Complication forum

Chairpersons: E. Esplugas, M.J. Kern

Panellists: E. Barbato, N. Piazza, Y. Chen, J. Shivkumar

Objectives:▸ To learn how to anticipate and treat common complications during PCI

▸ To demonstrate exceptional complication cases

▸ To show novel techniques to treat these complications

▸ Introduction - E. Esplugas

▸ Case 1 - M. Postu

▸ Case 2 - J. Shannon

▸ Case 3 - E. Barbato

▸ Conclusion - M.J. Kern

08:00-09:00 Room 242A Clinic

Forum

Very young patients presenting with myocardial infarction


Chairpersons: P. Cervinka, N. Melikian

▸ Introduction - P. Cervinka

▸ PCI for Stanford type A aortic dissection leading to subtotal occlusion ofleft main - L. Major

▸ Acute coronary syndrome in a teenager, left main total occlusion, shockA. Magdy

▸ Spontaneous coronary artery dissection in a 32 year-old woman eightweeks after delivery - G. Plehn

▸ Take-home message - N. Melikian

Wednesday 18th

52



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


08:00-09:00 Room 243 Innovation

Abstract session

Microvascular function after PCISession comprising selected EuroPCR 2011 abstract submissionsChairpersons: P. Wenaweser, S. Cook

▸ Introduction - P. Wenaweser

▸ Cholesterol levels predict the presence of coronary microvasculardysfunction - F. Mangiacapra

▸ Angiographic patterns of myocardial reperfusion after primary angioplastyand ventricular remodelling - G. Niccoli

▸ Microcirculatory function early after primary PCI is predictive of the extentof non-viable myocardium and late left ventricular function - A. Ntalianis

▸ Head-to-head comparison of Sirolimus-eluting stent vs. bare metal stentevaluating the endothelial dysfunction in the same patient with multiplecoronary artery lesions - A.N. Mischie

▸ Take-home message - S. Cook


Forum

Unusual forms of left main diseaseSession comprising selected EuroPCR 2011 clinical case submissionsChairpersons: J. McKibbin, D. Capodanno

▸ Introduction - J. Mckibbin

▸ Left main coronary stenosis after Bentall intervention: percutaneoustreatment - C. Bernelli

▸ An unusual case of left main stenosis - D. Mylotte

▸ PCI for left main coronary chronic total occlusion - T. Bochenek

▸ Take-home message - D. Capodanno

08:00-09:00 Room 253 Clinic

Abstract session

Coronary perforation and spontaneous dissection: clinical outcomeSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: J. Goicolea, C.H.P. Ang, A. Garachemani

▸ Introduction - J. Goicolea

▸ Spontaneous coronary artery dissection: characteristics of a large patientcohort and long-term clinical follow-up - M. Paulo Guzman

▸ Contemporary prevalence and scenarios of coronary perforation duringPCI - J.G. Del Angel Soto

▸ Replacement of heparin with bivalirudin does not change outcomes aftercoronary perforation related to PCI - R. Romaguera

▸ The different healing process of edge dissections fater Sirolimus- andZotarolimus-eluting stent implantation observed by optical coherencetomography - Y. Takeda

▸ Take-home message - C.H.P. Ang 53



Abstract session

New stents: bench testing


Chairpersons: J. Ormiston, G. Harris

▸ Introduction - J. Ormiston

▸ Stent fracture in various DES - How does it occur? - Y. Kinoshita

▸ Conformability of the Nevo; Sirolimus-eluting coronary stent system incomparison with the Xience; Everolimus-eluting coronary stent system:results from a bench top study and an angiographic assessment from theNevo II clinical trial - J. Gomez-Lara

▸ Scanning electron microscopic observation of coating irregularities andtheir precursors in unexpanded durable polymer-based DESM.W.Z. Basalus

▸ A novel approach to investigate incomplete stent apposition using virtualbench testing - P. Mortier

▸ Take-home message - G. Harris


Abstract session

Arterial access: use of closure devices


Chairpersons: S. Garg, I. Horvath

▸ Introduction - S. Garg

▸ Vascular complications in patients undergoing transfemoral coronaryangiography with and without use of vascular closure devices - J. Auer

▸ Randomised comparison of manual compression and use of Femosealvascular closure device for closure after femoral artery access coronaryangiography. The CLOSure dEvices Used in everyday Practice (CLOSE-UP) study - N.R. Holm

▸ Large single operator experience with Perclose closure device with noinfection and excellent outcomes - G. Kang

▸ The effects of time, repeat access and vascular closure device use on thecommon femoral artery: initial results of the REPEAT study - Z. Turi

▸ Take-home message - I. Horvath

Wednesday 18th

54

Wednesday is the innovation dayVisit the Innovation Incubator Space

Level 3 near Theatre Bordeaux and PCRTV studio. See page 59.


We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


08:00-12:00 Room 352AB Innovation

Glimpse into the future

Glimpse into the future - Future treatment decision-making based on

intracoronary lesion assessment

Chairpersons: P.W. Serruys, B. Meier

Panellists: B. De Bruyne, J. Goldstein, G. Guagliumi, A.F.W. Van Der Steen

Objectives:

▸ To understand the role of angiography and pressure-derived fractional

flow reserve in lesion assessment and decision-making

▸ To understand the potential and limitations of novel intravascular

diagnostic techniques

▸ To learn how innovative diagnostic strategies may influence treatment

decisions in the future

▸ Introduction and objectives - P.W. Serruys

▸ Intravascular imaging is not necessary - An angiographer's view - B. Meier

▸ My treatment decision-making is based on fractional flow reserve

normalisation - B. De Bruyne

08:25-09:05 Live demonstration from Erasmus University Medical Center,

ThoraxCenter, Rotterdam - The Netherlands

▸ My decision-making is based on IVUS assessment - A. Colombo

▸ IVUS - New approaches that should be used in every cathlab - E. Regar

▸ My decision-making is based on optical coherence tomography

C. Di Mario

▸ My decision in stent failure is based on optical coherence tomography

G. Guagliumi



▸ Stent treatment length should rely on virtual histology assessment

D. Dudek

▸ Stent treatment length should rely on near infra-red spectroscopic

assessment - J. Goldstein

▸ Invasive imaging and tissue characterisation: it's physics, not magic

A.F.W. Van Der Steen



▸ Multislice computed tomography will provide quantitative luminography,

plaque characterisation and non-invasive fractional flow reserve: the

ultimate dream - P.W. Serruys

▸ Discussion

▸ Take-home message - P.W. Serruys

55


08:30-09:30 Room 241 Clinic

Forum

Neurological complications during PCI: it can happen any day


submissions

Chairpersons: C. Nienaber, C. Macaya

▸ Introduction - C. Nienaber

▸ Bubble trouble - A.A. Fassa

▸ Contrast agent neurotoxicity mimicking subarachnoid hemorrhage

M. Klemenc

▸ Aborted stroke during thrombectomy in right coronary artery - L. Henareh

▸ Neuro-salvage for acute basilar artery embolism during coronary

intervention - M.S. Lin

▸ Take-home message - C. Macaya


Forum

PCI in thrombotic coronary artery lesions


Chairpersons: F. Weidinger, W. Wang

▸ Introduction - F. Weidinger

▸ Optical coherence tomography guided PCI in very late DES thrombosis

T. Adriaenssens

▸ Multimodality intracoronary imaging optimises primary PCI strategy in

stent thrombosis - P.S.C. Rees

▸ Acute myocardial infarction as first presentation of acute myeloblastic

leukaemia in a young woman - R. Goncalves

▸ What is the best strategy in coronary ectasia and acute myocardial

infarction with massive intracoronary thrombus? - Y. Noji

▸ How should I treat totally occluded ectatic right coronary artery containing

huge thrombus? - A. Rahman

▸ Take-home message - W. Wang

Wednesday 18th

56



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


08:30-10:30 Room 342AB

How should I treat?

Real life bifurcation: challenges and complications

Under the auspices of the Working Group on Interventional Cardiology of

the Estonian Society of Cardiology and the Working Group on

Interventional Cardiology of Latvian Society of Cardiology and the

Russian Society of Interventional Cardioangiology

Chairpersons: A. Erglis, J. Eha, D. Iosseliani

Objectives:

▸ To learn how to treat real life bifurcation lesions to avoid complications

▸ To teach how to manage complications in bifurcation PCI

▸ To understand the application of evidence from clinical randomised trial to

real life practice

▸ Introduction and objectives - D. Iosseliani

▸ Complications in real life bifurcation PCI - Perfect is the enemy of good

- Case presentation - I. Narbute

- How would I treat? - I. Kumsars

- How would I treat? - O. Sukhorukov

- How did I treat? - I. Narbute

- Discussion

- Consensus - A. Erglis

▸ Challenges in real life bifurcation PCI

- Case presentation - O. Sukhorukov

- How would I treat? - D. Asadov

- How would I treat? - I. Kumsars

- How did I treat? - O. Sukhorukov

- Discussion

- Consensus - D. Iosseliani

▸ Keep it simple in left main disease

- Case presentation - M. Elmet

- How would I treat? - T. Hermlin

- How would I treat? - I. Narbute

- How did I treat? - M. Elmet

- Discussion

- Consensus - J. Eha

▸ Take-home message - A. Erglis

57


08:30-10:30 Room 351

How should I treat?

Primary PCI for acute myocardial infarction in patients

with multivessel coronary disease

Under the auspices of the Working Group on PCI of the

Danish Society of Cardiology, the Working Group on PCI of

the Norwegian Society of Cardiology and the Working

Group on PCI of the Swedish Society of Cardiology

Chairpersons: S. Rotevatn, J. Carlsson, E. Joergensen

Objectives:▸ To learn the spectrum of patients with multivessel coronary disease

presenting with acute myocardial infarction

▸ To review the guidelines and confront with clinical challenges

▸ To understand how to treat patients with acute myocardial infarction andmultivessel coronary disease

▸ Introduction and objectives - S. Rotevatn

▸ PCI in a patient with acute myocardial infarction and severe multivesseldisease

- Case presentation - T. Ramunddal

- How would I treat? - U. Jensen

- How would I treat? - V. Tuseth

- How did I treat? - T. Ramunddal

- Discussion

- Consensus - J. Carlsson

▸ Acute myocardial infarction in a patient with multivessel coronary disease

- Case presentation - E.J.S. Packer

- How would I treat? - V. Tuseth

- How would I treat? - J.S. Jensen

- How did I treat? - E.J.S. Packer

- Discussion

- Consensus - S. Rotevatn

▸ Severe three-vessel disease in an 85-year-old man with inferior STEMI

- Case presentation - M. Maeng

- How would I treat? - J.S. Jensen

- How would I treat? - U. Jensen

- How did I treat? - M. Maeng

- Discussion

- Consensus - E. Joergensen

▸ Take-home message - J. Carlsson

STENT

FOR LIFE

Wednesday 18th

58




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


09:00-17:00 Near Theatre Bordeaux and TV studio

Innovation

Innovation Incubator Space

On your way to or from a session, visit the Innovation Incubator Space and

learn about the latest technology from innovative companies. Grab a bite

from the buffet and talk with the representatives at each table. This space is

open to everyone, all day long.

▸ Cardiatis - Multilayer flow modulator for global aneurysm repair

▸ Avinger - Optical coherence tomography for peripheral intervention

▸ Avidal Vascular - Wombat drug reservoir technology

▸ Envision Scientific - Focusnp: sirolimus based nano carrier eluting-

coronary stent system

▸ Svelte Medical Systems - Novel DES: an amino acid based drug carrier

▸ Abbott Vascular - ABSORB bioresorbable vascular scaffold for peripheral

use

▸ ReCor Medical - Therapeutic ultrasound for the treatment of mitral

regurgitation

▸ Meril Life Sciences - Novel nanotechnology based Mitsu: merilimus

eluting coronary stent system

▸ Concept Medical - Magictouch: a sirolimus based nano carrier eluting

balloon catheter for treatment of coronary artery disease

▸ Valtech - Cardioband: transfemoral, surgical like, adjustable mitral

annuloplasty

09:00-11:30 Theatre Bleu Evidence

Plenary session

New generation DES (ESC-EACTS revascularisation guidelines) - Head-to-

head comparisons focusing on patient-oriented outcomes

Chairpersons: W. Wijns, A.P. Kappetein

Panellists: S. Garg, J. Marco, L. Mauri, S. Silber, P. Vranckx

Objectives:

▸ To provide attendees with a comprehensive synthesis on head-to-head

comparisons between the DES with respect to clinical efficacy and safety

▸ To provide attendees with key scientific messages for selecting DES in

daily practice

59


▸ Introduction and objectives - A.P. Kappetein

▸ Patients at risk: all-comers versus selected - S. Garg

▸ Data adjudication and end-point definition - P. Vranckx

▸ Key statistical metrics for data interpretation - A.P. Kappetein

▸ Biomatrix - S. Windecker

▸ Endeavor

▸ Nobori - B. Chevalier

▸ Resolute

▸ Xience - G.W. Stone

▸ Yukon - J. Mehilli

▸ Panel discussion and audience interaction

▸ Take-home message - W. Wijns

09:00-12:00 Theatre Havane Clinic

LTT - How to treat a patient with high-risk non ST-segment

elevation acute coronary syndrome

Facilitators: C.K. Naber, T. Cuisset

Panellists: B. He, S. Mishra, M. Noc

Media driver: F. Mangiacapra

Live in-a-box® from Heart Centre, Essen - Germany


Abstract session

Dedicated stents for bifurcation lesion PCI


Chairpersons: A. Mehta, G. Pavlides, G. Stankovic

▸ Introduction - A. Mehta

▸ Complex coronary bifurcation lesions treated with the novel polymer-free

dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and

angiographic clinical results of the prospective, multicentre bipax clinical

trial - R. Costa

▸ The dedicated drug-eluting Bifurcation Optimisation Stent System (BiOSS)

Registry first-in-human results - R.J. Gil

▸ Treatment of bifurcations with the dedicated Sideguard nitinol stent

compared with conventional 2-stents strategies - N. Foin

▸ Facilitated culottes in coronary artery bifurcation stenting using a

dedicated side branch stent: two-year clinical outcome

D. Solomon Asgedom

Wednesday 18th

60



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Advanced bifurcation systems mother-daughter platform, a novel system

in treatment of coronary bifurcation lesions: preliminary results of the

prospective, multicentre first-in-man experience - M. Khorsandi

▸ Final Results from the AnGIoSculpt® MuLti-Center Coronary BIfurcation

STudY - AGILITY Trial - J.W. Moses

▸ Take-home message - G. Stankovic


LTT - How to perform transseptal catheterisation

Facilitators: A. Vahanian, G. Ducrocq

Panellists: B. Cauchemez, A. El Etriby, H. Gamra,

C. Ruiz, T.R.D. Shaw, K. Srinivasa

Media driver: L. Delorme

Live in-a-box® from Hôpital Bichat Claude Bernard, Paris - France


Abstract session

Transradial access: technical and procedural aspects


Chairpersons: R. Hoffmann, S. Saito

▸ Introduction - R. Hoffmann

▸ Effect of adding Nitroglycerine to Lignocaine on radial artery diameter

during local anesthesia for transradial coronary angiogram - S. Satheesh

▸ Efficacy of Nicorandil in preventing radial artery spasm during transradial

interventions - K. Manickam

▸ Usefulness of bivalirudin as compared to unfractionated heparin in PCI

using the radial approach - S. Mansour

▸ Single transradial catheter for right and left coronary diagnosis and

intervention - A. Youssef

▸ Feasibility and safety of a novel sheath less system during routine

percutaneous transradial coronary angiography - N. Gadkar

▸ Radial approach for coronary chronic total occlusion lesions: acute,

long-term results and impact of learning curve - F. Burzotta

▸ Take-home message - S. Saito

61


09:00-10:30 Room 341 Clinic

Abstract session

PCI in multivessel disease patients: determinants of long-term clinical

outcome


Chairpersons: A.T.L. Ong, P. Kohl, W.J. van der Giessen

▸ Introduction - A.T.L. Ong

▸ Complete revascularisation and clinical outcomes of patients with

multivessel disease - E. Barbato

▸ Clinical risk stratification is a better determinant of long-term survival

following multivessel PCI compared to anatomic risk stratification using

the Syntax score - R. Lehmann

▸ 'Residual' Syntax score after PCI for triple vessel coronary artery disease:

quantifying the adverse effect of incomplete revascularisation - C.J. Malkin

▸ Percutaneous revascularisation of coronary lesions with established

surgery class I indications without surgical back-up: one-year outcomes

R. Del Castillo

▸ Does high Syntax score really predict worse outcome in PCI-treated

patients with complete revascularisation strategy? - I. Hamanaka

▸ One-year retrospective study to evaluate the outcome in patients with first

time diagnosis of three-vessel coronary artery disease: implementation of

the Syntax score - A. Cuneo

▸ Take-home message - P. Kolh

09:00-10:30 Room 343 Clinic

Abstract session

Edge-to-edge mitral valve repair: clinical, hemodynamic and

echocardiographic evaluation


Chairpersons: T. Feldman, V. Delgado, S. Kar

▸ Introduction - T. Feldman

▸ Percutaneous mitral valve repair in high-risk patients - The Swiss

experience after the first 100 patients - D. Suerder

▸ Changes in systolic function after interventional mitral valve

reconstruction: a 2D speckle tracking analysis - T. Wengenmayer

▸ Role of intracardiac echocardiography during percutaneous edge-to-edge

mitral valve repair with the MitraClip system: a single centre experience

M. Barbierato

Wednesday 18th

62




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Quality of life of high-risk patients following percutaneous mitral valve

repair with the MitraClip system - V. Cammalleri

▸ MitraClip therapy demonstrates favorable mid-term outcomes in ACCESS-

EUROPE heart failure patients with left ventricular ejection fraction ≤ 30%:

preliminary report from the 6-month ACCESS-EU analysis cohort

F. Maisano

▸ Endovascular MitraClip-repair of severe mitral valve regurgitation in

patients with end-stage heart failure - R. Bekeredjian

▸ Take-home message - V. Delgado


Forum

Problems on the road to coronary intervention


Chairpersons: S. Kedev, C. Mialhe

▸ Introduction - S. Kedev

▸ Vascular closure device: complications with closure - A. George

▸ Femoral access complication: percutaneous treatment - I. Dato

▸ Double jeopardy! Percutaneous treatment of bilateral groin hemorrhage

after high-risk PCI - S. Arain

▸ A case of iatrogenic brachial artery dissection, rupture and artero-venous

fistula formation - A.R. De Caterina

▸ Falling in a trap - P.T. Tsui

▸ Take-home message - C. Mialhe

10:30-12:00 Room 242A

How should I treat?

Bifurcations in coronary chronic total occlusion PCI - Incidence,

treatment, strategies, results

Under the auspices of the Bulgarian Working Group on Interventional

Cardiology and the Siberian Association of Interventional

Cardioangiologists

Chairpersons: V. Gelev, A. Osiev

Objectives:

▸ To learn that bifurcation lesions after coronary chronic total occlusion is a

separate vital issue which demands an independent approach to the

decision

▸ To teach how to use different techniques of stenting after coronary chronic

total occlusion recanalisation

▸ To understand the necessity of carrying out further researches and

approaches to the decision

▸ To state that there are special features of bifurcation lesions in patients

who underwent coronary chronic total occlusion recanalisation and in

coronary non-chronic total occlusion patients

63


▸ Introduction and objectives - V. Gelev

▸ Stenting of bifurcation lesions after retrograde recanalisation of rightcoronary chronic total occlusion

- Case presentation - A. Biryukov

- How would I treat? - V. Ganyukov

- How would I treat? - I. Zheleva

- How did I treat? - A. Biryukov

- Discussion

- Consensus - A. Osiev

▸ Combined approach - Antegrade and retrograde for recanalisation ofbifurcation right coronary chronic total occlusion

- Case presentation - O. Radev

- How would I treat? - I. Zheleva

- How would I treat? - V. Ganyukov

- How did I treat? - O. Radev

- Discussion

- Consensus - V. Gelev

▸ Take-home message - A. Osiev

10:30-12:00 Room 242B Clinic

Plenary session

Percutaneous treatment of uncommon structural heart disease disorders -Ventricular septum defect, paravalvular leak and coronary fistulaChairpersons: P. Ruygrok, E. EeckhoutPanellists: F. Bourlon, J. Dugal

Objectives:▸ To understand the clinical presentation and evolution of uncommon

congenital or acquired structural heart disease disorders in order toprevent adverse outcomes

▸ To learn about the diagnostic work-up in order to choose the besttherapeutic strategy

▸ To review the possibilities and limitations of the available percutaneoustreatment modalities

▸ Introduction and objectives - P. Ruygrok

▸ Closure of ventricular septum defects after myocardial infarction - P. Ruygrok

▸ Case presentation - C. Ruiz

▸ Closure of paravalvular leaks - C. Rihal

▸ Case presentation - E. Eeckhout

▸ Interventions on coronary fistulae and malformations - H. Sievert

▸ Case presentation - N.Q. Nguyen

▸ Take-home message - E. Eeckhout

Wednesday 18th

64



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


10:30-12:00 Room 243 Clinic

Abstract session

Primary PCI in STEMI patients with left main or multivessel occlusion


Chairpersons: A. Rahman, F. Eberli, F. Weidinger

▸ Introduction - A. Rahman

▸ In-hospital and long-term outcomes of patients with STEMI with

unprotected left main coronary artery stenosis undergoing primary PCI in

a hospital without on-site cardiac surgery - F. Tomassini

▸ One-stage PCI of left main stenosis and infarct-related left anterior

descending or circumflex arteries in STEMI patients - E. Merkulov

▸ Treatment of multivessel coronary artery disease in primary PCI for

STEMI: culprit only revascularisation is associated with higher major

adverse cardiovascular event rates - D.A. Jones

▸ Acute simultaneous total occlusion of two major coronary arteries in

STEMI - J. Guo

▸ Is the Syntax score a predictor of early outcome in patients with

cardiogenic shock complicating acute myocardial infarction?

M. Abdel-Wahab

▸ Primary PCI in the presence of left bundle branch block - K. Lee

▸ Take-home message - F. Eberli


LTT - How to perform manual thrombus aspiration in STEMI

Facilitators: P. MacCarthy, P. Musialek, M. Oberhoff

Panellists: G. Brueren, F. Malik, H. Mardikar

Media driver: A.A. Fassa

Live in-a-box®

STENT

FOR LIFE

65


▸ CTO-1 collagenase total occlusion first-in-man clinical trial -

▸ Discussion

▸ First-in-man use of lineage-specified stem cells for the treatment of heart

failure: the C-CURE trial -

▸ Discussion

10:30-12:00

Drug-eluting balloons


Chairpersons: S.T. Lim, S. Silber, R. Starc

▸ Introduction -

▸ Paclitaxel-coated balloon in combination with bare metal stent for

treatment of de novo coronary lesions: an optical coherence tomography

first-in-man randomised trial balloon first vs. stent first


▸ Comparison of bare metal and DES restenosis after treatment with a novel

drug-eluting balloon - a subgroup analysis of the PEPPER first-in-man

trial -

▸ Trend towards lower target lesion revascularisation and measure adverse

cardiovascular event rates in patients treated with drug-eluting balloon

compared with DES -

▸ Treatment of the coronary in-stent restenoses with Paclitaxel coated

balloon catheters -

▸ 3-year clinical outcome after PCI with drug-eluting balloon in small

coronary vessels -

▸ Predictors of recurrent restenosis after Paclitaxel-eluting balloon for the

treatment of DES restenosis -

▸ Take-home message -


Abstract session

Left atrial appendage closure from single centre experience to large

randomised trials


Chairperson: I. Horvath

▸ Introduction - I. Horvath

▸ Last chance access closure of the left atrial appendage - A.K. Roy

▸ Transcatheter left atrial appendage occlusion in atrial fibrillation:

comparison of non-dedicated vs. dedicated Amplatzer devices - S. Gloekler

▸ Technique and 30-day results with the Amplatzer cardiac plug for left atrial

appendage occlusion in anticoagulant ineligible patients - D. Meerkin

▸ The safety of percutaneous left atrial appendage closure for stroke

prevention in atrial fibrillation patients: is there evidence for a learning

curve? - S. Kar

▸ Left atrial appendage closure and the Protect AF trial: results at 1500

patient-years of follow-up - S. Kar

▸ Anticoagulation after left atrial appendage closure using the Watchman

device in patients not taking Warfarin - M.W. Bergmann

▸ Take-home message - I. Horvath

10:30-12:00 Room 342AB Evidence

Hot Line session

Late breaking first-in-human trials

Chairpersons: A. Cribier, R. Erbel, J. Simpson

▸ BIOSOLVE-I safety and clinical performance of the first drug-eluting

absorbable metal scaffold - M. Haude

▸ Discussion

▸ First-in-man experience with the DES Orsiro in the treatment of patients

with single de novo coronary artery lesions (BIOFLOW-I) - M. Hamon

▸ Discussion

▸ TA-AVI: 3-month first-in-man results with the Symetis Acurate transapical

aortic valve - J. Kempfert

▸ Discussion

▸ Diagnosis of ischemia-causing stenoses obtained via non-invasive

fractional flow reserve (DISCOVER-FLOW): a prospective multicentre first-

in-man study - B.K. Koo

▸ Discussion

Wednesday 18th

66




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ CTO-1 collagenase total occlusion first-in-man clinical trial - B. Strauss

▸ Discussion

▸ First-in-man use of lineage-specified stem cells for the treatment of heart

failure: the C-CURE trial - D. Dolatabadi

▸ Discussion


Abstract session

Drug-eluting balloons


Chairpersons: S.T. Lim, S. Silber, R. Starc

▸ Introduction - S.T. Lim

▸ Paclitaxel-coated balloon in combination with bare metal stent for

treatment of de novo coronary lesions: an optical coherence tomography

first-in-man randomised trial balloon first vs. stent first


▸ Comparison of bare metal and DES restenosis after treatment with a novel

drug-eluting balloon - a subgroup analysis of the PEPPER first-in-man

trial - R. Toelg

▸ Trend towards lower target lesion revascularisation and measure adverse

cardiovascular event rates in patients treated with drug-eluting balloon

compared with DES - M. Unverdorben

▸ Treatment of the coronary in-stent restenoses with Paclitaxel coated

balloon catheters - G. Goranov

▸ 3-year clinical outcome after PCI with drug-eluting balloon in small

coronary vessels - M. Unverdorben

▸ Predictors of recurrent restenosis after Paclitaxel-eluting balloon for the

treatment of DES restenosis - S. Habara

▸ Take-home message - R. Starc

67


10:30-12:00 Room 351

How should I treat?

PCI of the left main in acute myocardial infarction

Under the auspices of the Interventional Cardiology

Working Group of the Czech Society of Cardiology and the

German Working Group of Interventional Cardiology

Chairpersons: M. Zelizko, A. Elsaesser

Objectives:

▸ To learn indications of left main PCI in myocardial infarction

▸ To teach technical skills of left main PCI and pharmacological management

▸ To understand limitations and importance of global clinical assessment

▸ Introduction and objectives - M. Zelizko

▸ STEMI - primary PCI of the left main

- Case presentation - I. Bernat

- How would I treat? - M. Mates

- How would I treat? - V. Klauss

- How did I treat? - I. Bernat

- Discussion

- Consensus - M. Zelizko

▸ Left main - PCI in acute coronary syndrome

- Case presentation - H. Moellmann

- How would I treat? - V. Klauss

- How would I treat? - M. Mates

- How did I treat? - H. Moellmann

- Discussion

- Consensus - A. Elsaesser

▸ Take-home message - A. Elsaesser

STENT

FOR LIFE

Wednesday 18th

68



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


10:30-12:00 Room 353 Clinic

Forum

TAVI cases - Part II


submissions

Chairpersons: J. Webb, G. Fournial

▸ Introduction - J. Webb

▸ Transcatheter implantation of the CoreValve self-expanding aortic

prosthesis for failed bioprosthetic aortic valve - M. Lelek

▸ TAVI for AR and mild calcification - A. Mostafa

▸ TAVI complicated by common femoral artery rupture and occlusion;

endovascular repair with viabahn endoprosthesis - A. Silvestro

▸ Left internal mammary artery graft occlusion during TAVI - O. Sousa

▸ Distal left anterior descending coronary artery obstruction: a rare

complication of transapical aortic valve implantation - D. Dvir

▸ Take-home message - G. Fournial



Medtronic CoreValve: the next generation


Chairperson: A. Linke

Panellists: J. Bosmans, E. Grube, B. Reimers

Objectives:

▸ To provide latest experience and usage/implementation of the Accutrack

delivery system

▸ To provide all the insights of the new indication of subclavian access

▸ To provide the latest information on product durability and the experience

with ReDo cases

▸ Introduction and objectives - A. Linke

11:35-12:20 Live in-a-box® from Clinique Pasteur, Toulouse - France

▸ Accutrack - D. Tchétché

▸ Subclavian access - F. Maisano

▸ Durability - N. Piazza

12:35-13:20 Live demonstration from Institute of Cardiology, Warsaw -

Poland

▸ Take-home message - A. Linke

69



Symposium

Breaking the link between stenting and dual antiplatelet therapy

With an unrestricted educational grant from CORDIS CARDIAC

& VASCULAR INSTITUTE

Chairpersons: C. Spaulding, M. Thomas

Objectives:

▸ To use clinical cases to discuss the current problems related to prolonged

dual antiplatelet therapy in clinical practice

▸ To review the current rate of stent thrombosis, the guidelines and ongoing

trials on dual antiplatelet therapy

▸ To understand the potential of future stent technologies to further reduce

the rate of stent thrombosis

▸ Introduction and objectives - M. Thomas

▸ Case presentation: late stent thrombosis with currently available DES

I. Nadra

▸ Discussion - Stent thrombosis in 2011: have things really changed?

L. Mauri

▸ Case presentation: planned PCI followed by a mandatory surgery: how

should we treat? - J. Silvain

▸ Discussion - Dual antiplatelet therapy: current guidelines and future

directions - G. Montalescot

▸ Case presentation: unplanned surgery 4 months after PCI: what should we

do? - S. Cook

▸ Discussion - Will changes in DES design modify dual antiplatelet therapy

paradigms? - C. Spaulding

▸ Discussion

▸ Take-home message - M. Thomas

Wednesday 18th

70




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease



Symposium

Reducing clinical risk for coronary artery disease and structural heart

disease intervention: the role of medical device innovation

With an unrestricted educational grant from BOSTON SCIENTIFIC

Chairpersons: K. Dawkins, J. Ormiston

Objectives:

▸ To evaluate innovation and advances in technology and engineering

▸ To discuss how these advances impact clinical outcomes for patients

▸ Introduction and objectives - J. Ormiston

▸ Do different DES polymers offer a clinical advantage? - M. Valgimigli

▸ How does stent design impact clinical outcomes: lessons from pre-clinical

work - R. Virmani

▸ Can stent performance on the bench predict stent performance in vivo?

J. Escaned

▸ Do real-world outcomes replicate randomised clinical trial data? Stent

performance differences within SCAAR - S. James

▸ Take-home message: safety and clinical outcomes can be improved by

continuing to innovate - J. Ormiston

▸ Performance goals for percutaneous structural heart solutions: the next

steps in left atrial appendage closure and percutaneous valve technologies

K. Dawkins


Symposium

Primary PCI: step-by-step decision process


Chairpersons: J. Marco, P. W. Serruys

Objectives:

▸ To understand the added value of a step-by-step decision-making process

for treatment of complex patients with STEMI

▸ To define risk-benefits for different approaches for each step in

management of patients with STEMI

▸ To demonstrate interaction of patient condition and treatment options

▸ Introduction and objectives - P. W. Serruys

▸ Case presentation - G. Olivecrona

▸ Vascular access site - M. Roffi

▸ Pharmacological management - R. Kornowski

▸ Thrombus management - G. Sardella

▸ New optical imaging techniques to guide treatment - P.W. Serruys

▸ Proper selection of the stents - H. Ince

▸ Discussion

▸ Take-home message - J. Marco

STENT

FOR LIFE

71


12:00-13:30 Room Maillot

Symposium

Titanium-nitride-oxide bioactive stent technology in acute coronary

syndrome patients: present and future

With an unrestricted educational grant from HEXACATH

Chairpersons: J. Fajadet, M. Sabate

Objectives:

▸ To review why acute coronary syndrome patients are a challenging

indication for PCI

▸ To understand the titanium-nitride-oxide coated stents potential interest

for acute coronary syndrome patients

▸ To describe the latest Titan2 bioactive stent clinical data and share the next

applications of this technology


▸ How the thrombogenic and inflammation context of acute coronary

syndrome patients must lead to a rationale stent choice - M. Sabate

▸ Perspective of optical coherence tomography findings after Titan2 stent

implantation in acute coronary syndrome patients - P. Karjalainen

▸ Optimal revascularisation in patients with acute myocardial infarction: the

CATS-AMI large scale registry - M. Angioi

▸ Randomised comparison between the bioactive stent Titan2 and the

Everolimus-eluting stent Xience V: the BASE-ACS trial - P. Karjalainen

▸ Introducing the future of bioactive stents - J. Fajadet

▸ Discussion

▸ Take-home message - J. Fajadet

12:00-13:30 Room 242A

How should I treat?

How to treat complex coronary disease in Asia Pacific


Chairpersons: S. Lu, I. Meredith

Objectives:

▸ To discuss the alternative approaches to treating multivessel disease

▸ To explain the benefits behind a staged approach to PCI treatment of

multivessel disease

▸ To determine the challenges behind treating a left main/bifurcation as part

of multivessel disease

Wednesday 18th

72



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - I. Meredith

▸ Complex multivessel disease PCI in a diabetic patient

- Case presentation - S. Worthley

- How would I treat? - P. Chandra

- How would I treat? - Y.S. Jang

- How did I treat? - S. Worthley

- Discussion

- Consensus - I. Meredith

▸ A complex triple vessel PCI

- Case presentation - G. Wen-Yi

- How would I treat? - H.S. Kim

- How would I treat? - M. Lee

- How did I treat? - G. Wen-Yi

- Discussion

- Consensus - I. Meredith

▸ Take-home message - I. Meredith

12:00-13:30 Room 242B Clinic

Abstract session

Which DES for diabetics?


Chairpersons: J. Belardi, U. Kaul, B. Merkely

▸ Introduction - J. Belardi

▸ Clinical evaluation of the Everolimus-drug eluting coronary stent Xience V

for the treatment of de novo coronary lesions in the daily practice in

diabetic patients - A. Iniguez

▸ Treatment with the Resolute Zotarolimus-eluting stent in subjects with

diabetes mellitus: pooled analysis from the Resolute clinical programme

S. Silber

▸ Clinical outcomes in diabetic and non diabetic patients treated with

Endeavor Resolute Zotarolimus eluting-stent: a multicentre Italian

observational study - A. Ielasi

▸ Major cardiovascular events after coronary Everolimus-eluting stent(s) in

diabetic patients. The Middle East diabetic Xience registry - T. Majwal

▸ Initial clinical and angiographic results of the Titanic XV prospective

randomised trial: the Titan vs. Everolimus (Xience V) stent in diabetic

patients - J.R. Lopez-Minguez

▸ Two-year clinical outcomes of diabetic patients treated with a new

generation DES - M. Wiemer

▸ Take-home message - U. Kaul

73


12:00-13:30 Room 243

How should I treat?

Treatment of primary PCI: the combination of a perfusion

and an aspiration technique

With an unrestricted educational grant from IHT - CORDYNAMIC

Chairperson: S.D. Kristensen

Objectives:

▸ To establish the key points for a successful primary PCI

▸ To present a new strategy to approach primary PCI

▸ To become familiar with new devices to obtain optimised results with the

new strategy presented


▸ Thrombus aspiration technique. Is it always the best choice?

- Case presentation - I. Malik

- How would I treat? - P. Widimsky

- How would I treat? - E. Garcia

- How did I treat? - I. Malik

- Discussion

- Consensus - S.D. Kristensen

▸ How can we improve lesion assessment in primary PCI?

- Case presentation - G. Marti

- How would I treat? - P. Widimsky


- How did I treat? - G. Marti

- Discussion

- Consensus - S.D. Kristensen

▸ Take-home message - S.D. Kristensen

12:00-13:30 Room 253

How should I treat?

Can we all treat Medina 1.1.1 bifurcation lesions?

With an unrestricted educational grant from MINVASYS

Chairpersons: A. Abizaid, R. Mehran

Objectives:

▸ To understand the technique and the concept

▸ To assess procedural and final results

▸ To discuss the achievements with and without the use of additional

assessment devices

STENT

FOR LIFE

Wednesday 18th

74




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - A. Abizaid

▸ Bifurcation lesion 1.1.1 with the Nile concept, without additionalassessment devices

- Case presentation - T. Carreres

- How would I treat? - B. Garcia Del Blanco

- How would I treat? - P. Motreff

- How did I treat? - T. Carreres

- Discussion

- Consensus - R. Mehran

▸ Bifurcation lesion 1.1.1 with the Nile concept, with additional assessmentdevices

- Case presentation - J. Wykrzykowska

- How would I treat? - B. Garcia Del Blanco

- How would I treat? - P. Motreff

- How did I treat? - J. Wykrzykowska

- Discussion

- Consensus - A. Abizaid

▸ Take-home message - R. Mehran


Plenary session

Cardiovascular Innovation Pipeline - Peripheral vascular disease and structural heart diseaseChairpersons: M.C. Morice, H. Sievert, P. Bonhoeffer

▸ Overview of companies - E. Lehto

▸ ReCor Medical - Therapeutic ultrasound for the treatment of mitralregurgitation - W. Schillinger


▸ Pi-R-Squared - Impacting valve repair - M. Jonas


▸ Cardatis - Multilayer flow modulator for global aneurysm repair - P. Gruffaz




▸ Odierna - Software for automatic IV-optical coherence tomography stentanalysis, image registration and 3D reconstruction - G. Ughi


▸ Avidal Vascular - the Wombat drug reservoir technology


75


12:00-13:30 Room 342AB

Symposium

Contrast agents and renal safety/contrast induced nephropathy -

Pathomechanisms, new clinical evidence, and practical guidance for PCI

in risk patients

With an unrestricted educational grant from BAYER HEALTHCARE

Chairpersons: M. Gilard, T. Lüscher

Objectives:

▸ To understand the pathomechanisms of contrast induced nephropathy and

the differences between contrast media classes

▸ To improve safety of interventions in patients at high risk of contrast

induced nephropathy

▸ To be informed about the newest and largest contrast induced

nephropathy trial

▸ To be informed about the current guidelines for the prevention of contrast

induced nephropathy

▸ Introduction and objectives - T. Lüscher

▸ Pathomechanisms of contrast induced nephropathy: why low-osmolar

contrast agents should be preferred, and why hydratation is the key

P. Persson

▸ Safe interventions in patients with impaired renal function - M. Möckel

▸ Findings from the direct STUDY - The largest, double-blinded prospective,

comparative, contrast induced nephropathy study to date - Y. Chen

▸ Practical recommendations and guidelines on interventions in patients

with impaired renal function - C. Rihal

▸ Discussion

▸ Take-home message - M. Gilard

12:00-13:30 Room 351

How should I treat?

How to treat a coronary chronic total occlusion, an European perspective

With an unrestricted educational grant from ABBOTT VASCULAR and

CROSSROADS, the Abbott Vascular Education Network

Chairperson: A. Serra

Objectives:

▸ To receive practical recommendations on coronary chronic total occlusion

treatment from a European perspective

▸ To learn how to prevent and to treat complications

▸ To receive recommendations on when to use antegrade or retrograde

approach

Wednesday 18th

76



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - A. Serra

▸ How to cross the lesion if the balloon doesn't cross

- Case presentation - E. Barbato

- How would I treat? - G. Werner

- How would I treat? - G. Sianos

- How did I treat? - E. Barbato

- Discussion

- Consensus - A. Serra

▸ How to optimise antegrade approach

- Case presentation - J. Spratt

- How would I treat? - G. Werner

- How would I treat? - G. Sianos

- How did I treat? - J. Spratt

- Discussion

- Consensus - A. Serra

▸ Take-home message - A. Serra

12:00-13:30 Room 352AB

Symposium

Optical coherence tomography lesion assessment to impact decision-making in PCIWith an unrestricted educational grant from ST. JUDE MEDICALChairpersons: F. Prati, E. Regar

Objectives:▸ To show how lesion assessment with optical coherence tomography can

influence decision-making in PCI

▸ To discuss what might be the place of optical coherence tomography inclinical practice

▸ To discuss how to start an optical coherence tomography programme

▸ Introduction and objectives - E. Regar

▸ The role of optical coherence tomography in assessing stent placementC. Di Mario

▸ The role of optical coherence tomography in acute coronary syndromes:new insights in the pathophysiology or a new tool to guide treatment?E. Regar

▸ The role of optical coherence tomography in assessing stent strutcoverage: lessons for dual anti-platelet therapy - A.V. Finn

▸ Why and how can optical coherence tomography become part of yourclinical practice - T. Adriaenssens

▸ Discussion

▸ Take-home message - F. Prati

77



All you need to know about prevention of bleeding

complications and access site selection

Chairpersons: T. Cuisset, F.J. Neumann

Objective:


audience should have an up-to-date knowledge of the field, relevant for




▸ Introduction - F.J. Neumann

▸ Background - Bleeding complications have become a major concern in

patients undergoing coronary interventions - J-P. Bassand

▸ Clinical data - How to optimise the safety of antithrombotic agents

K. Huber

▸ Technical aspects - How access site selection and technical aspects can

decrease the rate of bleeding complications - P. Vranckx

▸ Guidelines - Any help from the Guidelines for bleeding prevention and

access site selection? - S. Silber

▸ Unsolved issues with transradial access - Impact of transradial approach

on patient outcome - J. Nolan

▸ Questions & answers - T. Cuisset


Main session

Revascularisation in patients with stable angina and complex multivessel

disease

Chairpersons: B. De Bruyne, L. Torracca

Panellists : P. Avraamides, F. Casselman, S.B. King III, D. Hasdai,

S.M. Kalarickal, T. Mabin, T. Majwal, P. Musialek, M. Ostojic, S. Windecker,

R. Zambahari

Objectives:

▸ To provide a better definition of multivessel coronary disease by

anatomical vs. functional viewpoint

▸ To reconsider the practical diagnostic work-up in patients with risk

factors, angina or ischemia and complex multivessel disease

▸ To understand the relative role and impact of medical treatment, PCI and

CABG

Wednesday 18th

78




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - B. De Bruyne


Poland

▸ Keynote lecture - Reflect together on two essential issues: the changing

definitions of complete revascularisation and what determines the choice

between PCI and surgery - S. Windecker

14:40-15:30 Live demonstration from Chest Hospital, Kuwait Heart Center,

Safat - Kuwait

▸ How should I treat - Under the auspices of the Working Group for

Interventional Cardiology of the Cyprus Society of Cardiology and the

Working Group on Interventional Cardiology of the Cardiology Society of

Serbia

- Introduction and objectives - M. Ostojic

- Case presentation - M. Tesic

- How would I treat? - D. Orlic

- How would I treat? - G. Georgiou

- How did I treat? - M. Tesic

- Discussion & consensus - P. Avraamides


Poland

▸ Final key remarks - L. Torracca

13:30-16:30 Theatre Bleu Clinic

Plenary session

Percutaneous intervention for mitral regurgitation

Chairpersons: A. Vahanian, F. Maisano

Panellists: J. Hausleiter, S. Kar, K.H. Kuck, J. van der Heijden, N. Wunderlich

With continuous live demonstration from The National Hospital, The Heart

Center, Copenhagen - Denmark

Objectives:

▸ To understand which patients with mitral regurgitation could qualify for

transcatheter mitral repair

▸ To understand the key role of non-invasive imaging modalitites for the

selection of patients and guidance of transcatheter mitral regurgitation

▸ To provide an overview of the state of the experience of the MitraClip

therapy

79


▸ Introduction and objectives - F. Maisano

▸ Who might be candidates for percutaneous treatment of mitral

regurgitation from a surgeon's point of view - N. Moat

▸ Discussion

▸ How to grade mitral regurgitation severity before and after percutaneous

treatment - M. Sarano

▸ Discussion

▸ Impact of functional mitral regurgitation in heart failure patients. Do we

need mitral regurgitation grade <1 after treatment? - V. Delgado

▸ Overview of experience :

- Peer-reviewed published data on annuloplasty device - G. Pedrazzini

- The EVEREST trial: 2-year follow-up - T. Feldman

- European experience with the MitraClip therapy and the Access registry

F. Maisano

▸ Discussion

▸ Final key remarks - A. Vahanian


Plenary session

Secondary revascularisation - Part II

Revascularisation of saphenous vein graft attrition:

complex decisions in high-risk patients

Chairpersons: C. Macaya, P. Kolh

Panellists: A. Abizaid, I.A. Alhaddad, M. Borger, J. Escaned, P. Vermeersch,

D.O. Williams

Objectives:

▸ To understand the role of a multidisciplinary approach in the selection of

revascularisation modalities in patients with saphenous vein graft attrition

▸ To learn about the added value of computed tomography angiography

prior to invasive coronary angiography

▸ To learn how to improve the safety and efficacy of PCI on saphenous vein

graft

Wednesday 18th

80



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - C. Macaya

13:35-14:25 Live demonstration from Instituto Cardiovascular / Hospital

Clínico San Carlos, Madrid - Spain

▸ DES vs. bare-metal stent in saphenous vein graft: do we need a large

randomised trial? - D.O. Williams

▸ Implementing distal and proximal embolic protection devices in

saphenous vein graft PCI - L. Mauri

▸ Emerging percutaneous options in patients with degenerated saphenous

vein grafts - A. Colombo

▸ Emerging surgical options in patients with degenerated saphenous vein

grafts - M. Borger

▸ Revascularisation of occluded saphenous vein graft: a bridge too far or a

reasonable option? - R. Hoffmann

▸ Best of both worlds: combining multislice computed tomography and invasive

angiography in patients with saphenous vein grafts - C. Van Mieghem


15:30-16:20 Live demonstration from Instituto Cardiovascular / Hospital

Clínico San Carlos, Madrid - Spain

▸ Final key remarks - J. Escaned


LTT - How to treat a patient with STEMI caused by a

large thrombus

Facilitators: J. Goicolea, P. MacCarthy, M. Noc

Panellists: G. Brueren, M. Gilard

Media driver: L. Delorme

Live in-a-box® from Catharina Ziekenhuis, Eindhoven

The Netherlands

13:30-15:00 Room 242A

How should I treat?

Complications during early invasive strategy in NSTEMI

Under the auspices of the Egyptian Working Group of

Interventional Cardiology (EWGIC) and the Saudi Arabia

Cardiology Interventional Group (SACIG)Chairpersons: M. Sobhy, M.A. Youssef

Objectives:▸ To redefine the timing of invasive strategy in NSTEMI patients

▸ To understand, in multivessel disease patients, which vessel should betreated first

▸ To understand the role of thrombus aspiration in NSTEMI patients

▸ To underline the place and the timing of emergency CABG in NSTEMI patients

STENT

FOR LIFE

STENT

FOR LIFE

81


▸ Introduction and objectives - M. Sobhy

▸ Expected complications during early invasive strategy in NSTEMI

- Case presentation - M. Sadaka

- How would I treat? - A. El Etriby

- How would I treat? - W. Ahmad

- How did I treat? - M. Sadaka

- Discussion

- Consensus - M. Sobhy

▸ Managing NSTEMI in patient with multivessel disease and ischemic mitralregurgitation; is PCI an option for such a patient rather than CABG andmitral repair?

- Case presentation - H. Mhish

- How would I treat? - M. Balghith

- How would I treat? - S. El Tobgy

- How did I treat? - H. Mhish

- Discussion

- Consensus - M.A. Youssef

▸ Take-home message


Abstract session

IVUS in acute coronary syndrome: how lesion morphology may impact on

outcome


Chairpersons: A. Pichard, J.B. Ge

▸ Introduction - A. Pichard

▸ Coronary atherosclerotic disease in Saudi patients: a pilot IVUS analytical

study of patients presenting with acute coronary syndrome - S. Lawand

▸ Is angiography enough for optimal stenting of the culprit lesion in patients

with acute myocardial infarction (STEMI and NSTEMI)? An intravascular

ultrasound and virtual histology (IVUS-VH) study - J. Jakala

▸ Reproducibility of volumetric virtual histology IVUS analyses in

coronary lesions prior to stenting: an European multicentre study on

between-centre reproducibility - J. Huisman

▸ Role of IVUS in acute myocardial infarction patients undergoing PCI - K. Ahmed

▸ VH-IVUS findings predict major adverse cardiovascular events, post-PCI

myocardial infarction and troponin rise: the VIVA (VH-intravascular

ultrasound in vulnerable atherosclerosis) study - P.A. Calvert

▸ Continuous neointimal hyperplasia formation after five years of different

generations of DES: is there enough evidence of late 'catch-up'? - C. Collet

▸ Take-home message - J.B. Ge

Wednesday 18th

82


We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

PCI for unprotected left main stenosis


Chairpersons: A.P. Kappetein, S.J. Park, F.W. Mohr

▸ Introduction - A.P. Kappetein

▸ Risk assessment for PCI of the unprotected left main coronary artery in an

all-comer population - C. Dubois

▸ Everolimus-eluting stent implantation for unprotected left main disease: a

single-centre experience - T.C. Aranzulla

▸ Importance of medical therapy among patients with unprotected left main

trunk disease who underwent PCI - M. Shiba

▸ The value of a combination of the Syntax Score and the Euroscore for the

prediction of clinical outcomes in patients after left main coronary artery

stenting - J.M. Sinning

▸ How safe and efficacious is PCI for unprotected left main stem disease in

a high volume non-surgical centre? - J.P. Fernandez

▸ Results and predictors of long-term outcomes after unprotected left main

coronary artery angioplasty in octogenarians - S. Rekik

▸ Take-home message - S.J. Park


LTT - How to use rotablator

Facilitators: F. Mauri, B. Merkely

Panellists: S. Kedev, F. Ribichini

Media driver: E. Sorbets

Live in-a-box® from Clinique Pasteur, Toulouse - France

83



Plenary session

Best of Innovations in Cardiovascular Interventions (ICI) Technoparade

Chairpersons: R. Kornowski, C. Lotan

Objective:

▸ To explain the pathways for development of biotechnical innovation

▸ Introduction - The Innovations in Cardiovascular Interventions (ICI)

meeting and its philosophy - C. Lotan

▸ Israel and biotechnology: the 'start-up' nation - R. Kornowski

▸ Globalisation of innovation - M.W. Krucoff

▸ Real View - Holographic 3D/4D imaging display - E. Bruckheimer

▸ Valtech - Technology for mitral valve regurgitation - D. Brown

▸ Neovasc Reducer - Coronary sinus implant for refractory myocardial

ischemia - S. Banai

▸ Corindus - Robotics in the catheterisation laboratory - G. Weisz

▸ CorAssist - ImCardia implanted extra-ventricular energy transfer device for

diastolic dysfunction - A. Elami


▸ Take-home message - Innovation: how to succeed in the early stage and

the late stage of a new technology? - C. Lotan


Forum

Plug it


Chairpersons: B. Meier, F. Bourlon

▸ Introduction - B. Meier

▸ Acquired gerbode defect closure using an Amplatzer device: long-term

follow-up - J.G. Allin

▸ Short- and mid-term follow up after percutaneous closure of a

pseudoaneurysm of the mitral aortic intervalvular fibrosa - M. Denk

▸ Percutaneous closure of ruptured sinus of valsalva aneurysm - J.G. Allin

▸ Simultaneous double-plug closure of mitral paravalvular leak - G. Smolka

▸ Transcatheter treatment of a fissuration of an ascending aortic aneurysm

with an Amplatzer septal occluder device - M. Galli

▸ Take-home message - F. Bourlon

Wednesday 18th

84



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

PCI techniques for bifurcation lesions


Chairpersons: B. Chevalier, I. Iakovou, M. Lee

▸ Introduction - B. Chevalier

▸ Angiographic and IVUS predictors of side branch failure during PCI with

provisional side branch stenting approach in complex coronary

bifurcation lesions - R. Costa

▸ Final proximal post-dilatation to optimise results in bifurcation stenting

N. Foin

▸ 2 steps post-dilatation instead of kissing balloon after provisional stenting

of bifurcations: insight from bench model and first in-vivo experience

N. Foin

▸ Non-compliant balloons for final kissing inflation in coronary bifurcation

lesions treated with provisional T-stenting: a pilot study - D. Mylotte

▸ Simultaneous kissing stents to treat left main stem bifurcation disease:

real world results in 140 consecutive patients - J. Gunn

▸ Early and long-term outlook of PCI for bifurcation lesions in young

patients - G.M. Sangiorgi

▸ Take-home message - M. Lee

13:30-15:30 Room 351

How should I treat?

Severe aortic stenosis with concomitant coronary artery disease or with

low ejection fraction in elderly patients

Under the auspices of the Austrian Working Group on Interventional

Cardiology, the British Cardiovascular Intervention Society (BCIS),

the Dutch Working Group of International Cardiology and the Slovenian

Working Group of Invasive and Interventional Cardiology

Chairpersons: W. Wisser, M. de Belder, J. Piek, M. Bunc

Objectives:

▸ To understand the issues behind the management of concomitant

significant coronary disease

▸ To suggest optimal treatment options in patients with severe aortic

stenosis with concomitant coronary disease

▸ To understand how to manage expected or unexpected ventricular

dysfunction during TAVI

85


▸ Introduction and objectives - M. de Belder

▸ A patient with "suicide ventricle" during TAVI

- Case presentation - S. Redwood

- How would I treat? - B. Prendergast

- How would I treat? - P. Den Heijer

- How did I treat? - S. Redwood

- Discussion

- Consensus - M. de Belder

▸ A high-risk patient with severe aortic stenosis and significant coronary

disease

- Case presentation - J. Baan

- How would I treat? - P. Den Heijer

- How would I treat? - B. Prendergast

- How did I treat? - J. Baan

- Discussion

- Consensus - J. Piek

▸ Elderly patient with severe aortic stenosis, multivessel coronary disease

and low ejection fraction

- Case presentation - I. Kranjec

- How would I treat? - D. Zorman

- How would I treat? - M. Heigert

- How did I treat? - I. Kranjec

- Discussion

- Consensus - M. Bunc

▸ Take-home message - W. Wisser



Glimpse into the future - TAVI: what lays ahead and how to improve

procedural outcomes

Chairpersons: J. Webb, N. Piazza

Panellists: L. Büllesfeld, E. Grube, R. Lange, M.B. Leon

Objectives:

▸ To understand and explore the role of imaging modalities to facilitate

patient selection and device implantation

▸ To know ancillary techniques to facilitate TAVI in the future

▸ To be familiar with emerging implants and indications for TAVI

Wednesday 18th

86




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - J. Webb

▸ Glimpse into future imaging modalities - Novel imaging modalities in the

evaluation of patients undergoing TAVI prior, during and after the

procedure - L. Buellesfeld

13:45-14:00 Recorded case and commentary by L. Buellesfeld

▸ Glimpse into ancillary TAVI devices

– Novel percutaneous access and closure devices - M.B. Leon

– Percutaneous closure of transapical access: hype or progress? - C. Ruiz

– Innovations in embolic protection during TAVI - E. Grube

14:50-15:05 Recorded case on TAVI facilitated by embolic protection device

and commentary by E. Grube

▸ Glimpse into future TAVI devices and indications

– Tissue engineered heart valves: ready for clinical use? - S. Hoerstrup

– TAVI for treatment of degenerated surgical bioprostheses - N. Piazza

– Overview of new transfemoral TAVI systems in the coming year - J. Webb

– Overview of new transapical TAVI systems in the coming year - T. Walther

– TAVI: will it become the default strategy? - R. Lange

▸ Take-home message - N. Piazza

13:30-15:00 Room 353

How should I treat?

Coronary chronic total occlusion: who should intervene and when

Under the auspices of the French Group of Interventional Cardiology (GACI)

and the South African Society of Cardiovascular Intervention (SASCI)

Chairpersons: T. Lefèvre, G. Cassel

Objectives:

▸ To understand how to select the optimal indications for coronary chronic

total occlusion treatment

▸ To understand how to select the optimal approach and avoid

complications

▸ To be able to set-up a coronary chronic total occlusion programme in a

dedicated cath lab

▸ Introduction and objectives - T. Lefèvre

▸ Complex challenging coronary chronic total occlusion

- Case presentation - N. Boudou



- How did I treat? - N. Boudou

- Discussion

- Consensus - T. Lefèvre

87


▸ Triple vessel disease including coronary chronic total occlusion:

cardiologist or surgeon?

- Case presentation - J.R. Vorster



- How did I treat? - J.R. Vorster

- Discussion

- Consensus - G. Cassel

▸ Take-home message - G. Cassel

14:30-16:30 Room 251 Clinic

Forum

Management of coronary perforations during PCI - Part I


submissions

Chairpersons: V. Gelev, G. Fu

▸ Introduction - V. Gelev

▸ A case of coronary rupture - Retrograde approach for right coronary

artery chronic total occlusion - M. Chan

▸ Conservative strategy for localised coronary perforation - S. Wafa

▸ Novel treatment of coronary artery perforation - M.N. Khan

▸ Complication: coronary perforation of left anterior descending

R. Vijayvergiya

▸ Coronary stent fracture leading to coronary vessel perforation - S. Kohli

▸ Take-home message - G. Fu

15:00-17:00 Room 242A

How should I treat?

How to predict and prevent the stent thrombosis

Under the auspices of the Association of Interventional Cardiology of

Hungary and the Association of Interventional Cardiology of Romania and

the Scottish Cardiac Society

Chairpersons: D. Deleanu, H. Eteiba, I. Ungi

Objectives:

▸ To understand the possible mechanisms and principal causes of stent

thrombosis in order to reduce the risk of this complication

▸ To understand the possible mechanisms and principal causes of stent

thrombosis in order to recognise the risk factors with imaging techniques

Wednesday 18th

88



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - D. Deleanu

▸ Stent thrombosis

- Case presentation - A. Konyi

- How would I treat? - G. Szabo

- How would I treat? - L. Zarma

- How did I treat? - A. Konyi

- Discussion

- Consensus - I. Ungi

▸ Stent thrombosis due to coagulopathy

- Case presentation - C. Udroiu


- How would I treat? - G. Szabo

- How did I treat? - C. Udroiu

- Discussion

- Consensus - D. Deleanu

▸ Stent thrombosis after primary PCI

- Case presentation - K.G. Oldroyd

- How would I treat? - M. Lindsay


- How did I treat? - K.G. Oldroyd

- Discussion

- Consensus - H. Eteiba

▸ Take-home message - H. Eteiba


Abstract session

Coronary chronic total occlusion recanalisation: technical aspectsSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: T. Santoso, A. Protopopov, G. Sianos

▸ Introduction - T. Santoso

▸ Impact of calcium distribution for successful revascularisation of coronary

chronic total occlusion: assessment from computed tomography coronaryangiography - M. Araki

▸ Impact of novel 0.010-inch Athlete Wizard guidewire use on successful

recanalisation of coronary chronic total occlusions via antegrade accessin a large single-centre registry - A. Kido

▸ Safety and efficacy of the Rendezvous method in retrograde recanalisation

for coronary chronic total occlusions - H. Tanaka

▸ Safety of retrograde recanalisations to coronary chronic total occlusion viatransseptal pathways with use of a novel metal-catheter - H. Takimura

▸ Well developed collateral circulation is associated with better vascular functiondistal to recanalised coronary chronic total occlusions - S. Brugaletta

▸ Coronary chronic total occlusion treatment guided by fractional flow

reserve - R. Sachdeva

▸ Take-home message - G. Sianos 89



Abstract session

Primary PCI in STEMI patients: new techniques


Chairpersons: J.E. Nordrehaug, D. Carrié, F. Schiele

▸ Introduction - J.E. Nordrehaug

▸ A pooled analysis of the effect of endovascular cooling on infarct size in

patients with STEMI - D. Erlinge

▸ Drug-eluting balloon in acute myocardial infarction (DEBAMI) trial

T.H. Koh

▸ ST-segment resolution and clinical outcome with ischemic post-

conditioning - and comparison to magnetic resonance - J. Lonborg

▸ Ischemic postconditioning can reduce the infarct size in patients with

STEMI - T. Watanabe

▸ Single-centre experience using M-Guard stent platform in primary PCI in

STEMI - P. Anthopoulos

▸ Novel use of a pericardium-covered stent (PCS) to treat massive intra-

coronary thrombus - J. Gunn

▸ Take-home message - D. Carrié


LTT - How to perform PCI via transradial access

Facilitators: V. Dangoisse, S. Kedev, F. Mauri

Panellists: S. Mishra, D. Tchétché




Abstract session

New stents: pre-clinical studies


Chairpersons: W.J. van der Giessen, S. Verheye, P. Wong

Wednesday 18th

90




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction - W.J. van der Giessen

▸ Safety of Nevo Sirolimus-eluting stents with RES technology

demonstrated using overlapping exaggerated dose formulation stents in

the porcine coronary artery model - G.S. Price

▸ Stenting with Xience V in comparison to Endeavor Resolute and bare

metal stent in an atherosclerotic rabbit double injury model - C. Van Dyck

▸ Capture of circulatory endothelial progenitor cells and accelerated

re-endothelialisation of a bioengineered stent in human ex vivo shunt and

rabbit denudation model - H.J. Duckers

▸ Anti-CD34 stent surface modification reduce thrombogenicity and increase

endothelialisation - R. Virmani

▸ Endothelialisation of polymer-free drug coated stents - R. Virmani

▸ Lipostent: a liposome based gene-eluting stent resulting in enhanced

re-endothelialisation in a preclinical model - F. Sharif

▸ Take-home message - S. Verheye


Plenary session

Cardiovascular Innovation Pipeline - Coronary

heart disease

Chairpersons: P.W. Serruys, R. Waksman, W. Wijns

▸ Overview of companies - H. Call


J.F. Granada


▸ Arterial Remodeling Technology - Novel PLA-dedicated proprietary

scaffold design - A. Lafont


▸ Biotronik - Dreams - Drug-eluting absorbable metal scaffold: concept,

product, clinical experience - B. Warnack



balloon catheter for treatment of coronary artery disease - M. Doshi


▸ Micell Technologies - MiStent DES: a novel third generation DES with a

fully-absorbable coating and enhanced drug delivery capabilities

J. McClain





91


15:00-16:30 Room 343 Clinic

Abstract session

TAVI: clinical outcomes and complicationsSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: G. Sorropago, P. Wenaweser

▸ Introduction - G. Sorropago

▸ Single centre TAVI experience reported according to the criteria newly

established by the Valve Academic Research Consortium - B. Staehli

▸ The impact of periprosthetic aortic regurgitation on outcome after TAVIJ.M. Sinning

▸ Predictors of moderate-to-severe paravalvular aortic regurgitation

immediately after CoreValve implantation and the impact of postdilatationK. Takagi

▸ Release patterns of cardiac markers after TAVI as compared to surgicalaortic valve replacement - S. Bleiziffer

▸ Transcatheter aortic valve replacement decreases acutely secondary

pulmonary hypertension, with prognostic implications on in-hospitalmortality - C. Stoicescu

▸ Can the formal assessment of frailty predict outcome in patients

undergoing TAVI? - C. Raphael

▸ Take-home message - P. Wenaweser


Forum

Technical challenges in primary PCISession comprising selected EuroPCR 2011 clinical case submissionsChairpersons: P. Widimsky, S.A. Bin Yahaya

▸ Introduction - P. Widimsky

▸ Stent dislodgement in a patient with a STEMI resulting in dissection of left

main and left circumflex - S. Kohli

▸ Self-expanding stent for mobile ostial left anterior descending lesioncausing STEMI - R.J. Van Geuns

▸ Geographical miss of ostial right coronary artery because of aorticdissection during primary PCI - lessons to be learned - A.J. Peace

▸ Paradoxical coronary embolus - a rare cause of acute myocardialinfarction on positive pressure ventilation - J. Bennett

▸ STEMI caused by stent fracture with aneurysmal change - J.Y. Yang

▸ Take-home message - S.A. Bin Yahaya

STENT

FOR LIFE

Wednesday 18th

92



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease



Forum

PCI in heavily calcified coronary artery lesions


Chairpersons: P. Kala, B. Merkely

▸ Introduction - P. Kala

▸ Transradial PCI with rotablation in critical calcified lesion - W.J. Chung

▸ Multi device approach for a complex highly tortuous and calcified severe

disease of right coronary artery - S. Tarbine

▸ RASER PCI: a novel debulking technique - M. Egred

▸ Guideliner, child-in-a-mother catheter for successful retrieval of an

entrapped rotablator burr - M. Egred

▸ Take-home message - B. Merkely



Percutaneous mitral valve repair therapy: building a successful

programme



Chairpersons: K.H. Kuck, S. Kar

Objective:

▸ To learn about the indications for and the technique of percutaneous mitral

valve repair

▸ Introduction and objectives - K.H. Kuck

16:35-17:20 Recorded case

▸ Which patients can be treated - J. Hausleiter

▸ Which patients should not be treated - F. Maisano

▸ The importance of imaging - N. Wunderlich

▸ The heart team, a must! - J. van der Heijden

17:40-18:25 Live demonstration from The National Hospital, The Heart

Center, Copenhagen - Denmark

▸ Take-home message - S. Kar

93



Symposium

Potential advantages of stent platform on biodegradable polymerbiolimus-eluting stents in complex patient populations?With an unrestricted educational grant from BIOSENSORS INTERNATIONALChairpersons: B. Meier, M.C. Morice

Objectives:▸ To evaluate the benefit of DES with biodegradable polymers in complex

lesion/patient populations

▸ To understand differences among patients included in all-comers randomised clinical trials as opposed to registry studies

▸ To understand the lessons learned from long-term optical coherencetomography and its clinical implications

▸ Introduction and objectives - B. Meier

▸ Benefits of biodegradable polymer DES technology in complex patientpopulations enrolled in an all-comers trials - M.C. Morice

▸ Biolimus A9: your solution for treating bifurcation lesions - Dedicatedstent designs vs. workhorse DES designs! - S. Verheye

▸ Are results from an all-comers randomised clinical trial comparable withthe results from an all-comers registry? First report of the primaryendpoint of the eBioMatrix registry - P. Urban

▸ What do we learn from long-term optical coherence tomography? Can wecorrelate the findings with clinical outcomes? - A. Abizaid

▸ Discussion

▸ Take-home message - B. Meier


Symposium

Interventional cardiology in perspective: evidence-based application of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndrome PCIWith an unrestricted educational grant from ELI LILLYChairpersons: D. Antoniucci, G. Montalescot

Objectives:▸ To understand when to use glycoprotein IIb/IIIa inhibitors for patients with

an acute coronary syndrome undergoing PCI in the setting of improvedantiplatelet and anticoagulation therapy

▸ To identify acute coronary syndrome patients undergoing PCI suitable forcombined triple antiplatelet therapy

▸ To find the right balance between bleeding and thrombosis in high-riskacute coronary syndrome patients undergoing PCI

STENT

FOR LIFE

Wednesday 18th

94




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - G. Montalescot

▸ Understanding the kinetics of platelet activation and aggregation: a rational

approach to treatment selection and combination - P. Coste

▸ Use of glycoprotein IIb/IIIa inhibitors in modern antiplatelet and

anticoagulation regimens: an evidence-based overview - S. Savonitto

▸ Putting bleeding risk into perspective: patient stratification to improve

outcomes - M. Levi

▸ Applying the evidence: clinical cases to guide practice - P. Sinnaeve

▸ Discussion

▸ Take-home message - D. Antoniucci


Symposium

Advancing the Paccocath technology and the future of drug-eluting

balloon angioplasty

With an unrestricted educational grant from B. BRAUN and MEDRAD

INTERVENTIONAL/POSSIS

Chairpersons: J.F. Granada, B. Scheller

Objectives:

▸ To understand the concept and the basic principals of the Paccocath

balloon coating technology

▸ To get an overview/summary of the pre-clinical and clinical drug-eluting

balloon evaluation for coronary and peripheral applications

▸ To learn about the possible coronary and peripheral indications of the

Paccocath drug-eluting balloon technology

▸ To learn about procedural treatment recommendations and how the drug-

eluting balloon should be used to achieve optimal long-term results

▸ To take home practical tips & tricks for the drug-eluting balloon usage

▸ Introduction to the Paccocath technology - J.F. Granada

▸ Comprehensive review of clinical data with the Paccocath technology

B. Scheller

▸ Treatment recommendations of the German Consensus Group - D. Mathey

▸ Paccocath technology advances: insights into pre-clinical studies of the

latest generation Cotavance drug-eluting balloon - J.F. Granada

▸ A new look into Paccocath clinical data: THUNDER trial and beyond - G. Tepe

▸ Current Cotavance clinical trial status and future study designs - N. Diehm

▸ Discussion

▸ Take-home message - B. Scheller

95


16:30-18:00 Room 241

How should I treat?

Primary PCI for high-risk acute coronary syndrome:

the unexpected and the dramatic


Chairpersons: M. Gilard, P. Urban

Objectives:

▸ To understand what can be the approach regarding thrombus aspiration

for NSTEMI patients

▸ To understand what can be the approach for a patient in cardiogenic shock

▸ Introduction and objectives - M. Gilard

▸ NSTEMI patient with visible thrombus

- Case presentation - B. De Smet

- How would I treat? - J. Goicolea

- How would I treat? - L. Hellsten

- How did I treat? - B. De Smet

- Discussion

- Consensus - M. Gilard

▸ Patient in cardiogenic shock

- Case presentation - J.C. Stauffer

- How would I treat? - B. Chevalier

- How would I treat? - M. Mason

- How did I treat? - J.C. Stauffer

- Discussion

- Consensus - M. Gilard

▸ Take-home message - M. Gilard

STENT

FOR LIFE

Wednesday 18th

96



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


16:30-18:00 Room 242B Clinic

Abstract session

TAVI and coronary artery disease


Chairpersons: V. Bapat, C. Kaiser

▸ Introduction - V. Bapat

▸ Impact of coronary artery disease in elderly patients undergoing TAVI:

insight the Italian CoreValve registry - C. Tamburino

▸ Does previous coronary bypass surgery increase the risk for patients

undergoing TAVI? - O. Wendler

▸ TAVI in patients after previous CABG: feasibility and outcome

A. Narayana

▸ The effects of pre-existing significant coronary artery disease upon

outcome after TAVI using the Edwards bioprosthesis - M. Khawaja

▸ The impact of coronary artery disease on clinical outcomes in patients

undergoing TAVI - T. Pilgrim

▸ Impact of pre-procedural percutaneous coronary intervention on

outcomes after TAVI - G. Richardt

▸ Take-home message - C. Kaiser


Abstract session

Accuracy of IVUS and optical coherence tomography to quantify coronary

artery disease and evaluate PCI results


Chairpersons: A. Pichard, H.M. Garcia-Garcia

▸ Introduction - A. Pichard

▸ The prediction of severity and risk profile of coronary artery disease assed

by IVUS and virtual histology from non-invasive examinations and genetic

analysis - T. Kovarnik

▸ Single and repeated endovascular imaging cause significant but equal

acute endothelial injury of a temporary nature as opposed to stent

induced injury - H.M. Van Beusekom

▸ Optimal IVUS criteria and their accuracy for defining the functional significance

of intermediate coronary stenoses of different locations - S.J. Tahk

▸ Absence of a relation between plaque composition in proximal non-target

coronary vessels vs. cardiovascular event risk: a pilot study with

volumetric radiofrequency-based IVUS - J. Huisman

▸ Impact of anemia on coronary plaque components: virtual histology-IVUS

analysis - Y.J. Hong

▸ Optical coherence tomography assessment of vessel trauma after stent

implantation with long-term outcomes - K. Bouki

▸ Take-home message - H.M. Garcia-Garcia

97



All you need to know about bifurcation stenting

Chairpersons: Y. Louvard, J. Ormiston

Objective:

▸ At the end of this 90-minute ‘All you need to know about...’

session the audience should have an up-to-date knowledge

of the field, relevant for their clinical practice. They should be

familiar with the current evidence base, existing guidelines

and have an understanding of the open questions that need

addressing in the near future.

▸ Introduction - Y. Louvard

▸ Background - All you need to know about bifurcation before treatment

G. Stankovic

▸ Clinical data - All about randomised clinical trials, meta-analysis,

registries... - N. Curzen

▸ Technical aspects - Stenting the main vessel first across the side branch,

practical aspects - J.F. Lassen

▸ Guidelines - Recommendations from the ESC guidelines and the European

Bifurcation Club - R. Albiero

▸ Unresolved issues - Role for double stenting strategies, role for dedicated

devices - M. Ferenc

▸ Questions & answers - M. Pan, G. Stankovic

Wednesday 18th

98




We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


16:30-18:00 Room 252AB

How should I treat?

Complex bifurcation and chronic total occlusion lesions: Asia meets Europe


Chairpersons: E. Barbato, M.A. Rosli

Objectives:

▸ To share knowledge and experience between experts from different

geographic areas on the challenges and current solutions for treating

complex bifurcation and chronic total occlusion lesions

▸ To improve understanding of the technical issues in complex bifurcation

and chronic total occlusion lesion management

▸ Introduction and objectives - M.A. Rosli

▸ Complex chronic total occlusion lesion

- Case presentation - N. Inoue

- How would I treat? - D. Hildick-Smith

- How would I treat? - S. Soerianata

- How did I treat? - N. Inoue

- Discussion

- Consensus - E. Barbato

▸ Complex bifurcation lesion

- Case presentation - O. Darremont

- How would I treat? - S. Soerianata

- How would I treat? - D. Hildick-Smith

- How did I treat? - O. Darremont

- Discussion

- Consensus - M.A. Rosli

▸ Take-home message - E. Barbato

99


16:30-18:00 Room 253

How should I treat?

What treatment is best for the acutely compromised acute myocardialinfarction patient: door to balloon or door to device?With an unrestricted educational grant from MAQUET CARDIOVASCULARChairperson: N.H. Pijls

Objectives:▸ To know how to handle cardiogenic shock during primary PCI

▸ To understand the principles of left ventricular unloading prior to reperfusion

▸ To learn how to choose and insert a support device during PCI-related

calamities

▸ Introduction and objectives - N.H. Pijls

▸ Cardiogenic shock

- Case presentation - M. Abdel-Wahab

- How would I treat? - D. Fraser

- How would I treat? - H. Thiele

- How did I treat? - M. Abdel-Wahab

- Discussion

- Consensus - N.H. Pijls

▸ Main vessel PCI after cardiac arrest

- Case presentation - T. Schwab

- How would I treat? - D. Fraser

- How would I treat? - H. Thiele

- How did I treat? - T. Schwab

- Discussion

- Consensus - N.H. Pijls

▸ Take-home message - N.H. Pijls

Wednesday 18th

100



We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease



Plenary session

ABC for inventors

Chairpersons: P. Bonhoeffer, J. Simpson

Objectives:

▸ To understand the pros and cons of different types of funding for the

development of ideas

▸ To understand concepts of patent protection

▸ To get insights into the strategy of moving an idea from conception to

commercialisation

▸ Introduction and objectives - P. Bonhoeffer

▸ Concepts and opportunities of research funding - A. Kastrati


▸ Concepts and opportunities of commercial funding - P. Marco


▸ How and why to protect ideas - intellectual property - M.B. Leon


▸ The regulators interest in developing ideas or stopping them

M.W. Krucoff


▸ Transition from academic projects to commercial exploitation

S. Hoerstrup


▸ Pros and cons to develop technology in Europe, US, Asia - S. Oesterle


▸ My personal experience with TAVI - A. Cribier


▸ Panel discussion: how can we make life easier for inventors

101


16:30-18:00 Room 342AB

Symposium

Vascular access and medical management of acute coronary syndrome:

what does the future hold?

With an unrestricted educational grant from SANOFI AVENTIS

Chairperson: S.R. Mehta

Objectives:

▸ To explore the risks and benefits associated with radial and femoral access

for the treatment of acute coronary syndrome

▸ To review the results of recently completed trials of new antithrombotics

and anticoagulants in acute coronary syndrome

▸ To highlight ongoing Phase III trials, focusing on treatment of acute

coronary syndrome with Otamixaban

▸ Introduction and objectives - S.R. Mehta

▸ Radial vs. femoral access: US approach - M. Cohen

▸ Radial vs. femoral access: European approach - C. Cavalini


▸ What does the future hold?

- New antiplatelets and antithrombotics - C. Cavalini

- SEPIA-acute coronary syndrome results - M. Cohen

- TAO trial - S.R. Mehta

▸ Take-home message - S.R. Mehta

16:30-18:00 Room 351

How should I treat?

Practical experience in bifurcation stenting: is there a simple solution?

With an unrestricted educational grant from TRYTON MEDICAL

Chairperson: T. Lefèvre

Objectives:

▸ To review the treatment options of the real-world patients with bifurcation

disease

▸ To discuss recent clinical data that motivates for the best available treatment


▸ Patient treated on left main disease

- Case presentation - R.J. Van Geuns


- How would I treat? - J.W. Park

- How did I treat? - R.J. Van Geuns

- Discussion


Wednesday 18th

102


We

dn

esd

ay 1

8th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Patient treated on a complex bifurcation (Medina 1.1.1)

- Case presentation - G. Tarantini


- How would I treat? - J.W. Park

- How did I treat? - G. Tarantini

- Discussion


▸ Take-home message - T. Lefèvre

16:30-18:00 Room 352AB

Symposium

Precision guided therapy: simple techniques to go beyond angiography ineveryday practice With an unrestricted educational grant from VOLCANOChairperson: J. Fajadet

Objectives:▸ To raise the importance of fractional flow reserve and prospect data in

intermediate lesion assessment: "a simple start to the PCI strategy"

▸ To clarify the positioning of advanced diagnostics using fractional flowreserve and imaging during coronary interventions

▸ Introduction and objectives - J. Fajadet

▸ Different guidance tools do different things: how the indication can helpdecide between fractional flow reserve, IVUS and optical coherencetomography - G. Guagliumi

▸ Precision guided acute myocardial infarction and the role of IVUS, virtualhistology IVUS and VIBE - D. Dudek

▸ Fractional flow reserve guided SYNTAX scores - K.G. Oldroyd

▸ Discussion


17:00-18:00 Room 242A Clinic

Abstract session

Registries of new generation of bare metal stentsSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: R. Byrne, M. Awata, B.K. Goyal

▸ Introduction - R. Byrne

▸ Effect on clinical restenosis of an ultra-thin strut cobalt chromium stentvs. a thin strut stainless steel stent - P. Grossi

▸ Coronary angioplasty with bare metal stents: are there any differences?F. Costa

▸ Nine-month outcomes with a second generation cobalt chromium baremetal stent in the treatment of stenotic coronary artery lesions: resultsfrom the PIONIR study - S. Hoffmann

▸ Long-term comparison of stainless steel and cobalt-chromium bare metal stents:clinical impact of the metallic alloy in a real world scenario - A.G. Spadaro

▸ Take-home message - M. Awata103



Main session

Current challenges with TAVI for severe aortic stenosis

Chairpersons: A. Vahanian, T. Walther

Panellists: M. Bunc, P. de Jaegere, J. Fajadet, E. Garcia, U. Gerckens,

R. Hoedl, A.P. Kappetein, R. Virmani, W. Wisser

Objectives:

▸ To provide an update on the indications for TAVI

▸ To understand PCI indications and timing in patient candidates for TAVI and

suffering from severe coronary artery disease

▸ To understand how to prevent and treat major procedure-related

complications during TAVI

▸ Introduction and objectives - A. Vahanian

▸ How shoud I treat - Under the auspices of the Austrian Working Group on

Interventional Cardiology and the Slovenian Working Group of Invasive and

Interventional Cardiology

- Introduction and objectives - W. Wisser

- Case presentation - R. Hoedl

- How would I treat? - J. Aichinger

- How would I treat? - D. Zorman

- How did I treat? - R. Hoedl

- Discussion/Consensus - M. Bunc

▸ Keynote lecture - Reflect together on the means and strategies to improve

current outcomes with TAVI - U. Gerckens

09:05-09:55 Live demonstration from St Thomas Hospital, London - United

Kingdom

▸ Complication case - Severe paravalvular aortic regurgitation after TAVI

T. Schmitz

▸ Complication case - TAVI complicated by common femoral artery rupture

and occlusion. Endovascular repair with Viabahn endoprosthesis

A. Silvestro


Kingdom

▸ The vision of the pathologist - R. Virmani

▸ Final key remarks - J. Fajadet

Thursday 19th

104



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


08:00-12:00 Theatre Bleu Innovation


Glimpse into the future - Bioresorbable scaffolds: a new era in clinical

interventional cardiology

Chairpersons: P.W. Serruys, R.J. van Geuns

Panellists: A. Abizaid, Y. Onuma, J. Ormiston, R. Waksman

Objectives:

▸ To understand the potential of bioresorbable scaffolds in the treatment of

coronary artery disease

▸ To learn the principles of biodegradation and vascular restoration in

response to bioresorbable scaffolds

▸ To gain insight into pre-clinical and clinical data with bioresorbable

scaffolds

▸ Introduction: 10 reasons why metallic DES should be replaced by

bioresorbable scaffold - P.W. Serruys

▸ ABC's of bioresorption of metallic scaffolds and how to design them

B. Warnack

▸ The bioresorption process of polylactide devices: tissue and cellular

mechanisms - R. Virmani



▸ Bioresorption and new materials - M. Vert

▸ Pre-clinical and clinical evaluation of poly-tyrosine carbonate scaffold

A. Abizaid

▸ Pre-clinical and clinical evaluation of drug-eluting resorbable metallic stent

R. Waksman

▸ Biosolve I - S. Verheye

▸ Five-year clinical and non-invasive angiographic follow-up of Absorb

Cohort A trial - J. Ormiston

▸ Six-month and one-year follow-up of Absorb Cohort B trial: clinical results

and multi-imaging modality assessment - P.W. Serruys

▸ Tips & tricks for implantation of bioresorbable scaffold: why is vessel

sizing important? - R.J. van Geuns



▸ Preliminary results of Absorb Extend - A. Abizaid

▸ Take-home message - R.J. van Geuns

105


08:00-12:00 Theatre Bordeaux Technique

Plenary session

Complex coronary chronic total occlusion interventions:

live from Toyohashi Heart Center, Japan and CCT

meeting@EuroPCR

Chairpersons: M. Ochiai, E. Tsuchikane

Panellists: A. Galassi, M. Kimura, G. Sianos, G. Werner

With continuous live demonstration from Toyohashi Heart Center, Toyohashi -

Japan

Objectives:

▸ To step up to the next level in antegrade approach

▸ To learn the latest techniques in retrograde approach

▸ To understand pathophysiology of coronary chronic total occlusion

lesions: images for coronary chronic total occlusion procedures

▸ Introduction and objectives - M. Ochiai

▸ Retrograde approach - What are the new guidewires and devices - S. Saito

▸ Complex antegrade approach - What are the new guidewires and devices

M. Yamane

▸ Retrograde approach - Tips & tricks for increased success - K. Igarashi

▸ Concluding remarks and take-home message - E. Tsuchikane

08:00-09:30 Room 241 Clinic

Forum

Saphenous vein graft interventions


Chairperson: M. Strozzi

▸ Introduction - M. Strozzi

▸ Saphenous vein graft angioplasty with rotablation - K. Longman

▸ Left internal mammary artery graft intervention - K. Chhatrapati

▸ Angioplasty of single surviving degenerated venous graft without distal

protection device using dumb-bell technique - A. Dhall

▸ It was a complete stitch-up post-CABG PCI left internal mammary artery -

left anterior descending anastamosis - R.T. Gerber

▸ The dilemma of treating an undilatable stenosis in a giant saphenous vein

graft - R. Sachdeva

▸ Take-home message - M. Strozzi

Thursday 19th

106


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Forum

PCI in thrombotic saphenous vein graft lesions


Chairpersons : P. Vermeersch, K-H. Sim

▸ Introduction - P. Vermeersch

▸ Thrombosis and in-stent restenosis in saphenous vein graft-OM treated

with TAXUS stent - an optical coherence tomography perspective

M. Chan

▸ A case of STEMI at the site of graft after Piehler operation - T. Shibasaki

▸ Saphenous vein graft acute occlusion intervention - K. Poon

▸ Take-home message - K-H. Sim


Abstract session

Optical coherence tomography: revealing the results of PCI with DES and

bioresorbable stents


Chairpersons: H.M. Garcia-Garcia, P. Motreff, F. Prati

▸ Introductory lecture - Value and limitations of optical coherence tomography

for the evaluation of coronary implants: current status - H.M. Garcia-Garcia

▸ Optical coherence tomography assessment of early strut coverage in

patients treated with the pro-kinetic Probio-coated bare cobalt-chromium

stent - P. Stella

▸ Tissue coverage of a hydrophilic polymer-coated Zotarolimus-eluting stent

vs. a fluoropolymer-coated Everolimus-eluting stent at 13-month

follow-up: an optical coherence tomography substudy from the

RESOLUTE all-comers trial - J.L. Gutiérrez-Chico

▸ Long-term tissue coverage of a bioresorbable polylactide polymer-coated

Biolimus-eluting stent: comparative sequential assessment with optical

coherence tomography till complete resorption of the polymer


▸ Take-home message - P. Motreff

107



Forum

Coronary aneurysms and fistulae


Chairpersons: P. Ruygrok, N.Q. Nguyen

▸ Introduction - P. Ruygrok

▸ Successful revascularisation by using 5Fr delivery catheter with

Kawasaki's disease combined with acute myocardial infarction

Y. Nomura

▸ Gigantic coronary arteriovenous fistula embolisation - D. Hazarbasanov

▸ High cardiac output heart failure treated with covered stent

S. Yaroslavtsev

▸ Take-home message - N.Q. Nguyen


Forum

Bifurcation techniques


Chairpersons: G. Stankovic, S. Dutta

▸ Introduction - G. Stankovic

▸ Successful percutaneous coronary stent explantation by caged sidebranch

wire - S.E. Hardt

▸ Reverse wire technique with double port microcatheter in treating severe

angulated left anterior descending stenosis lesion - Y. Nozaki

▸ Double-kissing crush technique for treatment of an unprotected left main

lesion in a high-risk patient - V. Kushwaha

▸ Take-home message - S. Dutta

Thursday 19th

108



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

Impact of lesion morphology and deployement technique on DES

outcomes


Chairperson: H. Eteiba

▸ Introduction - H. Eteiba

▸ Stent balloon inflation duration is a critical factor for optimal stent

deployment - D. Mylotte

▸ Very small vessels (<2.5mm) treated with Nobori DES: two-year clinical

outcomes - D. Carrié

▸ Charlson comorbidity index as a predictor of clinical outcomes after PCI

P. Urban

▸ Five-year clinical outcome in patients with small vessel disease treated

with drug-eluting vs. bare metal stenting - E. Puymirat

▸ Take-home message - H. Eteiba

08:00-09:00 Room 341 Clinic

Abstract session

DES and endothelial function: a difficult relationship?


Chairpersons: M. Hamilos, A. Lerman, M. Ostojic

▸ Introduction - M. Hamilos

▸ Endothelial Nitric Oxide Synthase (eNOS) activity and Vasomotor

dysfunction of coronary Aateries after DES: link or chance?

A. Perez de Prado

▸ Incomplete neointimal coverage is correlated with coronary endothelial

dysfunction after DES implantation - Y. Mitsutake

▸ A prospective randomised comparison of vasodilation after implantation

of everolimus-eluting stents and bioactive titanium-nitrid-oxide-coated

stents in acute coronary syndromes - association to stent strut coverage

T. Kiviniemi

▸ Effects of angiotensin-converting enzyme inhibitor and angiotensin

receptor blocker on coronary endothelial function after DES implantation

Y. Mitsutake

▸ Take-home message - A. Lerman

109


08:00-09:00 Room 343 Clinic

Abstract session

Devices and imaging the results


Chairpersons: E. Eeckhout, P. Bonhoeffer

▸ Introduction - E. Eeckhout

▸ Percutaneous closure of multiple paravalvular leaks with amplatzer

vascular plug III device - J. Dutary

▸ Atrial septostomy in patients with end-stage pulmonary hypertension:

novel approach to transseptal puncture - A. Amaducci

▸ Rotational angiography (DYNA-CT) for mitral valve imaging: a work in

progress - J. Seeburger

▸ Magnetic resonance imaging for optimized implantation and long-term

monitoring of patients receiving a left atrial appendage occluder - A. Sinha

▸ Take-home message - P. Bonhoeffer


Forum

Management of coronary perforations during PCI - Part II


Chairpersons: B. Meier, D. Deleanu

▸ Introduction - B. Meier

▸ A case of coronary rupture when deploying Cypher select+ - Y. Fujimoto

▸ Delayed cardiac tamponade following rotational atherectomy and PCI to

severely calcified ostial left anterior descending lesion - Y. Malaiapan

▸ A horrible coronary rupture during rotational atherectomy which was

succesfully sealed with three covered stents into a long bare metal stent

as a substitute of vessel wall - S. Otsuji

▸ Take-home message - D. Deleanu

08:00-09:00 Room 353 Clinic

Abstract session

DES registries - Part I


Chairpersons: F. Alfonso, D. Echeverri, A. Ernst

Thursday 19th

110


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction - F. Alfonso

▸ How does the Everolimus-drug eluting coronary stent Xience V; work for

the treatment of patients with non ST elevation acute coronary syndrome

with coronary angioplasty in the daily practice - A. Iniguez

▸ Exploring the possible clinical impact of polymer coating in DES

technology: clinical outcome of consecutive patients treated by

Zotarolimus-eluting Endeavor stent and Zotarolimus-eluting Resolute

stent - G.P. Talarico

▸ Head-to-head comparison of Everolimus- vs. Zotarolimus- and Sirolimus-

eluting stents: one-year clinical outcomes from the ProEnCy registry

G. Richardt

▸ Off label use of DES with biodegradable polymer at two years - G.B. Danzi

▸ Take-home message - D. Echeverri

08:30-10:00 Room 242A

How should I treat?

Strategies of treatment in patients with complex multivessel coronary

artery disease

Under the auspices of the Danish Working Group of Interventional

Cardiology and the Lebanese Working Group of Interventional Cardiology

Chairpersons: A. Sarkis, L. Thuesen

Objectives:

▸ To learn the risk stratification in the multivessel disease patient

▸ To understand the optimal treatment strategy in the multivessel patient

▸ To discuss prioritisation, staging and different technical skills with

percutaneous revascularisation in multivessel patient

▸ Introduction and objectives - L. Thuesen

▸ Diabetic patient with three vessel disease including a complex left anterior

descending lesion

▸ Case presentation - G. Ghanem

- How would I treat? - Z. Ghazzal

- How would I treat? - P. Hostrup

- How did I treat? - G. Ghanem

- Discussion

- Consensus - A. Sarkis

▸ Elderly patient with three vessel disease including a coronary chronic total

occlusion lesion

- Case presentation - M. Maeng

- How would I treat? - P. Hostrup

- How would I treat? - Z. Ghazzal

- How did I treat? - M. Maeng

- Discussion

- Consensus - L. Thuesen

▸ Take-home message - A. Sarkis 111



LTT - How to treat a patient with multivessel coronary

disease

Facilitators: M. Haude, M. Heigert, M. Gilard

Panellists: D. Carrié, M. Deshpande, A. Elsässer, M. Oberhoff

Media driver: L.A. Malek

Live in-a-box®


Plenary session

Computed tomography for coronary and structural heart disease:

interactive case reading

Chairpersons: J.J. Bax, F. Civaia

Panellist: C. Van Mieghem

Objectives:

▸ To acquire a systematic and practical approach for reading cardiac

computed tomography

▸ To understand tips, tricks and artefacts, as well as common pitfalls

▸ To take home which are currently "good" and "poor" indications for cardiac

computed tomography in the various common clinical scenarios

(coronary and valvular disease)

▸ Introduction and objectives - F. Civaia

▸ Case reading 1 - C. Van Mieghem

▸ Case reading 2 - C. Van Mieghem

▸ Case reading 3 - F. Civaia

▸ Case reading 4 - V. Delgado

▸ Case reading 5 - V. Delgado

▸ Case reading 6 - F. Civaia

▸ Final key remarks: appropriate clinical indications for cardiac computed

tomography in 2011 - J.J. Bax

09:00-10:30 Room 243 Clinic

Abstract session

PCI for bifurcation lesions: clinical results


Chairpersons: G. Pavlides, B. Farah, K. Niemela

Thursday 19th

112



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction - G. Pavlides

▸ Challenging bifurcation stenting: two-year clinical outcomes after

treatment with a new generation DES - A. Serra

▸ A multicentre randomised comparison of drug-eluting balloon plus bare

metal stent vs. bare metal stent vs. DES in bifurcation lesions treated with

a single-stenting technique: 6-month angiographic and 12-month clinical

results of the DEBIUT (Drug-Eluting - A. Belkacemi

▸ Final kissing balloon dilatation in simple stenting of coronary bifurcation

lesions: pooled analysis of the BBC ONE study and the Nordic-Baltic

bifurcation studies - N.R. Holm

▸ Initial results of BLAST: bifurcation lesion analysis and stenting of thin cap

fibroatheroma (TCFA/FA) as measured by VH-intravascular ultrasound - a

global multicentre, prospective, randomised study - T. Lefèvre

▸ Improving clinical risk prediction for PCI for bifurcation lesions: the ACEF

(age, creatinine, ejection fraction) score - G.M. Sangiorgi

▸ Take-home message - K. Niemela


All you need to know about gender differences

in percutaneous intervention

Chairpersons: A. Chieffo, A. Hoye

Panellists: F. Malik, A.S. Petronio, D.O. Williams

Objective:






▸ Introduction and objectives - A. Hoye

▸ Background - Clinical problem: scope of the problem, gender biases

C. Rihal

▸ Clinical data - Coronary and carotid revascularisation in women

M.C. Morice

▸ Issues in practice - Pharmacological management in acute coronary

syndrome - R. Mehran

▸ Recommendations - Do we need specific recommendations for the

treatment of women with cardiovascular disease? - G. Mikhail

▸ Unresolved issues - Approach to percutaneous valve treatment in women,

aortic and mitral - T. Feldman

▸ Questions & answers with the panellists

113



Forum

Unusual cases in primary PCI

Session comprising selected EuroPCR 2011 clinical

case submissions

Chairpersons: D. Dudek, S. Chen

▸ Introduction - D. Dudek

▸ Percutaneous treatment of giant coronary aneurysm - J. Dutary

▸ Acute anterior myocardial infarction and sudden death caused by tumoral

myocardial invasion - E. Gutierrez

▸ Chest pain in a post-partum woman - S. Chia

▸ Unusual case of primary angioplasty - S. Basavarajaiah

▸ A "Ball-Valve" thrombus causing STEMI - S.S. Kalra

▸ Take-home message - S. Chen


Abstract session

Radial or femoral access: revisiting an old dispute


Chairpersons: M.A. Rosli, V. Dangoisse

▸ Introduction - M.A. Rosli

▸ Safety and efficacy of transradial vs. transfemoral arterial primary

coronary angioplasty for acute myocardial infarction single-centre

experience - A. Youssef

▸ Early invasive strategy for acute coronary syndromes: clinical impact of

radial vs. femoral approach in the era of triple antiplatelet therapy

J. Delgado Silva

▸ Comparison of radial vs. femoral approach with drug-eluting stenting for

coronary bifurcations: results from the COBIS (coronary bifurcation

stenting) registry - S.H. Her

▸ Left radial approach for coronary artery catheterisation: a comparison with

right radial approach - R. Diletti

▸ A randomised study of transradial vs. transulnar artery approach for

coronary interventions - G. Hahalis

▸ Same wrist intervention via the cubital (ulnar) artery in case of radial

puncture failure for percutaneous cardiac catheterisation or intervention:

the multicentre prospective SWITCH registry - P. Agostoni

▸ Take-home message - V. Dangoisse

STENT

FOR LIFE

Thursday 19th

114


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

Management of arterial access in TAVI


Chairpersons: F. Casselman, N. van Mieghem

▸ Introduction - F. Casselman

▸ Feasibility and safety of percutaneous management of vascular access site

complications - implications for transfemoral aortic valve implantation

S. Stortecky

▸ Transaortic TAVI using Edwards Sapien valve: a novel approach for the

O. Nawaytou

▸ One-year results of the subclavian access for TAVI with the CoreValve

bioprosthesis in 132 consecutive patients - M. De Carlo

▸ Are there differences in clinical outcomes between patients treated

through a transaxillary vs. a transfemoral access route for TAVI?

S. Bleiziffer

▸ Transfemoral aortic valve implantation: new criteria to predict vascular

complications - K. Hayashida

▸ Large calibre arterial access device closure for percutaneous aortic valve

interventions: use of the Prostar system in 118 cases - J. Cockburn

▸ Take-home message - N. van Mieghem

115



Plenary session

Invasive strategies for STEMI initially treated with fibrinolysis:

a case-based discussion

Chairpersons: C.K. Naber, J.J. Piek

Panellists: M. Alameda, J. Belardi, F. Fernandez-Aviles, J. Goicolea,

S.M. Hiremath, A. Leitao-Marques, F. Van de Werf

Objectives:

▸ To understand time-related issues and trade-offs

▸ To understand the specifics of performing PCI after fibrinolysis

▸ To learn how to avoid complications during PCI for STEMI post-fibrinolysis

▸ Introduction and objectives - C.K. Naber

▸ Case presentation and practical interactive discussion - S.M. Hiremath

▸ Discussion - F. Fernandez-Aviles, F. Van de Werf

▸ Concluding remarks - S.M. Hiremath

▸ Keynote lecture - Reflect together on how to manage STEMI patients who

are referred for PCI after thrombolysis - F. Fernandez-Aviles

▸ Stent dislodged from its balloon and stuck in left main and left anterior

descending ostium - Case presentation and practical interactive

discussion - V. Sardana

▸ Discussion - S.M. Hiremath

▸ Case presentation and practical interactive discussion - S.M. Hiremath

▸ Discussion - F. Fernandez-Aviles, F. Van de Werf

▸ Concluding remarks - S.M. Hiremath

▸ How should I treat case - Under the auspices of the Portuguese

Association of Interventional Cardiology and the Working Group on

Percutaneous Coronary Interventions of the Spanish Society of Cardiology

- Introduction and objectives - A. Leitao-Marques

- Case presentation - J.M. Ruiz Nodar

- How would I treat? - H. Pereira

- How would I treat? - M. Masotti

- How did I treat - J.M. Ruiz Nodar

- Discussion & consensus - J. Goicolea

▸ Reanimator II - L. Davin

▸ Discussion - M. Alameda, J. Belardi

▸ Consensus and final key remarks - J.J. Piek

STENT

FOR LIFE

Thursday 19th

116



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

DES and bioactive stents for STEMI


Chairpersons: D. Iosseliani, J. Koolen, P. Yan

▸ Introduction - D. Iosseliani

▸ Sustained patency of Paclitaxel-eluting stents vs. bare metal stents 4 years

after implantation in acute STEMI - M.A. Vink

▸ DES with biodegradable polymers in acute myocardial infarction

F. Fath-Ordoubadhi

▸ Comparison between Zotarolimus-eluting stents and first generation DES

in the treatment of patients with acute STEMI - K.W. Park

▸ One-year clinical safety and efficacy study on acute STEMI patients

undergoing primary PCI using Endeavour Resolute Zotarolimus-eluting

stent vs. driver bare metal stent: a single-centre study - S.H. Ong

▸ HEBE-III randomised trial: A Zwolle sub-study with the Genous stent

H. Suryapranata

▸ Take-home message - J. Koolen


Forum

Mitral valve interventions


submissions

Chairpersons: O. Franzen, F. Maisano

▸ Introduction - O. Franzen

▸ Chordal rupture and leaflet tear after MitraClip implantation - T. Gorgadze

▸ Use of the MitraClip to treat mitral regurgitation in a patient with an

amplatzer patent foramen ovale occluder - M. Neuss

▸ Novel percutaneous closure of a mitral paravalvular leak - T. Keeble

▸ Surgical bailouts in complicated transcatheter repair of severe mitral

paravalvular leak - N. Al-Attar

▸ Perioperative STEMI during mitral valve annuloplasty: role of early

angiography - B. Vaquerizo

▸ Take-home message - F. Maisano

117



Abstract session

3D coronary angiography and novel imaging techniques: implications

for PCI


Chairpersons: A. Linke, J. Escaned, S. Nanto

▸ Introduction - A. Linke

▸ Feasibility of a new C-arm angiography (DYNA-CT) based three-

dimensional coronary reconstruction algorithm in combination with

myocardial perfusion assessment - A. Sinha

▸ Clinical validation of a new 3-dimensional imaging system for quantitative

and qualitative judgement of coronary artery stenoses - A. Sinha

▸ The impact of acquisition angle differences on three-dimensional

quantitative coronary angiography - S. Tu

▸ Accuracy of device localisation in PCI based on the IC-PRO guidance

system - A. Sinha

▸ New image processing system improves coronary artery anatomy

assessment, device selection, positioning and post-deployment analysis

A. Frimerman

▸ Percutaneous recanalisation of coronary chronic total occlusion:

pre-procedural road mapping with MDCT coronary angiography (MDCT-CA)

D. Tavella

▸ Take-home message - J. Escaned

10:00-12:00 Room 351

How should I treat?

Fractional flow reserve in unstable or myocardial infarction patients with

multivessel coronary artery disease

Under the auspices of the Working Group of Interventional Cardiology of

the Croatian Cardiac Society, the Working Group for Interventional

Cardiology of the Cyprus Society of Cardiology, the Working Group of

Hemodynamics and Intervention of the Hellenic Cardiological Society and

the Working Group on Interventional Cardiology of the Cardiology Society

of Serbia

Chairpersons: L. Michalis, P. Avraamides, A. Ernst, M. Ostojic

Objectives:

▸ To understand the role of fractional flow reserve in post myocardial

infarction patients with multivessel coronary artery disease

▸ To assess the myocardial viability and subsequently the need for

revascularisation in post myocardial infarction patients with moderate

coronary artery stenosis

▸ To understand the role of non invasive and invasive tests in identifying

coronary lesions responsible for myocardial ischemia

Thursday 19th

118


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - L. Michalis

▸ Post myocardial infarction with moderate stenosis in the infarct-related

artery. Assessment of myocardial ischemia and viability using a pressure

wire. Comparison with other non-invasive modalities

- Case presentation - M. Hamilos

- How would I treat? - K. Toutouzas

- How would I treat? - M. Strozzi

- How did I treat? - M. Hamilos

- Discussion

- Consensus - L. Michalis

▸ Patients with stable angina and multivessel multilesion coronary

angiography. Percutaneous treatment based upon coronary pressure

measurements

- Case presentation - J. Bulum

- How would I treat? - M. Strozzi

- How would I treat? - K. Toutouzas

- How did I treat? - J. Bulum

- Discussion

- Consensus - A. Ernst

▸ PCI in acute coronary syndrome patient with borderline stenosis of left

anterior descending artery as assessed with non invasive coronary flow

reserve and invasive fractional flow reserve

- Case presentation - T. Komodromos

- How would I treat? - G. Georgiou

- How would I treat? - D. Orlic

- How did I treat? - T. Komodromos

- Discussion

- Consensus - P. Avraamides

▸ Take-home message - M. Ostojic

10:30-12:00 Room 242B

Forum

China meets EuroPCR

With the collaboration of China Interventional Therapeutics (CIT)

Facilitators: E. Grube, J. Marco

Panellists: M. Buchbinder, R. Gao 高润霖, J.B. Ge 葛均波, P. Urban

Participants: J. Chen 陈纪言, S. Chen 陈绍良, Y. Chen 陈韵岱, G. Fu 傅国胜,

S. Lu 吕树铮, S. Qiao 乔树宾, W. Wang 王伟民

119


10:30-12:00 Room 243 Clinic

Abstract session

Clinical outcome after TAVI: mid-term follow-up Session comprising selected EuroPCR 2011 abstract submissionsChairpersons: I. Lang, G. Manoharan, T. Modine

▸ Introduction - T. Modine

▸ Survival and predictors of late mortality after TAVI of severe symptomatic

aortic stenosis with the CoreValve prosthesis - A.J. Munoz-Garcia

▸ Final one-year outcomes of >2,300 patients in the source of registry, usingthe Edwards Sapien bioprostesis for TAVI in Europe - O. Wendler

▸ Three years of TAVI: results of a single centre experience with the

Medtronic CoreValve prosthesis in 111 patients - M. Abdel-Wahab

▸ Outcomes following TAVI with both Edwards SAPIEN and CoreValvedevices in a single centre: the on-going Milan experience - C. Godino

▸ Procedural, 30-day, 6 month and one-year outcome following Corevalve orEdwards TAVI: results of the Belgian Registry - J. Bosmans

▸ Improvements in TAVI outcomes in lower surgical risk patients: a glimpseinto the future - N. Piazza

▸ Take-home message - I. Lang


Hot Line session

Late breaking scienceChairpersons: B. De Bruyne, R. Kornowski, M.W. Krucoff

▸ Introduction - B. De Bruyne

▸ STIB trial - V. Legrand

▸ Late vascular healing after implantation of sirolimus-eluting and paclitaxel-eluting stents: an optical coherence tomography study - S. Windecker

▸ Incidence and prognostic significance of new-onset atrial fibrillation

recorded by an implantable cardiac monitor in post acute myocardialinfarction patients - P.E. Bloch Thomsen

▸ Single high-dose erythropoietin administration immediately after

reperfusion in STEMI: primary results of the randomised EPOMI trialF. Prunier

▸ HEBE-III randomised trial: a Zwolle sub-study with the Genous stentH. Suryapranata

▸ The effect of exenatide on reperfusion injury in patients with acute

myocardial infarction - T. Engstroem

▸ Rosuvastatin pre-treatment in patients undergoing elective PCI to reducethe incidence of myocardial periprocedural necrosis (ROMA trial): one-year follow-up - G. Sardella

▸ Post-conditioning during coronary angioplasty in acute myocardialinfarction: the POST-AMI trial - G. Tarantini

Thursday 19th

120


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



LTT - How to perform optical coherence tomography

imaging

Facilitators: G. Guagliumi, M. Radu

Panellists: T. Akasaka, P. Motreff, L. Räber




Abstract session

Testing antiplatelet reactivity in daily practice


Chairpersons: M. Valgimigli, T. Cuisset, P. Sinnaeve

▸ Introduction - M. Valgimigli

▸ Routine tailoring of antiplatelet therapy after coronary stent implantation

has the potential to eradicate early definite stent thrombosis in compliant

patients - G. Christ

▸ Peri-procedural variations of platelet function in patients undergoing PCI

F. Mangiacapra

▸ Individualising clopidogrel therapy according to the multiplate

aggregometry test reduces the ischemic complications in patients after

PCI and stenting - D. Hazarbasanov

▸ Platelet aggregation in stable angina patients treated with aspirin and

clopidogrel is modulated by a 6.3 / 6.7 kb polymorphism of the platelet

Alpha2A-adrenergic receptor - A.J. Peace

▸ Real-time clopidogrel gain-of-function and loss-of function genotype

screening with NanosphereVerigene2C19/CBSNucleic Acid - M. Tebaldi

▸ Closing lecture: testing antiplatelet reactivity in daily practice

F.J. Neumann

▸ Take-home message - T. Cuisset


Abstract session

Fractional flow reserve: additional or complementary to coronary

invasive imaging?


Chairperson: P. MacCarthy

121


▸ Introduction - P. MacCarthy

▸ Comparison of different strategies to obtain maximal hyperaemia in the

assessment of fractional flow reserve for intermediate coronary stenosis:

intravenous adenosine vs incremental dosages of intracoronary adenosine

vs intracoronary nitroprusside (Nitrop) - A.M. Leone

▸ Development and validation of the fractional flow reserve angiographic scoring

tool (FAST) to improve the angiographic grading and selection of intermediate

lesions that require fractional flow reserve assessment - S.P. Hoole

▸ Non-invasive computation of fractional flow reserve in patients with

multivessel coronary artery disease - A. Erglis

▸ Defer PCI on fractional flow reserve basis: 4-year follow-up in single-

centre retrospective study - S. Uguccioni

▸ Optical coherence tomography parameters are only moderately predictive

of fractional flow reserve, suggesting complimentary roles of these

technologies in intermediate coronary lesion assessment - S.P. Hoole

▸ Performance of three-dimensional vs. two-dimensional quantitative

coronary angiography in discriminating functionally significant coronary

stenoses according to fractional flow reserve - F. Mangiacapra

▸ Take-home message - P. MacCarthy

10:30-12:00 Room 343 Clinic

Abstract session

Cross-talk between PCI and surgery


Chairpersons: G. Fournial, A. Jonsson, K. Niemela

▸ Introduction - G. Fournial

▸ Is there any impact of borderline significant non-coronary lesions on long-

term outcomes of CABG surgery? - K. Shafranskaya

▸ The "2nd Italian CABG Project" - short-term outcomes in patients with

CABG - S. Rosato

▸ PCI in patients with coronary artery disease and previous CABG: acute and

long-term results - A. Sanchez

▸ Intraoperative shuntography for immediate control of coronary bypass

surgery - B. Alekyan

▸ Prophylactic placement of percutaneous LVAD for high risk PCI in patients

with systolic dysfunction - K. Shah

▸ Perioperative cardiac risk of non-cardiac surgery after Sirolimus eluting

stent - 5-year follow-up - Y. Ohno

▸ Take-home message - A. Jonsson

Thursday 19th

122


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Forum

Complications during primary PCI for STEMI


Chairpersons: N. van Mieghem, F. Mauri

▸ Introduction - N. van Mieghem

▸ Guideliner catheter; friend or foe? - M. Spence

▸ Iatrogenic coronary pseudoaneurysm: what to do? - A. Gomez Menchero

▸ Right coronary artery perforation during primary angioplasty in a patient

with IIb/IIIa inhibitors - T. Gorgadze

▸ Coronary stent avulsion caused by thrombectomy catheter entrapment

A. Tommasino

▸ No-reflow phenomenon complicating acute left heart failure, cardiogenic

pulmonary edema, lethal ventricular arrhythmia, cardiac arrest during

delayed PCI in a patient with acute myocardial infarction - Q. Wang

▸ Take-home message - F. Mauri

10:30-12:00 Room 353 Clinic

Abstract session

PCI in STEMI patients: biochemical markers and clinical outcome


Chairpersons: P. Clemmensen, M. Sabate

▸ Introduction - M. Sabate

▸ Clinical impact of high sensitivity C-reactive protein on twelve-month

mortality in overweight/obese patients with acute myocardial infarction

undergoing PCI - K. Ahmed

▸ Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in

patients with STEMI undergoing primary PCI with DES - T.H. Yang

▸ Association of interleukin-10 level with increased 30-day mortality in

patients with STEMI undergoing primary coronary intervention

A. Youssef

▸ Clinical utility of biomarkers to predict major bleeding events after STEMI:

a Horizons-AMI substudy with 3-year follow-up - R. Mehran

▸ C-reactive protein as a predictor of major adverse cardiovascular events in

primary PCI - K.S. Rathod

▸ Association between admission blood glucose level and in-hospital

cardiovascular mortality and prognosis in patients with acute myocardial

infarction - M. Ardeshiri

▸ Take-home message - P. Clemmensen

123



Symposium

Clinical evidence and technological advances in the evolution of TAVI

With an unrestricted educational grant from EDWARDS LIFESCIENCES

Chairpersons: F.W. Mohr, S. Windecker

Objectives:

▸ To understand the impact of the PARTNER trial in aortic stenosis treatment

▸ To understand the impact of SOURCE/SOURCE XT registries on daily

clinical practice

▸ To highlight how Europe is further improving outcomes by driving product

evolution

▸ Introduction and objectives - S. Windecker

▸ Deep dive into clinical data: difference in mortality and quality of life

factors in PARTNER and impact on clinical community - M.B. Leon

▸ Deep dive into clinical data: impact on clinical TAVI options and role of

surgical aortic valve replacement - T.M. Dewey

▸ SOURCE/SOURCE XT Registries expanding the TAVI horizon - How real-life

clinical practice is evolving clinical indications and complication

management - H. Baumgartner

▸ How key development iterations in valve design, performance and access

impact ease of use and procedural success - A. Colombo

▸ Discussion

▸ Take-home message - F.W. Mohr



Complex bifurcations and coronary chronic total occlusion


Chairpersons: M.C. Morice, A. Chieffo

Panellists: B. Chevalier, E. Christiansen, K. Igarashi, Y. Louvard, A. Osiev,

S. Soerianata

Objectives:

▸ To learn how to optimise outcome for the patients presenting with

complex bifurcation lesions by applying contemporary state-of-the-art

technique

▸ To learn when and how best to open chronic total occlusion lesions

▸ To discuss best options for treatment modalities in daily routine for those

patients

Thursday 19th

124



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - M.C. Morice

12:05-12:55 Live in-a-box® from Institut Cardiovasculaire Paris Sud, Massy -

France

▸ Clinical outcome of Nobori DES in bifurcation and coronary chronic total

occlusion lesions - A. Serra

13:05-13:55 Live in-a-box® from Institut Cardiovasculaire Paris Sud, Massy -

France

▸ Take-home message - A. Chieffo


Symposium

Risk stratification and antithrombotic therapy during

high-risk PCI

With an unrestricted educational grant from

THE MEDICINES COMPANY

Chairperson: S.D. Kristensen

Objectives:

▸ To apply 2010 European Society of Cardiology guidelines to treatment

choices of anticoagulant and antiplatelet therapies

▸ To describe the challenges involved in high-risk PCI procedures and

identify predictors of vascular complications

▸ To identify strategies to improve survival and health economic outcomes

for high-risk PCI procedures


▸ Matching anticoagulant with antiplatelet therapy: implementing the ESC

2010 Guidelines - P.G. Steg

▸ Bleeding risk, registries and the radial approach - G. Musumeci

▸ High-risk NSTEMI intervention: which antithrombotic when? - F.J. Neumann

▸ Improving survival and health economic outcomes - A. Gershlick

▸ Discussion

▸ Take-home message - S.D. Kristensen

STENT

FOR LIFE

125



Symposium

Treating STEMI patients successfully: a case-based approachWith an unrestricted educational grant from ABBOTT VASCULAR and CROSSROADS, the Abbott VascularEducation NetworkChairpersons: M. Noc, T. Majwal

Objectives:▸ To provide insight in the complexity of STEMI patients

▸ To provide an overview on the different treatment options

▸ To provide an algorithm for STEMI treatment

▸ Introduction and objectives - M. Noc

▸ The high-risk STEMI patient - B. Farah

▸ Thrombo-aspiration or not - A. Kastrati

▸ DES or not - M. Lee

▸ The patient in cardiogenic shock - B. Merkely

▸ Discussion

▸ Take-home message - T. Majwal


Symposium

How to assess and treat patients who are not suitable candidates forprolonged dual antiplatelet therapyWith an unrestricted educational grant from ORBUSNEICHChairpersons: M. Haude, S. Silber

Objectives:▸ To explore the potential of imaging tools to assess stent apposition and

arterial healing

▸ To evaluate the benefits of endothelial progenitor cell-capture technology

in patient outcomes

▸ To discuss treatment options for complex patients who are not suitablecandidates for prolonged dual antiplatelet therapy

▸ Introduction and objectives - M. Haude

▸ Endothelial progenitor cell-capture technology: mechanism of action and

potential benefits - H.J. Duckers

▸ Which patients are not candidates for dual antiplatelet therapy? What arealternative treatment options for such patients? - J. Hill

▸ How can we assess arterial healing after PCI? - S. Lee

▸ What are the requirements for an optimal stent platform in the future?

R.J. De Winter

▸ Discussion

▸ Take-home message - S. Silber

STENT

FOR LIFE

Thursday 19th

126


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


12:00-13:00 Room 242B

Forum

India meets EuroPCR

Facilitators: E. Grube, P. Urban

Panellists: D. Blanchard, J. Dugal, P. Grant, J. Shivkumar


Abstract session

Primary PCI in STEMI: thrombus aspiration or filter devices


Chairpersons: F. Malik, M. Claeys, D. Dudek

▸ Introduction - F. Malik

▸ Impact of thrombus aspiration on myocardial perfusion and left ventricle

function in patients with anterior STEMI treated with primary angioplasty

M. Lelek

▸ Predictors of short-term mortality in patients with STEMI undergoing

primary percutaneous transluminal coronary angioplasty - S. Pyxaras

▸ Impact of thrombus aspiration on plasma levels of platelet-derived growth

factor in patients with STEMI - T. Koizumi

▸ Non-obstructive coronary disease leading to STEMI: assessment of

residual stenosis after thrombus aspiration - J. Brito

▸ Rheolytic thrombetcomy for acute coronary thrombotic occlusion of left

main in patients with acute myocardial infarction complicated by

cardiogenic shock - G. Parodi

▸ Impact of PercuSurge guidewire device on prevention and reduction of

recovery time from complete heart block in patients with acute inferior

myocardial infarction undergoing primary PCI - A. Youssef

▸ Take-home message - D. Dudek

127


12:00-13:30 Room 253 Clinic

Abstract session

Secondary prevention after PCI: evidence for plaque regression


Chairpersons: L. Mauri, J.J. Piek

▸ Introduction - L. Mauri

▸ Impact of patient and procedural characteristics for appropriate secondary

prevention therapy after PCI - Analysis from Japanese prospective

multicentre registry - A. Endo

▸ Effects of low dose Pioglitazone on restenosis and atheroma plaques in

patients with diabetes mellitus undergoing PCI - H.W. Lee

▸ Effect of high-dose lipid lowering treatment compared to low-dose lipid

lowering treatment with Rosuvastatin on carotid intima media thickness in

high-risk patients - R. Egede

▸ Influence of high-dose lipid lowering treatment compared to low-dose

lipid lowering treatment on plaque composition assessed by intravascular

ultrasound virtual histology in patients with STEMI: the VIRHISTAMI trial

R. Egede

▸ Take-home message - J.J. Piek

12:00-13:30 Room 341 Clinic

Abstract session

PCI for acute coronary syndromes in the elderly


Chairpersons: Z. Siudak, S. Aziz, J. Mehilli

▸ Introduction - Z. Siudak

▸ The impact of increased age on outcome from an early invasive strategy in

patients with acute coronary syndromes: the ACACIA registry - C.J. Malkin

▸ Predictors of treatment in acute coronary syndromes in the elderly: impact

on decision making and clinical outcome after interventional vs.

conservative treatment - S. Schnupp

▸ In-hospital mortality in the octogenarians in the primary PCI era in

comparison to thrombolysis - M. Egred

▸ PCI for acute coronary syndrome in elderly patients: results from a high

volume centre - R. Showkathali

▸ PCI outcomes in nonagenarians: data from a systematic review

I. Sheiban

▸ Prognosis after PCI in elderly patients - L. Antonsen

▸ Take-home message - S. Aziz

Thursday 19th

128



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


12:00-13:30 Room 342AB

Symposium

Does size matter? Stentys self-apposing stent for STEMI and complex

anatomy

With an unrestricted educational grant from STENTYS

Chairpersons: P.W. Serruys, M. Buchbinder

Panellists: G. Amoroso, C. Tamburino, R.J. van Geuns, S. Verheye,

R. Wessely

Objectives:

▸ To learn about today's shortfalls in primary PCI for acute myocardial

infarction and complex anatomy

▸ To learn about Stentys self-apposing technology and to be updated on the

clinical strategy

▸ To learn about the long-term safety and efficacy of the Stentys self-apposing

stent


▸ Challenging thrombus and malapposition in STEMI - R. Wessely

▸ Stentys self-apposing technology and the new approach to acute

myocardial infarction treatment - G. Amoroso

▸ Discussion

▸ Long-term behaviour of Nitinol stents in coronary arteries: two-year IVUS

follow-up of the Stentys stent - S. Verheye

▸ Discussion

▸ Building on early successes: one-year follow-up of the Stentys stent in

STEMI patients (APPOSITION programme) - R.J. van Geuns

▸ Discussion


▸ Take-home message - M. Buchbinder

12:00-13:30 Room 351

How should I treat?

How to avoid, detect and treat complications in a TAVI procedure


Chairperson: S.J.D. Brecker

Objectives:

▸ To understand how to detect and anticipate some major complications

during a TAVI procedure

▸ To understand how to treat these complications and avoid similarities in

the future, "implement lessons learned"

129


▸ Introduction and objectives - S.J.D. Brecker

▸ Redo case

- Case presentation - U. Gerckens

- How would I treat? - J.C. Laborde

- How would I treat? - N. Moat

- How did I treat? - U. Gerckens

- Discussion

- Consensus - S.J.D. Brecker

▸ Vascular access and closure

- Case presentation - H. Danenberg

- How would I treat? - M. van Sambeek

- How would I treat? - P. Wenaweser

- How did I treat? - H. Danenberg

- Discussion

- Consensus - S.J.D. Brecker

▸ Take-home message - S.J.D. Brecker

12:00-13:30 Room 352AB

Symposium

Treating bifurcation: the Nile concept for a safe and efficient approach

With an unrestricted educational grant from MINVASYS

Chairpersons: A. Abizaid, J. Fajadet

Objectives:

▸ To assess safety and efficacy of the concept

▸ To understand the value of the provisional approach

▸ To review and discuss achievements of the concept in challenging

bifurcation lesions

▸ Introduction and objectives - J. Fajadet

▸ Principles and current understanding of the bifurcation lesion - A. Medina

▸ The Nile concept and Medina (1.1.1) - P. Motreff

▸ The Nile concept and Medina (1.0.1) - P. Brunel

▸ The Nile concept and the left main - I. Petrov

▸ The Nile concept in acute coronary syndrome - B. Garcia Del Blanco

▸ Discussion

▸ Take-home message - A. Abizaid

Thursday 19th

130


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

Optical coherence tomography: to assess the results of PCI


Chairpersons: G. Guagliumi, K.T. Chan, J. Escaned

▸ Introduction - G. Guagliumi

▸ Correlation of optical coherence tomography in the clinical and pre-clinical

setting - C. Malle

▸ Reliable assessment of stent healing in the rabbit iliac artery model by

optical coherence tomography - K. Steigerwald

▸ The use of 3-dimensional reconstruction of optical frequency domain

imaging to improve our understanding of conventional PCI: the potential

for clinical application - V. Farooq

▸ Optical coherence tomography findings of plaque rupture occurred by

balloon angioplasty - H. Ishimori

▸ Late expansion of thin-strut self expanding stents designed for non-

obstructive vulnerable plaque as imaged by intravascular ultrasound and

optical coherence tomography - H.M. van Beusekom

▸ An automated algorithm for identification and quantification of clusters of

malapposed stent struts in optical coherence tomography images

K. Onsea

▸ Take-home message - K.T. Chan

13:00-14:30 Room 242B

Forum

Taiwan meets EuroPCR

With the collaboration of the Taiwan Society of Cardiology

Facilitators: D. Blanchard, S.B. King III

Panellists: J.J. Cheng, J.S. Hung, C.D. Tseng

Participants: I.C. Hsieh, P.M. Ku, W.L. Lee, S.C. Liu, H.L. Huang


Main session

Primary PCI in STEMI - towards optimal results in complex

lesions

Chairpersons: P. MacCarthy, M. Noc

Panellists: G. Brueren, H. Danenbert, S. Dani, V. Guetta, D. Iosseliani,

S.D. Kristensen, M. Lesiak, J. McLenachan, T. Pawlowski, D. Tresukosol,

D.O. Williams

Objectives:

▸ To provide an update on optimal PCI strategy and device selection in

complex angiographic scenarios

▸ To provide practical procedural tips and tricks

▸ To learn about prevention and management of complications that may

occur when treating complex lesions

STENT

FOR LIFE

131


▸ Introduction and objectives - P. MacCarthy

13:35-14:25 Live in-a-box® from Catharina Ziekenhuis, Eindhoven -

The Netherlands

▸ Keynote lecture - Reflect together on how to resolve obstacles to

myocardial reperfusion in patients undergoing timely primary PCI

J. McLenachan

▸ How should I treat case - Under the auspices of the the Israeli Working

Group on Interventional Cardiology and the Polish Association of

Cardiovascular Interventions

- Case presentation - T. Pawlowski

- How would I treat? - R.J. Gil

- How would I treat? - C. Lotan

- How did I treat? - T. Pawlowski

- Discussion

- Consensus - M. Lesiak

▸ How should I treat case - Under the auspices of the the Israeli Working

Group on Interventional Cardiology and the Polish Association of

Cardiovascular Interventions

- Case presentation - V. Guetta

- How would I treat? - C. Lotan

- How would I treat? - R.J. Gil

- How did I treat? - V. Guetta

- Discussion/Consensus - H. Danenberg

16:05-16:55 Live in-a-box® from Catharina Ziekenhuis, Eindhoven -

The Netherlands

▸ Complication case - Coronary stent avulsion caused by thrombectomy

catheter entrapment - A. Tommasino

▸ Final key remarks - M. Noc


Plenary session

Where cardiologists and cardiac surgeons can meet: the beginning

of a great future

Chairpersons: J-L. Pomar, P. Kolh

Panellists: A. Colombo, M. de Belder, J. Marco, T. Modine, F.W. Mohr,

L. Torracca

Objectives:

▸ To explore the potential for a common future between

interventionalists and surgeons

▸ To discuss pros and cons of hybrid procedures

▸ To share the experience of hybrid teams

Thursday 19th

132



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - J-L. Pomar

Revascularisation in patients at high surgical risk

▸ How to define high surgical risk - M. Kohonen, K. Niemelä

▸ Discussion / Consensus from the panel

▸ How should I treat?

- Presentation - K. Niemelä

- How would I treat? - P. Kolh

- How would I treat? - A. Colombo

- How did we treat? - M. Kohonen, K. Niemelä

- Discussion & consensus from the panel

Hybrid coronary revascularisation

▸ Which patients may be considered for myocardial revascularisation using

a hybrid procedure - E. Barbato, F. Casselman

▸ How should I treat?

- Presentation - E. Barbato

- How would I treat? - T. Modine

- How would I treat? - S. Kedev

- How did we treat? - E. Barbato, F. Casselman

- Discussion & consensus from the panel

Integrated training in interventional cardiology and cardiac surgery

▸ My personal experience - T. Modine, J. Sadaba Sagredo, R. Lange,

A. Jonsson, F.W. Mohr

▸ Roundtable discussion



LTT - How to treat a patient with coronary bifurcation

lesions

Facilitators: J. Fajadet, T. Lefèvre, G. Stankovic

Panellists: O. Darremont, J. Ormiston, M. Pan


Live in-a-box® from Institut Cardiovasculaire Paris Sud,

Massy - France

133


13:30-15:00 Room 242A

How should I treat?

PCI after thrombolysis in STEMI

Under the auspices of the Portuguese Association of

Interventional Cardiology and the Working Group on PCI of

the Spanish Society of Cardiology

Chairpersons: P. Farto E Abreu, M. Valdés Chávarri

Objectives:

▸ To understand the role of PCI after thrombolysis for acute myocardial

infarction in order:

- to reduce major adverse cardiac events

- to decrease recurrences

- to improve patient risk stratification and clinical management

▸ Introduction and objectives - P. Farto E Abreu

▸ Invasive approach after successful thrombolysis

- Case presentation - P. Mota

- How would I treat? - P. Braga

- How would I treat? - J.A. Gomez-Hospital

- How did I treat? - P. Mota

- Discussion

- Consensus - P. Farto E Abreu

▸ Pharmaco-invasive approach

- Case presentation - I. Lozano

- How would I treat? - J.A. Gomez-Hospital

- How would I treat? - P. Braga

- How did I treat? - I. Lozano

- Discussion

- Consensus - M. Valdés Chávarri

▸ Take-home message - M. Valdés Chávarri

STENT

FOR LIFE

Thursday 19th

134


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

Advances in cell-based regenerative therapy post-STEMI


Chairpersons: F. Fernandez-Aviles, J. Bartunek, M. Ostojic

▸ Introduction - F. Fernandez-Aviles

▸ Percutaneous, intra-myocardial injection of unselected bone marrow-

derived mononuclear cells via NOGA-XP significantly improves ejection

fraction in post-infarct patients: ALSTER STEM CELL - M.W. Bergmann

▸ Randomised controlled clinical trial of the use of autologous bone marrow

derived progenitor cells to salvage myocardium in patients with acute

anterior myocardial infarction - D. Locca

▸ G-CSF induced arteriogenesis in humans: molecular insights into a

randomised controlled trial - P. Meier

▸ Level and value of circulating endothelial progenitor cells in patients with

acute myocardial infarction undergoing primary coronary angioplasty

H.Y. Fang

▸ Clinical registry follow-up of endothelial progenitor cell capture stent in

patients suffering from non ST-segment elevation acute coronary

syndrome - I.J. Amat

▸ Intracoronary delivery of allogeneic mesenchymal precursor cells directly

after acute myocardial infarction improves cardiac function and

myocardial perfusion and decreases left ventricular remodeling in sheep

J. Houtgraaf

▸ Take-home message - J. Bartunek


All you need to know about intracoronary imaging

Chairpersons: J. Escaned, C. Di Mario

Objective:






▸ Introduction and objectives - J. Escaned

▸ Background - R. Erbel

▸ Technical aspects - M. Gilard

▸ Clinical data - H.M. Garcia-Garcia

▸ Guidelines and recommendations

▸ Unresolved issues and outlook - F. Prati

▸ Clinical cases - K-H. Sim

▸ Wrap-up - C. Di Mario135


13:30-15:00

Incidence and treatment of in-stent restenosis


Chairpersons: L. Thuesen, B. He

▸ Introduction -

▸ In-stent restenosis is not simply a benign clinical entity as it presents as

acute coronary syndromes in 40% of cases -

▸ Repeated DES vs. balloon angioplasty for management of DES associated

restenosis in de novo and in-stent restenosis lesions -

▸ Serial morphological and functional assessment of in-stent restenosis

P. Agostoni

▸ Long-term clinical outcome after treatment of restenotic lesions with a

new generation DES -

▸ Comparison of restenosis patterns in 1st and 2nd generation DES

Y. Sakamoto

▸ Stent recoil varies with DES type and influences long-term luminal loss. A

comparative longitudinal study using a novel methodology for in vivo

assessment of stent recoil -


13:30-15:00

Valve malpositioning and procedural refinement during TAVI procedures


Chairperson: U. Gerckens

▸ Introduction -

▸ Procedural valve dislodgment with the Medtronic CoreValve: incidence,

predictors and how to overcome -

▸ Correction of prosthesis malpostitioning during TAVI with CoreValve

M. Vavuranakis

▸ The valve-in-valve technique for treatment of aortic bioprosthesis

malposition: an analysis of incidence and 1-year clinical outcomes from

the Italian CoreValve registry -

▸ Management of ventricular embolisation in TAVI -

▸ Manual mini-aortography during pre-implantation balloon aortic

valvuloplasty: a simple tool for successful TAVI -

▸ A high dose of adenosine to induce transient asystole for valvuloplasty in

patients undergoing TAVI: is it a valid alternative to rapid pacing? A

prospective pilot study -



LTT - How to use pressure-derived fractional flow reserve

Facilitators: B. De Bruyne, N. Melikian, A.J. Peace

Panellist: P. Grant


Live in-a-box® from Cardiovascular Center, Aalst - Belgium


Abstract session

Transradial access: safety and complications


Chairpersons: V. Dangoisse, L. Grinfeld

▸ Introduction - V. Dangoisse

▸ Safety of transradial approach in 10,676 consecutive percutaneous

coronary procedures - A. Tommasino

▸ Transradial approach in patients with post-catheterisation occlusion of

radial artery - C. Trani

▸ Transradial coronary angiography: predictors of adversity - F. Costa

▸ Management of access site vascular complications in patients undergoing

transradial percutaneous coronary procedures - M. Brancati

▸ Recanalisation and re-use of late occluded radial artery after transradial

coronary interventions: a new technique for interventionalists, practicising

radial artery approach - A. Babunashvili

▸ Avoid radial approach in little old ladies: myth or fact? - P. Mota

▸ Take-home message - V. Dangoisse

Thursday 19th

136



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

Incidence and treatment of in-stent restenosis


Chairpersons: L. Thuesen, B. He

▸ Introduction - L. Thuesen

▸ In-stent restenosis is not simply a benign clinical entity as it presents as

acute coronary syndromes in 40% of cases - K.S. Rathod

▸ Repeated DES vs. balloon angioplasty for management of DES associated

restenosis in de novo and in-stent restenosis lesions - M.A.F. Abdelmegid

▸ Serial morphological and functional assessment of in-stent restenosis

P. Agostoni

▸ Long-term clinical outcome after treatment of restenotic lesions with a

new generation DES - N. West

▸ Comparison of restenosis patterns in 1st and 2nd generation DES

Y. Sakamoto

▸ Stent recoil varies with DES type and influences long-term luminal loss. A

comparative longitudinal study using a novel methodology for in vivo

assessment of stent recoil - J. Escaned

▸ Take-home message - B. He


Abstract session

Valve malpositioning and procedural refinement during TAVI procedures



▸ Introduction - U. Gerckens

▸ Procedural valve dislodgment with the Medtronic CoreValve: incidence,

predictors and how to overcome - N. van Mieghem

▸ Correction of prosthesis malpostitioning during TAVI with CoreValve

M. Vavuranakis

▸ The valve-in-valve technique for treatment of aortic bioprosthesis

malposition: an analysis of incidence and 1-year clinical outcomes from

the Italian CoreValve registry - M. Barbanti

▸ Management of ventricular embolisation in TAVI - M. Ferrari

▸ Manual mini-aortography during pre-implantation balloon aortic

valvuloplasty: a simple tool for successful TAVI - B. Borz

▸ A high dose of adenosine to induce transient asystole for valvuloplasty in

patients undergoing TAVI: is it a valid alternative to rapid pacing? A

prospective pilot study - G. Davidavicius

▸ Take-home message - U. Gerckens

137


13:30-15:00 Room 351

Plenary session

Best of AsiaPCR/SingLive 2011

Chairpersons: T.H. Koh, S. Saito, W. Wijns

Panellists: P. Chandra, J.B. Ge, R. Zambahari

▸ Introduction - T.H. Koh

▸ The best abstract - Transapical aortic valve implantation: first-in-man

experience with the Symetis Acurate - J. Kempfert

▸ The 2nd best abstract - Five-year clinical and angiographic outcome after

primary stenting of totally occluded native coronary arteries (PRISON II -

Late Study): a randomised comparison of bare metal stent implantation

with Sirolimus-eluting stent implantation for the treatment of total

coronary occlusions - M.J. Suttorp

▸ The 3rd best abstract - Outcome of coronary interventions in octo and

nanogenarians - M. Liang

▸ The best clinical case - A juvenile with severe stenosis at the bilateral

coronary artery ostium - Y. Mitsutake

▸ The most educational complication case - Run-away stent. Off-label use of

biopsy forceps - E. Merkulov

▸ The best How should I treat? - Left main stenosis and two CTOs in a

patient with NSTEMI and shock - K.L. Tsui

▸ PCI tips & tricks - Coronary wire pacing technique - S.T. Lim

▸ PCI tips & tricks - Crossing the uncrossable lesion after successful wiring

N. Inoue

▸ Closing remarks - S. Saito



Glimpse into the future - Novel approaches to treatment of mitral valve

disease

Chairpersons: O. Franzen, C. Ruiz

Panellists: D. Adams, T. Feldman, F. Maisano, A. Vahanian

Objectives:

▸ To understand the pathophysiology and clinical relevance of mitral

regurgitation

▸ To become familiar with novel techniques of mitral valve repair

▸ To learn about percutaneous techniques of mitral valve replacement

Thursday 19th

138


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction and objectives - O. Franzen

▸ Overview of new surgical options for mitral valve repair - D. Adams

▸ Glimpse into future transcatheter mitral valve repair devices

- New devices for mitral valve leaflet repair - T. Feldman

- Mitral valve intervention using combined transcatheter devices

A. Vahanian

- New devices for direct mitral valve annuloplasty - L. Buellesfeld

- Other new concepts for transcatheter mitral valve repair - C. Ruiz

- New devices for transcatheter mitral valve replacement - G. Lutter

- Catheter-based access to the mitral valve in the future - Venous, arterial or

transapical? - M. Buchbinder

14:50-15:05 Recorded case on transcatheter mitral valve replacement and

commentary by L. Sondergaard


▸ Glimpse into future transcatheter mitral valve repair indications

- Expanding indications for transcatheter mitral valve repair - The

interventional cardiologist's point of view - O. Franzen

- Expanding indications for transcatheter mitral valve repair - The surgeon's

point of view - F. Maisano

▸ Presentation of two cases and panel discussion

- Case 1 - O. Franzen

- Case 2 - F. Maisano


▸ Take-home message - C. Ruiz


Abstract session

DES/protection devices in saphenous vein graft PCI


Chairpersons: F. Airoldi, H. Bueno, J.W. Moses

▸ Introduction - F. Airoldi

▸ DES offer limited benefit over bare metal stents inserted during vein graft

PCI - M. Akhtar

▸ Long-term follow-up of DES vs. bare metal stents in the treatment of

saphenous vein graft lesions: a single centre study - L.F. Ybarra

▸ Two-year clinical outcomes after treatment of saphenous vein graft with a

new generation DES - R. Wessely

▸ Comparative analysis of a distal protection system and the new stent M-Guard

for the treatment of complex lesions in saphenous vein grafts - V. Esteves

▸ Intravascular ultrasound predictors of no-reflow after percutaneous

saphenous vein graft intervention with distal protection devices - Y.J. Hong

▸ Long-term clinical outcomes of PCI in grafts vs. native vessels in patients

with previous coronary artery bypass grafting - I. Xanthopoulou

▸ Take-home message - H. Bueno139


14:00-16:00 Rooms 101/102/103

Meet with the trialists

Objective:

▸ To allow in-depth questions and answers with the principal investigators

of trials presented at the 2011 EuroPCR late breaking trial sessions

▸ A prospective, randomised and multicentre trial comparing Titan-2 BAS

and Xience-V stent: the BASE-ACS trial - P. Karjalainen

▸ Vascular healing in response to Sirolimus-eluting stents during five year

follow-up: an optical coherence tomography study - L. Räber

▸ Diagnosis of ischemia-causing stenoses obtained via non-invasive

fractional flow reserve (DISCOVER-FLOW): a prospective multicentre first-

in-man study - B.K. Koo


Forum

Complication forum

Chairpersons: A. Lerman, E. Eeckhout

Panellists: M.J. Kern, M. Lee, T. Mabin, A. Mehta, C. Rihal

Objectives:

▸ To learn how to anticipate and treat common complications during PCI



▸ Introduction - A. Lerman

▸ Case 1 - S. Takeshi

▸ Case 2 - M. Mohandes

▸ Case 3 - A. Qasim

▸ Case 4 - J. Tan

▸ Case 5 - R. Sachdeva

▸ Case 6 - W. Kehasukcharoen

▸ Conclusion - E. Eeckhout

Thursday 19th

140



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


14:30-16:00 Room 242B

Plenary session

EuroIntervention / European Heart Journal @ EuroPCR

Chairpersons: T. Lüscher, P.W. Serruys

Objective:

▸ The authors of the three best TAVI papers selected by the Editorial Board

of EuroIntervention and three best TAVI papers selected by the Board of

European Heart Journal present their work accompanied by an invited

commentary

▸ Introduction - T. Lüscher, P.W. Serruys

▸ EuroIntervention Journal 1: Comments as reviewer of “Outcomes and

complications of TAVI using a balloon expandable valve according to the

Valve Academic Research Consortium (VARC) guidelines” - N. Piazza

▸ Author comments and update - D. Tchétché

▸ Discussion

▸ European Heart Journal 2: Comments as reviewer of “Percutaneous

transarterial aortic valve implantation. ‘What do we know?’ (Clinical

review article)” - P. de Jaegere

▸ Author comments and update - A. Cribier

▸ Discussion

▸ EuroIntervention Journal 3: Comments as reviewer of “Reappraisal of

percutaneous aortic balloon valvuloplasty as a preliminary treatment

strategy in the TAVI area” - H. Eltchaninoff

▸ Author comments and update - D. Himbert

▸ Discussion

▸ European Heart Journal 4: Comments as reviewer of “One year follow-up

of the multi-centre European Partner transcatheter heart valve study (Fast

track clinical paper)” - S. Windecker

▸ Author comments and update - P. Nataf

▸ Discussion

▸ EuroIntervention Journal 5: Comments as reviewer of “Prevalence an

prognostic implications of baseline anemia in patients undergoing TAVI”

J-P. Bassand

▸ Author comments and update - N. van Mieghem

▸ Discussion

▸ European Heart Journal 6: Comments as reviewer of “TAVI - First results

from a multicentre real world registry (Clinical paper)” - F.A. Flachskampf

▸ Author comments and update - R. Zahn

▸ Discussion

▸ Take-home message - P.W. Serruys

141


15:00-16:30 Room 242A

How should I treat?

Native and induced coronary aneurysm: from the imaging to the

treatment

Under the auspices of the Italian Society of Invasive Cardiology (GISE)

and the Working Group on Interventional Cardiology and Acute Coronary

Syndrome of the Swiss Society of Cardiology

Chairpersons: G. Guagliumi, G. Pedrazzini

Objectives:

▸ To understand the prognostic role of native and DES induced coronary

aneurysm

▸ To learn about pathophysiology of native (giant) and DES induced

coronary aneurysm

▸ To define the optimal treatment for native and DES induced aneurysm

▸ Introduction and objectives - G. Guagliumi

▸ Unusual treatment of a giant aneurysm

- Case presentation - S. Cook

- How would I treat? - C. Kaiser

- How would I treat? - C. Trani

- How did I treat? - S. Cook

- Discussion

- Consensus - G. Pedrazzini

▸ Asymptomatic coronary aneurysm after DES: progression and imaging

use for decision-making process

- Case presentation - E. Piccaluga

- How would I treat? - C. Trani

- How would I treat? - C. Kaiser

- How did I treat? - E. Piccaluga

- Discussion

- Consensus - G. Guagliumi

▸ Take-home message - G. Pedrazzini

15:00-16:30 Room 243 Clinic

Abstract session

Functional and clinical impact of successful coronary chronic total

occlusion recanalisation


Chairpersons: G. Heyndrickx, M. Ochai, N. Reifart

Thursday 19th

142


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction - G. Heyndrickx

▸ Long-term clinical outcome of patients with coronary chronic total

occlusion treated with new generation DES - B. Chevalier

▸ Clinical and procedural outcome of PCI for coronary chronic total

occlusion with DES: a large single-centre experience - T. Hamid

▸ Prognostic role of successful vs. unsuccessful revascularisation in 'true'

coronary chronic total occlusions treated by DES - G. Niccoli

▸ A randomised comparison of the efficacy and safety of Zotarolimus-

eluting stents vs. Sirolimus-eluting stents for PCI in coronary chronic

total occlusions: the catholic total occlusion study (CATOS) trial - H.Y. Kim

▸ Efficacy on cardiac function in PCI for coronary chronic total occlusions

analysed by echocardiography - H. Takimura

▸ Successful recanalisation of chronic total occlusions is associated with

increased long term survival - R. Weerackody

▸ Take-home message - M. Ochiai


All you need to know about percutaneous assist-devices

Chairpersons: J.J. Piek, P. Leprince

Objective:






▸ Introduction - P. Leprince

▸ Background - Introduction on the available percutaneous assist-devices

currently evaluated in clinical trials - C.J. Vrints

▸ Clinical data - Assist devices in elective high-risk PCI, emergency PCI and

cardiogenic shock - P. Vranckx

▸ Issues in clinical practice - Practical experience and technical aspects with

the use of intra aortic balloon pumping - F. Eberli

▸ Guidelines - What do the guidelines tell us on the use of percutaneous

assist-devices - H. Thiele

▸ Unresolved issues - Limitations of available assist-device and expectations

from new devices - J. Henriques

▸ Questions & answers - J.J. Piek

143



Forum

Toys or tools for unusual PCI


Chairpersons: A. Baumbach, F.Y. Kuo

▸ Introduction - A. Baumbach

▸ Application of Guideliner in difficult angulated right coronary artery PCI,

with failure of previous attempt - H.Y. Fang

▸ Guideliner microcatheter in order to improve back-up support during a

complex coronary stenting procedure through a tortuous left internal

mammary graft - C.I. Park

▸ A successful PCI case that was used 4 in 6 system for right coronary

artery lesion with anomalous origin - S. Kumazaki

▸ Sheathless transradial PCI with rotablation in critical calcified lesion

H.Y. Fang

▸ Take-home message - F.Y. Kuo


Abstract session

Platelet reactivity in patient subsets


Chairperson: G. Montalescot

▸ Introduction - G. Montalescot

▸ Drastic increase in residual platelet reactivity under clopidogrel therapy in

hemodialysis patients with coronary artery disease - O. Morel

▸ Early determination of clopidogrel responsiveness by platelet-reactivity-

index identifies patients at risk for cardiovascular events after myocardial

infarction - A. Schaefer

▸ Evaluation of feasible timing of elective non-cardiac procedure after antiplatelet

discontinuation in patients who previously underwent PCI - J.R. Cho

▸ High residual platelet reactivity after clopidogrel loading and long-term

thrombotic events in patients with acute coronary syndrome undergoing

invasive treatment: the RECLOSE-ACS trial - D. Antoniucci

▸ Lack of correlation between platelet reactivity and glycaemic control in

type 2 diabetes mellitus patients treated with aspirin and clopidogrel

F. Mangiacapra

▸ The impact of glycemic control on platelet reactivity in type II diabetes

mellitus - D. Mylotte

▸ Take-home message - G. Montalescot

Thursday 19th

144



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

Bioabsorbable scaffold: animal and human observations


Chairperson: R.J. van Geuns

▸ Introduction - R.J. van Geuns

▸ Evaluation of preclinical safety of Absorb cohort b bioresorbable vascular

scaffold by employing multiple modalities - J. Powers

▸ Preclinical insights into clinical safety and delivery of vascular restoration

therapy by a bioresorbable vascular scaffold - L. Perkins

▸ Angiographic geometric changes of the lumen vessel wall after

bioresorbable vascular scaffolds and metallic platform stents at one-year

follow-up - J. Gomez-Lara

▸ Can we oversize bioresorbable scaffolds? The art experience - A. Lafont

▸ Spatial distribution and temporal evolution of scattering centers by optical

coherence tomography in the poly(L-lactide) backbone of a bioresorbable

vascular scaffold - J.L. Gutiérrez-Chico

▸ 540-days follow-up of fully bioabsorbable salicylate-based Sirolimus-

eluting stent evaluated by optical coherence tomography - R. Jabara

▸ Take-home message - R.J. van Geuns

15:00-16:30 Room 343 Clinic

Abstract session

TAVI: clinical outcome in various patient subsets


Chairpersons: G. Fournial, A.S. Petronio

▸ Introduction - G. Fournial

▸ 30-day all-cause mortality after surgical aortic valve replacement and

TAVI for the treatment of severe aortic stenosis in high-risk patients:

a two-centre study - N. Dumonteil

▸ A comparison of transfemoral TAVI and surgical aortic valve replacement

in high-risk elderly patients with severe aortic stenosis - A. Giacomini

▸ A United Kingdom-based cost utility analysis of TAVI for inoperable

patents with severe aortic stenosis treated by medical management

S. Mealing

▸ TAVI in low-flow low-gradient aortic stenosis: early experience - C. Fiorina

▸ TAVI in low-gradient aortic stenosis - A. Lauten

▸ Clinical outcome of high-risk patients with severe aortic stenosis and

reduced left ventricular ejection fraction undergoing conservative

treatment or TAVI - T. Pilgrim

▸ Take-home message - A.S. Petronio

145


15:00-16:30 Room 351 Clinic

Plenary session

Imaging valvular disease: clinical and pathologic correlates. Lessons for

TAVI and transcatheter therapies

Chairpersons: R. Virmani, V. Delgado

Panellists: G. Manoharan, V. Schächinger

Objectives:

▸ To confront pathological findings with clinical presentation

▸ To review how pathology helps in understanding clinical imaging

▸ To understand biological interactions with implanted cardiovascular devices

▸ Welcome and session objectives - R. Virmani

▸ Aortic valve: aortic stenosis by etiology, aortic regurgitation by etiology,

relationship of the conduction system to LVOT, role of the size of the

membraneous valve to the conduction system location - E. Ladich

▸ Mitral valve: degenerative and functional, rheumatic valve stenosis,

relationship of valve annulus to coronary sinus and left circumflex artery,

importance of chordae tendinae - N. Carter-Monroe

▸ Tricuspid valve incompetence - N. Carter-Monroe

▸ Percutaneous valve procedures in animals and man (TAVI, mitral devices)

N. Carter-Monroe, E. Ladich

▸ Take-home message - V. Delgado

16:00-17:00 Room 242B

Plenary session

How to write a paper? Joint session EuroIntervention / Journal of the

American College of Cardiology

Chairpersons: P.W. Serruys, P. Cummins, S.B. King III, R.J. van Geuns

Objective:

▸ Tips & tricks for a successful publication

▸ Introduction - P.W. Serruys

▸ Impact factor is not the whole story - N. Bruining

▸ Discussion

▸ Common downfalls for medical papers - G. Biondi-Zoccai

▸ Discussion

▸ Statistics tips and tricks - A. Kastrati

▸ Discussion

▸ How to review a medical paper? - S.B. King III

▸ Discussion

▸ The future of medical publishing - F. Doncieux

Thursday 19th

146


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease




Advancing TAVI for optimal patient outcomes: new product

advancements, tips & tricks


Chairpersons: H. Reichenspurner, A. Vahanian

Objectives:

▸ To share real-world insights on critical success factors (e.g. patient

selection, annulus sizing, access choice)

▸ To show recent advances in product design and procedural technique

▸ Introduction and objectives - H. Reichenspurner


Kingdom

▸ Accurate valve placement with new transfemoral and transapical delivery

systems - E. Garcia

▸ Discussion

▸ Edwards SAPIEN XT 29mm valve-benefits to new size options - T. Walther

▸ Discussion


Kingdom

▸ Access trade-offs and determining best strategy - G. Isabella

▸ Discussion

▸ What is unique about the Edwards SAPIEN XT valve design and key

learnings regarding valve performance? - H. Eltchaninoff

▸ Discussion

▸ Take-home message - A. Vahanian


Symposium

Applied novel antiplatelet therapy in acute coronary

syndrome/PCI

With an unrestricted educational grant from DAIICHI

SANKYO EUROPE GmbH and ELI LILLY & COMPANY

Chairpersons: D. Ardissino, P. Clemmensen

Objectives:

▸ To describe recent efficacy and safety data on new antiplatelet therapies

for acute coronary syndrome patients treated with PCI

▸ To provide rationale and practical recommendations for differential

treatments to improve acute coronary syndrome patient outcomes

▸ To discuss the importance of long-term antiplatelet inhibition to protect

acute coronary syndrome/PCI patients against ischemic complications

STENT

FOR LIFE

147


▸ Introduction and objectives - D. Ardissino

▸ Reliable protection from stent thrombosis in acute coronary

syndrome/PCI patients: best practice - T. Cuisset

▸ Morbidity and mortality benefit for STEMI/PCI patients: evidence and

interactive cases - G. Montalescot

▸ Predictable antithrombotic protection for diabetic patients with acute

coronary syndrome/PCI - P. Widimsky

▸ Risk stratification and management of unstable angina patients/NSTEMI in

PCI patients - P. Sinnaeve

▸ Discussion

▸ Take-home message - P. Clemmensen


Symposium

Cre8: future DES technology, today

With an unrestricted educational grant from CID

Chairpersons: A. Colombo, R. Mehran

Objectives:

▸ To highlight the drawbacks of durable polymers

▸ To understand how CID has combined a polymer-free DES with a

controlled drug elution

▸ To learn about the latest data from the NEXT study

▸ Introduction and objectives - R. Mehran

▸ Limitations of contemporary polymeric DES - S. Verheye

▸ Cre8: the new polymer-free, reservoirs based and bio inducer DES

A. Abizaid

▸ The NEXT study: the first international randomised trial with Cre8

J. Schofer

▸ Unmet patients clinical needs and CID innovative DES technology - F. Prati

▸ Discussion

▸ Take-home message - A. Colombo

Thursday 19th

148



Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease



Symposium

Drug-eluting balloons: current status and new perspectives With an unrestricted educational grant from MEDTRONICChairpersons: G. Tepe, B. Scheller

Objectives:▸ To provide a comprehensive overview of the span of potential clinical

indications for drug-eluting balloons in the coronary and peripheral areas

and understand where and why drug-eluting balloons should be

considered to address unmet needs

▸ To provide attendees with results of Medtronic drug-eluting balloons(IN.PACT) within coronary and peripheral applications

▸ To share current limitations and future needs to further establish drug-

eluting balloon clinical evidence

▸ Introduction and objectives - G. Tepe

▸ Drug-eluting balloons in coronary in-stent restenosis: insights fromoptical coherence tomography - P. Stella

▸ Discussion

▸ Drug-eluting balloons in very long and diffuse coronary lesions

G.M. Sangiorgi

▸ Discussion

▸ Drug-eluting balloons in peripheral hemodialysis fistulas - D. Patanè

▸ Discussion

▸ Drug-eluting balloons for lower limb arterial diseas - A. Schmidt

▸ Discussion

▸ Take-home message - G. Tepe


Forum

Coronary chronic total occlusion: current techniques - Part ISession comprising selected EuroPCR 2011 clinical case submissionsChairpersons: M. Ochiai, G. Heyndrickx, A. Protopopov

▸ Introduction - M. Ochiai

▸ Retrograde recanalisation via an ipsilateral intraseptal collateral for chronic

total occlusion of a left anterior descending artery - S. Mizuno

▸ Post CABG; failed saphenous vein graft intervention or native vesselcoronary chronic total occlusion recanalisation? - G. Sianos

▸ PCI to left anterior descending coronary chronic total occlusion antegradeand retrograde approach from the same guiding catheter - H.Y. Fang

▸ Subintima tracking or just undersizing? Lessons from a right coronaryartery coronary chronic total occlusion case - F.Y. Kuo

▸ Modify mother and child technique for coronary chronic total occlusionA. Goldsmit

▸ Take-home message - G. Heyndrickx 149


16:30-18:00 Room 243 Clinic

Abstract session

Conduction abnormalities after TAVI


Chairperson: M. Schalij

▸ Introduction - M. Schalij

▸ Frequency of conduction abnormalities after TAVI with the Medtronic-

CoreValve and the effect on left ventricular ejection fraction - A. Tzikas

▸ Predictors of permanent pacemaker implantation after transcatheter

CoreValve implantation - M. De Carlo

▸ Timing and potential mechanisms of new conduction abnormalities during

the implantation of the Medtronic CoreValve system in patients with aortic

stenosis - R.J. Nuis

▸ Impact on the need for permanent pacemaker requirement after CoreValve

prosthesis implantation with the new Accutrak delivery Catheter System

A.J. Munoz-Garcia

▸ Factors affecting need for permanent pacemaker insertion following

CoreValve transcatheter aortic valve implantation - the UK CoreValve

Collaborative - M. Khawaja

▸ Low implantation of the CoreValve prosthesis transcatheter is a predictor

for the need of a pacemaker only in patients in sinus rhythm - F. Guerrero

▸ Take-home message - M. Schalij

16:30-18:00 Room 251

How should I treat?

Unexpected complex lesions in patients with STEMI


Chairpersons: S. Saito, B. Chevalier

Objectives:

▸ To share knowledge and experience about technical solutions for patients

with complex lesions in the course of STEMI

▸ To discuss tips & tricks to improve procedure and patients outcome

▸ To better understand to whom, when and how to use some specific

devices and techniques

▸ Introduction and objectives - S. Saito

▸ Case 1 - Unexpected complex lesion in patient with STEMI

- Case presentation - M. Valgimigli

- How would I treat? - A. Iniguez

- How would I treat? - C.K. Naber

- How did I treat? - M. Valgimigli

- Discussion

- Consensus - B. Chevalier

STENT

FOR LIFE

Thursday 19th

150


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Case 2 - Unexpected complex lesion in patient with STEMI

- Case presentation - J. Koolen

- How would I treat? - A. Iniguez

- How would I treat? - C.K. Naber

- How did I treat? - J. Koolen

- Discussion

- Consensus - S. Saito

▸ Take-home message - B. Chevalier

16:30-18:00 Room 253 Clinic

Abstract session

Non-invasive and invasive coronary imaging prior to PCI


Chairpersons: J.J. Bax, R. Erbel, L. Lam

▸ Introduction - J.J. Bax

▸ Non-invasive evaluation of coronary flow reserve with transthoracic

doppler echocardiography predicts the presence of significant stenosis in

coronary arteries - I. Haraldsson

▸ High coronary calcium score assessed by multislice coronary computed

tomography does not predict the periprocedural outcome in patients

undergoing elective PCI - A. Ntalianis

▸ Evaluation of the diagnosis accuracy of coronary computed tomographic

angiography - W. Pimentel

▸ Complex assessment of coronary plaques using Cardio-computed

tomography multislice 64 and intravascular ultrasound - T. Benedek

▸ Does 3-dimensional quantitative coronary angiography confer additional

advantage over traditional 2-dimensional-quantitative coronary

angiography in the assessment of intermediate left main coronary artery

stenoses - a comparison with intravascular ultras - I. Porto

▸ Radiation dose of three diagnosis tests: myocardial perfusion

scintigraphy, invasive coronary angiography and cardiac computed

tomography - P. Sousa

▸ Take-home message - L. Lam

151


16:30-18:00 Room 341 Clinic

Abstract session

Acute coronary syndromes: risk stratification and outcomes


Chairperson: I. Kranjec

▸ Introduction - I. Kranjec

▸ Acute myocardial infarction: long-term predictive value of thrombolysis in

myocardial infarction (TIMI) and global registry of acute coronary events

global registry of acute coronary events (GRACE) risk scores - K. Jansen

▸ Early vs. delayed invasive strategy in patients with acute coronary

syndromes without ST-segment elevation: a meta-analysis of randomised

studies - E.P. Navarese

▸ Acute coronary syndrome in patients with non-obstructive coronary artery

disease: long-term prognosis - R. Rossini

▸ Acute myocardial infarction with normal coronary arteries: a benign

entity? - C. Jorge

▸ Impact of revascularisation on longer term survival of patients presenting

with troponin positive acute coronary syndrome: a real world experience

M.F. Khan

▸ Tomography angiography in acute coronary syndrome: the TIACS study

S. Hascoet

▸ Take-home message - I. Kranjec

16:30-18:00 Room 342AB

How should I treat?

How to overcome troubles in left main and bifurcations



Chairperson: T. Lefèvre

Objectives:

▸ To better understand the technical aspects of treating bifurcations

▸ To discuss the choice between bifurcation techniques and dedicated side

branch access stents

▸ To discuss the technicity of distal left main stenting


▸ Difficulties in accessing the side branch

- Case presentation - E. Christiansen

- How would I treat? - O. Darremont

- How would I treat? - G. Stankovic

- How did I treat? - E. Christiansen

- Discussion


Thursday 19th

152


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ A complex distal left main

- Case presentation - R. Albiero

- How would I treat? - O. Darremont

- How would I treat? - G. Stankovic

- How did I treat? - R. Albiero

- Discussion


▸ Take-home message - T. Lefèvre

16:30-18:00 Room 343 Clinic

Abstract session

DES registries - Part II


Chairperson: L. Gonçalves

▸ Introduction - L. Gonçalves

▸ Xience V registry - Study of Xience V Everolimus-eluting and Vision

cobalt-chromium coronary stent - B. Berta

▸ Xience Nile, a prospective multicentre Egyptian real life Xience V stent

registry - H. Ragy

▸ Biodegradable polymer coated DES registry, with three-year follow-up

L. Mimish

▸ Clinical evaluation of the Everolimus drug-eluting coronary stent Xience V;

for the treatment of de novo coronary lesions in a real practice scenario -

multicentre international SPAREX registry - A. Iniguez

▸ e-BioMatrix PMS Registry - A post market surveillance registry for the

BioMatrixTM DES - P. Urban

▸ The DIVERGE trial (DES Intervention for treating side branches

effectively): three-year clinical results - P. Agostoni

▸ Take-home message - L. Gonçalves

153



Plenary session

Interactive meeting with the principal investigators of essential ongoing

or future clinical trials

Chairpersons: L. Mauri, T. Lüscher

Objectives:

▸ To provide in-depth understanding of trial design

▸ To expose potential trialists to first hand information

▸ To allow high level interactive questions and answers

▸ Introduction and objectives - L. Mauri

EXCEL

▸ Summary and status of the trial - P.W. Serruys, A.P. Kappetein

▸ Discussion

Euro SURTAVI

▸ Summary and status of the trial - P.W. Serruys, A.P. Kappetein

▸ Discussion

IBIS 4

▸ Summary and status of the trial - L. Räber, S. Windecker

▸ Discussion

TROFI

▸ Summary and status of the trial - P.W. Serruys, L. Thuesen

▸ Discussion

ABSORB Proof

▸ Summary and status of the trial - Y. Onuma

▸ Discussion

▸ Take-home message - T. Lüscher

Thursday 19th

154


Thu

rsday 1

9th

Coro

nary a

nd

structu

ral h

eart d

isease


16:30-18:00 Room 353 Clinic

Abstract session

Risk of stent thrombosis and new generation DES


Chairperson: M. Strozzi

▸ Introduction - M. Strozzi

▸ Incidence of stent thrombosis in two large registries in Europe and Japan:

a patient level data analysis from the Bern-Rotterdam and J-CYPHER

registries - Y. Onuma

▸ Biodegradable polymers, dual antiplatelet therapy and very late stent

thrombosis: review of Nobori 2 study - G.B. Danzi

▸ Impact of stent thrombosis on clinical outcomes among patients

undergoing PCI with newer generation DES - G.G. Stefanini

▸ Thrombosis in real practice with second generation DES in special

settings: myocardial infarction and left main coronary artery - results from

the ESTROFA-2 Spanish registry - J.M. De La Torre Hernandez

▸ Clinical performance of DES with biodegradable polymeric coating, a

meta-analysis and systematic review - T. Ahmed

▸ Safety of dual antiplatelet therapy interruption after Resolute stent

implantation: an Italian multicentre observational evaluation

A. Tommasino

▸ Take-home message - M. Strozzi

155


09:00-13:00 Main arena Evidence

Main session

Cardiovascular interventions: intercontinental crossfire - With LIVE from

Asia-Pacific

Chairpersons: P.W. Serruys, M.B. Leon, R. Ng

Panellists : S. Aziz, P. Chandra, M. Deshpande, J. Fajadet, J. Gao, M. Kimura,

T.H. Koh, Y.L. Lim, J. Marco, O. Mendiz, P. Sergeant, M. Thomas, P. Wong

Objectives:

▸ To highlight the contribution of the Asia-Pacific region to the present and

future of the field

▸ To comprehend worldwide variations in the delivery of life-saving PCI

▸ To understand how the future of cardiovascular interventions worldwide

will be influenced by intercontinental cross-talk


09:05-10:00 Live demonstration from Cardiovascular Institute and Fu Wai

Hospital, Beijing - China

▸ Keynote lecture - Treatment of STEMI in the Asia-Pacific region - P. Wong

▸ Keynote lecture - PCI or CABG for myocardial revascularisation in the

Asia-Pacific region - Y.L. Lim

▸ Intercontinental crossfire discussion

11:15-12:15 Live demonstration from Cardiovascular Institute and Fu Wai

Hospital, Beijing - China

▸ Keynote lecture - Evolving trends in the treatment of structural heart

disease - my vision - M.B. Leon

▸ International crossfire discussion

▸ The world is flat and education is the solution! - R. Ng, J. Marco

▸ Final key remarks and take-home message - P.W. Serruys

Presentation of the 2011 Ethica Award - P.W. Serruys

Friday 20th

156



Friday 2

0th

Coro

nary a

nd

structu

ral h

eart d

isease



Forum

Complication forum

Chairpersons: S.T. Lim, E. Eeckhout

Panellists: A. Erglis, J.B. Ge, T. Lefèvre, M.A. Rosli, T. Santoso

Objectives:

▸ To learn how to anticipate and treat common complications during PCI



▸ Introduction - S.T. Lim

▸ Case 1 - A. Panneerselvam

▸ Case 2 - Y. Watanabe

▸ Case 3 - G. Aprigliano

▸ Case 4 - C.A. Murphy

▸ Case 5 - M. Bedossa

▸ Case 6 - I. Ntarladimas

▸ Case 7 - M. Cardenas Manilla

▸ Conclusion - E. Eeckhout


LTT - How to treat a patient with coronary chronic total

occlusion

Facilitators: N. Reifart, D. Tchétché, G. Werner

Panellists: S. Kedev, A. Mehta, C. Wolf


Live in-a-box® from Medizinische Klinik I, Darmstadt - Germany

157


09:10-12:10 Room 342AB Evidence

Hot Line session

Late breaking registries and trial updates

Chairpersons: C. Di Mario, M. Sabate, D.O. Williams

▸ Lower mortality with transradial PCI compared to transfemoral PCI in

14,000 patients with acute myocardial infarction - Results from the

SCAAR database - G. Olivecrona

▸ Cost-effectiveness and public health/budget - Impact of fractional flow

reserve-guided PCI in multivessel patients in Europe - Analysis of the

FAME study data - U. Siebert

▸ PROTECT II: prospective multicentre trial comparing Impella to intra-aortic

balloon pump in high-risk PCI - W. O'Neill

▸ One-year clinical outcome of the 2,000 patients enrolled in the coronary

angioplasty with the Titan2 bioactive stents in acute myocardial infarction

(CATS-AMI) registry - M. Angioi

▸ The Nevo RES-ELUTION I study, a randomised multicentre comparison of the

Nevo reservoir-based sirolimus-eluting stent with the Taxus Liberté

paclitaxel-eluting stent - First presentation of 2-year outcomes - C. Spaulding

▸ Nobori 1, phase 1, final 5-year results - B. Chevalier

▸ Five-year clinical outcomes of a polymer-free sirolimus-eluting stent

versus a polymer-based paclitaxel-eluting stent - The ISAR-test trial

L. King

▸ Five-year follow-up of diabetes trial: the final results - P. Jimenez-Quevedo

▸ A prospective multicentre registry, evaluating a real world usage of the

Tryton side branch stent: results of the e-Tryton study - P. Stella

▸ Nine-month clinical and angiographic clinical and angiographic follow-up

of de novo coronary bifurcation lesions treated with the novel Nile Pax

dedicated bifurcation polymer-free paclitaxel-coated stent: results from

the prospective multicentre, non-randomised BIPAX clinical trial

B. Garcia Del Blanco

▸ Long-term follow-up after treatment of coronary in-stent restenosis with a

paclitaxel-coated balloon catheter - Paccocath ISR I/II - B. Scheller

▸ Impact of the everolimus-eluting stent on stent thrombosis and adverse

cardiac events: a meta-analysis of 10 randomised trials including 16,593

patients - U. Baber

▸ Biodegradable polymer versus durable polymer drug-eluting stents for

patients with coronary artery disease: 3 years pooled analysis of

individual patient data from the ISAR-TEST 4, LEADERS and ISAR-TEST 3

randomised trials - R. Byrne

▸ Treatment with the Resolute zotarolimus-eluting stent in subjects with

diabetes mellitus: pooled analysis from the Resolute clinical programme

L. Mauri

▸ Final 1 year outcomes of more than 2,300 patients in the SOURCE registry

O. Wendler

Friday 20th

158


Friday 2

0th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ SPIRIT WOMEN randomised clinical trial - S. Windecker

▸ Clinical outcomes of MitraClip therapy in high-risk patients and in

functional mitral regurgitation patients: results of the EVEREST clinical

trial - T. Feldman

▸ Left atrial appendage closure and the PROTECT AF trial: results at 1,500

patient-years of follow-up - S. Kar

▸ FRANCE II - FRench Aortic National CoreValve and Edwards registry

M. Gilard

▸ A weighted meta-analysis of early and late clinical outcomes after

CoreValve percutaneous aortic valve replacement in seven national

registries - C. Ruiz

09:30-11:00 Room 242A Evidence

Plenary session

2010 ESC - EACTS guidelines on myocardial revascularisation: some

debated issues - A case-based discussion

Chairpersons: P. Kolh, W. Wijns

Panellists: K. Huber, M. Ostojic, J.L. Pomar, F. Ribichini, S. Silber

Objectives:

▸ To discuss to which extent guidelines apply to "real life" cases

▸ To understand barriers to guideline implementation

▸ To review some debated issues such as ad hoc PCI or preferred mode of

revascularisation for proximal left anterior descending stenosis

▸ Introduction and objectives - W. Wijns

▸ Case presentation 1 - Severe and calcified coronary artery disease.

Indication for "ad hoc" PCI or deferred revascularisation - F. Ribichini

▸ Panel discussion & audience interaction

▸ Case presentation 2 - Revascularisation strategy in hemodynamically

unstable patient with acute coronary syndrome - A.J. Peace


▸ Case presentation 3 - Complex proximal left anterior descending stenosis:

ad hoc or defer? Stent or internal mammary artery? - E. Sorbets



159


09:30-10:30 Room 242B

Forum

India meets EuroPCR

Facilitators: A. Colombo, E. Grube, P. Urban

Panellists: N. Deshpande, S.M. Kalarickal, K. Prathap


Abstract session

Imaging DES results: optical coherence tomography and other techniques


Chairperson: E. Regar

▸ Introduction - E. Regar

▸ Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap

segments in DES 9-13 months after implantation: in vivo-assessment with

optical coherence tomography - J.L. Gutiérrez-Chico

▸ Optical coherence tomography assessment of the acute effect of high-

pressure non-compliant balloon postdilation on underexpansion and

malapposition in DES - T. Adriaenssens

▸ Does a last generation thin-strut DES produce a better vascular response

compared with a first generation thick-strut DES? - H. Ikejima

▸ Arterial repair 4 to 8 months after Zotarolimus-eluting Endeavor stent

implantation: angioscopic evaluation in patients - T. Ishihara

▸ Angioscopic assessment of arterial repair of biodegradable

polymer-coated Biolimus A9-eluting stent: comparison with durable

polymer-coated Sirolimus-eluting stent in patients - M. Awata

▸ Impact of arterial injury on neointimal hyperplasia after Zotarolimus-

eluting stent implantation: an IVUS study - C. Collet

▸ Take-home message - E. Regar

09:30-11:00 Room 251 Clinic

Abstract session

PCI outcomes in specific patient subsets


Chairpersons: I. Al-Rashdan, A. Chieffo, G. Pedrazzini

Friday 20th

160



Friday 2

0th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction - I. Al-Rashdan

▸ Gender disparity in 7,545 consecutive patients undergoing PCI - analysis

from a single university centre - R. Jibran

▸ PCI in women - clinical and angiographic differences - in-hospital results

M. Cantarelli

▸ Gender difference in the effect of obesity on prognosis for patients

undergoing PCI - Z.J. Wang

▸ Clinical and angiographic outcomes following PCI with DES in patients of

chronic kidney disease - H. Takimura

▸ The increasing cohort of patients older than 85 years: challenges for

intervention cardiologists - N. Cabanelas

▸ The impact of anemia on long-term clinical outcome in patients

undergoing PCI - T. Pilgrim

▸ Take-home message - G. Pedrazzini

09:30-11:00 Room 253 Clinic

Abstract session

Evaluation of thrombus aspiration during primary PCI in STEMI patients


Chairpersons: M. Sobhy, T. Mabin

▸ Introduction - M. Sobhy

▸ Clinical impact of thrombus aspiration during primary PCI: results from

Korea acute myocardial infarction registry - D. Hachinohe

▸ Aspiration thrombectomy during primary PCI as adjunctive therapy to

early (in-ambulance) abciximab administration in patients with acute

STEMI - T. Ahmed

▸ Effectiveness of thrombectomy using the export aspiration catheter during

primary PCI in STEMI - P. Anthopoulos

▸ Thrombus aspiration with a tip-cut balloon angioplasty catheter may be

useful in young patients with STEMI - M. Celik

▸ Combined intracoronary Tirofiban and manual thrombus extraction during

primary PCI in patients with STEMI - D. Natarajan

▸ Thrombectomy vs. no thrombectomy before stenting in acute myocardial

infarction: an optical coherence tomographic evaluation - M. Magro

▸ Take-home message - T. Mabin

161


09:30-11:00 Room 341 Clinic

Plenary session

Cardiogenic shock: an update

With the collaboration of the Working Group on Acute

Cardiac Care of the European Society of Cardiology

Chairpersons: C.J. Vrints, H. Bueno

Panellists: D. Ardissino, R.J. de Winter, R. Ferrari, S. Savonitto, M. Tubaro,

P. Vranckx

Objectives:

▸ To provide an update on:

- the diagnosis and therapeutic management of patients presenting with

cardiogenic shock

- the pharmacological management of patients with cardiogenic shock

- the preferred revascularisation strategy in patients with cardiogenic shock

- the available systems for hemodynamic support: indications and results

▸ Introduction and objectives - C.J. Vrints

▸ Case 1: a patient with an anterior wall STEMI with a cardiogenic shock

with multivessel disease. PCI vs. CABG? - H. Bueno

▸ Lecture 1: revascularisation in cardiogenic shock - C.J. Vrints

▸ Case 2: a patient with a recent myocardial infarction presenting with

cardiogenic shock and a systolic heart murmur - H. Thiele

▸ Lecture 2: role of non-invasive imaging and cardiogenic shock - J.J. Bax

▸ Case 3: a patient with persisting cardiogenic shock after rescue PCI and

intra-aortic balloon pump placement - P. Vranckx

▸ Lecture 3: hemodynamic support - J. Henriques

▸ Take-home message - H. Bueno


Forum

Complications encountered during coronary chronic total occlusion

interventions


Chairpersons: A. Galassi, J. Chen

STENT

FOR LIFE

Friday 20th

162


Friday 2

0th

Coro

nary a

nd

structu

ral h

eart d

isease


▸ Introduction - A. Galassi

▸ Delayed perforation (after 2 hrs) of 1st retrograde coronary chronic total

occlusion recanalisation in Bangladesh - K.N. Khan

▸ Coronary artery perforation and dissection during a long and uncrossable

balloon coronary chronic total occlusion PCI using multiple parallel wire

technique and tornus - M. Mohandes

▸ Dilation of the septal collateral artery and subsequent cardiac tamponade

during retrograde PCI using a microcatheter for coronary chronic total

occlusion - H. Hashidomi

▸ Coronary dissection of donor artery in retrograde approach for coronary

chronic total occlusion PCI is a fatal complication, but a procedure could

succeed through this complication - Y. Hamazaki

▸ The nightmare of donor artery closure not once but twice during

retrograde technique - P.K. Goel

▸ Take-home message - J. Chen

09:30-11:00 Room 351 Clinic

Forum

Treating left main: when every minute counts


Chairpersons: F. Mauri, D. Hasdai

▸ Introduction - F. Mauri

▸ He is still alive - M. Nab

▸ Reposition and correction of stent disarrange during left main stenting

C. Costantini

▸ Rescue PCI using rotational atherectomy for left main ostial lesion in a

cardiogenic shock octogenarian - L.W. Chen

▸ NSTEMI with cardiogenic shock due to ostial left main stenosis - A. Fleig

▸ Planned bifurcation angioplasty complicated by a broken stent and an

extensive dissection of the left main - S. Manzo-Silberman

▸ Take-home message - D. Hasdai

163



Forum

Complications encountered during secondary revascularisation


Chairpersons: J. Escaned, A. Ernst

▸ Introduction - J. Escaned

▸ The predicament of saphenous vein graft - R. Sachdeva

▸ A case of stent occlusion after removal of a stuck buddy wire and a

balloon at PCI for in-stent restenosis - T. Iwaki

▸ Unravelling a DES - a tentative to retrieve a dislodged coronary stent

A. Burlacu

▸ Left main coronary artery aneurysm with thrombotic ostial stenosis 2

years after implantation of paclitaxel eluting stents - M. Schroeder

▸ CABG pseudoaneurysm as a late-complication after percutaneous

intervention: successful treatment with covered stents - O. Breithardt

▸ Take-home message - A. Ernst


Forum

Unusual PCI complications - Part II


Chairpersons: J.J. Piek, P. Avraamides

▸ Introduction - J.J. Piek

▸ Acute bypass intervention: aortic dislocation and retrieval of a coronary

stent - M. Möckel

▸ A case of severe stent shortening - J. Bennett

▸ A case of cuting balloon rupture causing unwrapped blades from right

radial artery approach managed successfully - R. Anantharaman

▸ Successful treatment of jailed guidewire rupture after left anterior

descending PCI, complicated by left main dissection, acute stent

thrombosis and retroperitoneal bleeding: it never rains but it pours

F. Economou

▸ Recurrent left anterior descending perforation management - S. Mansour

▸ Take-home message - P. Avraamides

Friday 20th

164



Friday 2

0th

Coro

nary a

nd

structu

ral h

eart d

isease


10:30-11:30 Room 242B

Forum

South Korea meets EuroPCR

Facilitators: M. Buchbinder, M.C. Morice

Panellists: H.S. Kim, S.J. Park

11:00-12:30 Room 242A Clinic

Abstract session

Percutaneous mitral valve intervention from balloon to replacement


Chairpersons: O. Franzen, F. Maisano, K.H. Srinivasa

▸ Introduction - O. Franzen

▸ Inoue technique for balloon mitral valvuloplasty in patients with

uncomplicated mitral stenosis - M. Zufarov

▸ Inoue balloon versus single balloon techniques in mitral valvuloplasty:

long-term follow-up - E. Peixoto

▸ Percutaneous mitral valvuloplasty clinical efficacy of balloon sizing based

on echocardiographic commissural diameter - A. Zahedmehr

▸ A post market study of the MitraClip system for the treatment of mitral

regurgitation in Europe: analysis of outcomes in a 6-month patient cohort

W. Schillinger

▸ Percutaneous mitral valve repair with the MitraClip system: 30-day

outcome in the initial Milan experience - C. Godino

▸ Antegrade transcatheter mitral valve implantation: a short-term experience

in swine model - A. Quadri

▸ Take-home message - K. Srinivasa


Abstract session

Randomised clinical trials - Update


Chairpersons: M.W. Krucoff, J. Belardi

▸ Introduction - M.W. Krucoff

▸ The platinum small vessel trial: evaluation of the novel thin-strut platinum-

chromium promus element small vessel everolimus-eluting stent

I. Meredith

▸ Two-year reports of efficacy and safety end points from the randomised,

multicentre and controlled Eucatax trial - J. Mieres

▸ Pooled analysis of the Resolute programme clinical safety results

L. Mauri

▸ Take-home message - J. Belardi

165


11:00-12:00 Room 251 Clinic

Forum

Management of giant coronary aneurysms


Chairpersons: M. de Belder, V. Legrand

▸ Introduction - M. de Belder

▸ Two cases of giant coronary aneurysm of the left coronary artery

bifurcation - S.E. Lee

▸ Exclusion of right coronary artery aneurysm with pericardial stent, within

drug-eluting stent - D. Austin

▸ Large mycotic coronary pseudoaneurysm and drug eluting stent fracture

P. Jimenez-Quevedo

▸ Take-home message - V. Legrand

11:00-12:30 Room 253 Clinic

Abstract session

Is stent thrombosis still an issue?


Chairperson: A.C.Y. Yeung

▸ Introduction - A.C.Y. Yeung

▸ Acute stent thrombosis resulting in STEMI is associated with worse

clinical outcomes than STEMI, due to native coronary thrombosis - T. Pain

▸ Incidence and predictors of coronary stent thrombosis: evidence from an

international collaborative meta-analysis including 30 studies, 225,536

patients and 4,203 thromboses - F. D'Ascenzo

▸ Prevalence of hyporesponsiveness to aspirin and clopidogrel in patients

with stent thrombosis: is it time for tailored therapy? - N. Sambu

▸ Incidence, predictors and outcome of stent thrombosis - up to 8-year

follow-up in real-world patients undergoing DES implantation - R. Costa

▸ Evaluating the safety of very short-term dual antiplatelet therapy after

Genous stent implantation: the multicentre pilot GENOUS trial

G.M. Sangiorgi

▸ Late and very late coronary stent occlusion: intravascular ultrasound

analysis of a series of consecutive patients - F. Ribichini

▸ Take-home message - A.C.Y. Yeung

Friday 20th

166


Friday 2

0th

Coro

nary a

nd

structu

ral h

eart d

isease



Abstract session

New stent technology and first-in-man


Chairpersons: A. Lansky, C. Young

▸ Introduction - A. Lansky

▸ First-in-man, multicentre assessment of the novel Acrobat Svelt balloon-

expandable stent-on-a-wire system - J.R. Costa Jr

▸ Randomised comparison of the efficacy and safety of a novel DES with

biodegradable polymer and cobalt-chromium alloy - Inspiron I trial

E.E. Ribeiro

▸ Preliminary results of the multicentric, double-blinded, randomised,

Vestasync II trial - J.R. Costa Jr

▸ One-year follow-up of the ProNOVA XR polymer free Sirolimus-eluting

coronary stent system in the treatment of patients with de novo coronary

artery lesions: the EURONOVA study - J. Legutko

▸ First-in-man experience with the DES Orsiro in the treatment of patients

with single de novo coronary artery lesions (BIOFLOW-I) - M. Hamon

▸ De novo coronary lesions treated with the novel polymer-free Biolimus-A9

coated stents: four- and twelve-month angiographic results from the

prospective, randomised, multicentre BIOFREEDOM clinical trial

R. Costa

▸ Take-home message - C. Young


Forum

Coronary chronic total occlusion: current techniques - Part II


submissions

Chairpersons: E. Barbato, G. Sianos

▸ Introduction - E. Barbato

▸ STEMI as a complication of retrograde chronic total occlusion

recanalisation - R. Sachdeva

▸ Corsair tip-in rendezvous technique is useful for every interventionist

M. Atsushi

▸ Successful use of the GuideLiner catheter in a chronic total occlusion case

A. Ntatsios

▸ A case of successful coronary chronic total occlusion intervention utilising

CrossBoss and Stingray - M. Chan

▸ False lumen stenting - the sword of Damocles - T. Koppara

▸ Take-home message - G. Sianos

167


11:00-12:30 Room 351 Clinic

Forum

Role of non-invasive imaging in PCI


Chairpersons: V. Schächinger, J. Schofer

▸ Introduction - V. Schächinger

▸ Large perfusion defect on scintigraphy - explained by severe

microcirculatory dysfunction - F. Cuculi

▸ Cardiovascular magnetic resonance to guide revascularisation in acute

coronary syndromes - E. McAlindon

▸ The role of cardiovascular magnetic resonance in troponin positive acute

coronary syndromes with unobstructed coronary arteries - E. McAlindon

▸ Recurrent Takotsubo cardiomyopathy in a 78 year-old lady -

characterisation using cardiac magnetic resonance imaging and the index

of microcirculatory resistance - F. Cuculi

▸ Pre-catheterisation treatment planning using coronary computed

tomography angiography and computational assessment of fractional

flow reserve - B.K. Koo

▸ Take-home message - J. Schofer

11:00-12:00 Room 353 Clinic

Forum

TAVI complications - Part II



▸ Introduction - U. Gerckens

▸ Corevalve embolisation causing catastrophic coronary obstruction

C. Eftychiou

▸ Successful reposition by snaring of a corevalve prosthesis eight days after

implantation to correct severe aortic regurgitation - A. Medina

▸ Severe aortic regurgitation following Medtronic core-valve implantation

V. Voudris

▸ Take-home message - U. Gerckens

Friday 20th

168



Friday 2

0th

Coro

nary a

nd

structu

ral h

eart d

isease


11:30-12:30 Room 242B

Forum

Russia meets EuroPCR

With the collaboration of the Russian Scientific Society of Interventional

Cardioangiology (RSICA)

Facilitators: H. Eltchaninoff, D. Iosseliani

Participant: S. Semitko

Panellists: V. Ganyukov, K. Niemela, A. Osiev

12:00-13:00 Room 251 Clinic

Forum

Solutions for coronary spasm


Chairpersons: A. Lerman, M.J. Kern

▸ Introduction - A. Lerman

▸ Devastating coronary spasm - A. Javed

▸ Severe coronary artery vasospasm appearing as severe 3 vessel disease

causing cardiogenic shock - M.J. Jaluague

▸ A case in which cardiopulmonary arrest occurred during PCI for the

chronic total occlusion of right coronary artery - F. Hajime

▸ Take-home message - M.J. Kern


Main session

Presentation of 2011 EuroPCR/EAPCI awards

and closing ceremony


Panellists: J. Marco, P.W. Serruys, J. Fajadet, M.C. Morice,

B. De Bruyne, A. Vahanian, M. van Sambeek, E. Eeckhout, A. Cremonesi,

H. Sievert, D. Scheinert, C. Ruiz, P. Bonhoeffer, T.H. Koh, M. Thomas


▸ 2011 EuroPCR innovation award - S. Windecker

▸ Best abstract - J. Fajadet

▸ Abstract presentation by the awardee

▸ Best clinical case - A. Baumbach

▸ Case presentation by the awardee

▸ Most educational complication case - E. Eeckhout


▸ EAPCI training awards - C. Di Mario

▸ Closing remarks - P.W. Serruys

169


Training villag

e - Level 3

Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

s

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Vascular closure

p. 173

Bifurcation lesions

p. 173

Tuesday 17

th

CORDIS CARDIAC




EDWARDS LIFESCIENCES

MEDTRONIC ACADEMIA

ST. JUDE MEDICAL

Radial approach

p. 173

AMI for nurses

p. 227

Bifurcation lesions

p. 174


p. 174


p. 174

MVD

p. 174

Hemostasis

management

p. 175

Hemostasis

management for

nurses

p. 227

Hemostasis

management

for nurses

p. 227

Hemostasis

management for

nurses

p. 227

Training villag

e - Level 3


Coro

nary a

nd

structu

ral h

eart d

isease

Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

sTraining villag

e - Level 3

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Vascular closure

p. 175

Radial approach

p. 175

Wednesday 18th

CORDIS CARDIAC





MEDTRONIC ACADEMIA

ST. JUDE MEDICAL

Bifurcation lesions

p. 176

Intracardiac echocardiography in TAVI

p. 176

Vascular closure

p. 175

AMI for nurses

p. 228

CTO

p. 177


p. 177


p. 177

MVD

p. 178

FFR for physicians

p. 178

STEMI

p. 176


p. 177


p. 177


p. 177

Bifurcation lesions

p. 177

MVD

p. 178

MVD for nurses

p. 228

AMI for nurses

p. 228

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for physicians

p. 178

FFR for physicians

p. 178

FFR for physicians

p. 178

FFR for physicians

p. 178

Train

ing

village


9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

TAVI

p. 183

Friday 20th

MEDTRONIC ACADEMIA

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Radial approach

p. 179

FFR for nurses

p. 229

AMI

p. 180

CORDIS CARDIAC





MEDTRONIC ACADEMIA

ST. JUDE MEDICAL

Vascular closure

p. 179

Intracardiac echocardiography

in TAVI

p. 179

Radial approach

p. 180

CTO

p. 180

Bifurcation lesions

p. 181

AMI

p. 180


p. 181


p. 181


p. 181


p. 181

TAVI

p. 182

TAVI

p. 182

TAVI

p. 182

TAVI

p. 182

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

FFR for nurses

p. 229

OCT for physicians

p. 182

OCT for physicians

p. 182

OCT for physicians

p. 182

OCT for physicians

p. 182

OCT for physicians

p. 182

Training villag

e - Level 3

Thursday 19th

Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

s


Coro

nary a

nd

structu

ral h

eart d

isease

173

Tuesday 17th May

Room CORDIS CARDIAC & VASCULAR INSTITUTE

13:00-14:00 Training Village

Vascular closure with ExoSeal



Trainer: M. el Omar

Objectives:

▸ To be able to discuss the pros and cons of vessel closure devices

▸ To understand how to reduce the risk of bleeding complications following

vessel closure

▸ To complete at least one vessel closure procedure with a training tool


The challenge of treating bifurcation lesions



Trainers: M. Ferenc, J.F. Lassen, G. Stankovic

Objectives:

▸ To provide delegates with the latest information on the treatment of

bifurcation lesions

▸ To provide practical sessions incorporating both bench models and

simulators to evaluate the various bifurcation techniques


Radial approach for coronary diagnostic and interventions



Trainers: T. Comberg, L. Hellsten

Objectives:

▸ To share the pros and cons of radial versus femoral approach

▸ To understand the technique of radial artery puncture, sheet insertion and

the different steps to successfully reach the coronary ostium access

▸ To review the evidence on radial approach for coronary interventions

Train

ing

village


Room CROSSROADS, the Abbott Vascular Education Network


Strategies for treatment of bifurcated lesions - Hands-on session

With an unrestricted educational grant from CROSSROADS, the Abbott


Trainers: M. De Benedictis, G. Stankovic

Objectives:

▸ To give an update on how to build a bifurcation procedure strategy based

on patient assessment

▸ To give an update on procedure techniques and device choices

▸ To provide hands-on experience on hybrid flow models

Room EDWARDS LIFESCIENCES


16:30-18:00

Transcatheter heart valves for patients with severe aortic stenosis


Trainers: A. Cribier, D. Himbert

Objectives:

▸ To provide a review of TAVI procedure steps, as well as valve and delivery

system preparation

▸ To train on new generation transfemoral and transapical delivery systems

using simulators with real cases examples

▸ To provide educational materials on patient screening, selection and

referral materials

Room MEDTRONIC ACADEMIA


Multivessel disease

With an unrestricted educational grant from MEDTRONIC ACADEMIA

Trainers: M. Heigert, P. Joly, P. Musialek, M. Oberhoff

Objectives:

▸ To review simulated case scenarios integrating Syntax

score/Euroscore/fractional flow reserve

▸ To discuss and plan treatment strategy with peers and experts

▸ To implement the chosen strategy during the simulation session

174

Training village


Train

ing

village

Coro

nary a

nd

structu

ral h

eart d

isease


175

Room ST JUDE MEDICAL


Hemostasis management


Trainers: A. Bortone, G.M. Sangiorgi

Objectives:

▸ To highlight the benefits of combined use of vascular closure devices and

bivaluridine in clinical practice

▸ To provide scientific evidence through research analysis of the

performance of intra and extra vascular closure devices

Wednesday 18th May



17:00-18:00




Trainer: M. el Omar

Objectives:



vessel closure

▸ To complete at least one vessel closure procedure with a training tool


Radial approach in challenging cases



Trainers: Y. Louvard, J. Nolan

Objectives:


▸ To review and discuss challenging cases and be able to understand

strategy options on radial approach




The challenge of treating bifurcation lesions



Trainers: M. Ferenc, J.F. Lassen, G. Stankovic

Objectives:

▸ To provide delegates with the latest information on the treatment of

bifurcation lesions

▸ To provide practical sessions incorporating both bench models and

simulators to evaluate the various bifurcation techniques


Intracardiac echocardiography in TAVI: fast and easy - safe and simple



Trainers: T. Bartel, L. Van Garsse, N. Vejlstrup

Objectives:

▸ To learn how and why use intracardiac echocardiography. Tips & tricks for

a quick navigation

▸ To learn how to acquire with intracardiac echocardiography the same

measurements as with transoesophageal echocardiography

▸ To learn how to perform the procedure faster and easier

▸ To learn how to perform the procedure safer and simpler



Emergency strategies for acute myocardial infarction-STEMI

patients - Hands-on session



Trainers: J. Greenwood, O. Varenne

Objectives:

▸ To give a short update on latest primary PCI procedure guidelines and

clinical practice

▸ To give an update on drug management pre-, per- and post-procedure

▸ To provide hands-on experience on simulators: an emergency scenario

developed for PCR

STENT

FOR LIFE

176

Training village


Train

ing

village

Coro

nary a

nd

structu

ral h

eart d

isease


177





Trainers: M. De Benedictis, T. Lefèvre

Objectives:






Strategies for coronary chronic total occlusion procedures - Hands-on

session



Trainers: A. Serra, G. Werner

Objectives:

▸ To give a short review on how to build coronary chronic total occlusion

procedure strategies based on patient assessment





10:30-12:00

12:30-14:00

14:30-16:00

16:30-18:00



Trainers: H. Eltchaninoff, E. Garcia, M. Kasel, K. Spargias,

P. Wenaweser

Objectives:


system preparation




referral materials


Training village

178



11:30-13:30

Multivessel disease


Trainers: J. Goicolea, P. Joly, M. Heigert, J. Koolen, V. Ninios, F. Tarantino,

F. Tomai, C. Wolf

Objectives:


score/Euroscore/Fractional flow reserve





11:00-12:15

14:00-15:15

15:30-16:45

PCI optimisation- fractional flow reserve - Case discussions through

virtual reality cases and wetlab demonstrations


Trainer: C. Vermeire

Objectives:

▸ To provide expertise on fractional flow reserve as an exact and effective

method to measure the hemodynamic impairment induced by a coronary

lesion

▸ To improve daily clinical practice through a more accurate decision

process


PCI optimisation: fractional flow reserve - Practical tips & tricks: case

review session


Trainers: M. J. Kern, S.J. Park

Objectives:

▸ To spread awareness on fractional flow reserve wider indications and the

impact of the clinical evidence on the daily practice

▸ To present case studies showing the higher accuracy of fractional flow

reserve vs. IVUS in supporting the physician's decision-making process

for the treatment strategy


179


Coro

nary a

nd

structu

ral h

eart d

isease

Thursday 19th May



Radial approach for coronary diagnostic and interventions



Trainers: T. Comberg, L. Hellsten

Objectives:


▸ To understand the technique of radial artery puncture, sheet insertion and

the different steps to successfully reach the coronary ostium access






Trainer: M. el Omar

Objectives:



vessel closure

▸ To complete at least one vessel closure procedure at a training tool


Intracardiac echocardiography in TAVI: fast and easy - safe and simple



Trainers: T. Bartel, L. Van Garsse, N. Vejlstrup

Objectives:

▸ To learn how and why use intracardiac echocardiography. Tips & tricks for

a quick navigation

▸ To learn how to acquire with intracardiac echocardiography the same

measurements as with transoesophageal echocardiography

▸ To learn how to perform the procedure faster and easier

▸ To learn how to perform the procedure safer and simpler

Train

ing

village


Training village

180


Radial approach in challenging cases



Trainers: Y. Louvard, J. Nolan

Objectives:


▸ To review and discuss challenging cases and be able to understand

strategy options on radial approach




16:30-18:30

Emergency strategies for acute myocardial

infarction-STEMI patients - Hands-on session



Trainers: J. Greenwood, O. Varenne

Objectives:

▸ To give a short update on latest primary PCI procedures guidelines and

clinical practice

▸ To give an update on drug management pre-, per- and post-procedure

▸ To provide hands-on experience on simulators: an emergency scenario

developed for PCR


Strategies for coronary chronic total occlusion procedures - Hands-on

session



Trainers: E. Barbato, J. Spratt

Objectives:

▸ To give a short review on how to build coronary chronic total occlusion

procedure strategies based on patient assessment



STENT

FOR LIFE


181


Coro

nary a

nd

structu

ral h

eart d

isease





Trainers: B. Farah, C.K. Naber

Objectives:







10:30-12:00

14:30-16:00

16:30-18:00



Trainers: V. Bapat, A. Fabbri, M. Lins, G. Olivecrona, W. Wisser

Objectives:


system preparation




referral materials

Train

ing

village


Training village

182



11:30-13:30

14:00-16:00

16:30-18:30

TAVI


Trainers: J. Bosmans, H. Danenberg, H. Eggebrecht, R. Hernandez Antolin,

H. Ince, A. Khattab, J. Kovac, A.S. Petronio, M. Spence, P. Wenaweser,

M. Zelizko

Objectives:

▸ To provide attendees with the opportunity to familiarise themselves with

the fundamentals and basic principles of TAVI using the CoreValve device

through presentations and simulation

▸ To understand CoreValve implantation technique by a step-by-step

approach using simulation sessions

▸ To discuss and plan implant strategies in different anatomical scenarios

with peers and experts



11:00-12:15

14:00-15:15

15:30-16:45

PCI optimisation- optical coherence tomography - Case discussions

through virtual reality cases


Trainer: C. Vermeire

Objectives:

▸ To discuss the usage of optical coherence tomography as a diagnostic tool

in different clinical cases

▸ To provide expertise on optical coherence tomography image reading


PCI optimisation- optical coherence tomography focus


Trainers: T. Adriaenssens, T. Akasaka

Objectives:

▸ To discuss optical coherence tomography in acute coronary syndromes

▸ To understand and discuss the role of optical coherence tomography for

stent optimisation


183


Coro

nary a

nd

structu

ral h

eart d

isease

Friday 20th May



TAVI


Trainers: L. Buellesfeld, H. Danenberg, J. Kovac

Objectives:

▸ To provide attendees with the opportunity to familiarise themselves with

the fundamentals and basic principles of TAVI using the CoreValve device

through presentations and simulation

▸ To understand CoreValve implantation technique by a step-by-step

approach using simulation sessions

▸ To discuss and plan implant strategies in different anatomical scenarios

with peers and experts

Train

ing

village




Endovascular programme

PART II

11T0768_PCRpocket_04_Endo 18/04/11 11:26 Page185


Main session



Panellists: A. Cremonesi, T. Lüscher, C. Rihal, C. Ruiz,

P.W. Serruys, R. Whitbourn


Germany



T. Lüscher


Main session



Panellists: E. Eeckhout, J.B. Ge, T.H. Koh, J. Marco,

M.C. Morice, R. Ng, P.W. Serruys, M. Thomas, A. Vahanian



PCR courses




PCR communications









Tuesday 17th

186


Tue

sday 1

7th

End

ova

scula

r

Endovascular

12:00-14:30 Room Maillot Break-out

Plenary session

What's new in endovascular interventions?

Chairperson: A. Cremonesi

Panellists: F. Ribichini, M. Roffi, D. Scheinert, M. van Sambeek


Germany

▸ Opening and introduction - A. Cremonesi

▸ Major steps in endovascular interventions in 2010/2011 - M. Roffi

▸ Endovascular Late breaking trials

- DESERVE study: diffusion weighted - magnetic resonance imaging based

evaluation of the effectiveness of endovascular clamping during carotid

artery stenting with the Mo.Ma device. Results from a prospective,

multicentre study - A. Cremonesi

- Transascending aortic approach for TAVI - a step toward cerebral protection

S. Papadatos

- MARIS - 1,000 patient superficial femoral artery registry - H. Krankenberg

- Drug-eluting balloon for the treatment of femoro-popliteal arterial disease:

mid-term results from a multicentre Italian registry - A. Micari

- CONNECT IDE study - chronic total occlusion crossing with the Wildcat

catheter - J.P. Pigott

- TriVascular Ovation - global clinical experience with a Novel, 14FR

abdominal stent graft system - H. Krankenberg

▸ Take-home message - A. Cremonesi

13:30-15:00 Room 242A Clinic

Abstract session

Carotid artery stenting patient and lesion characterisation


Chairpersons: S. MacDonald, R. Vijayvergiya

▸ Introduction - S. MacDonald

▸ Sex-related differences in carotid plaque features: are men at higher risk of

carotid instability and inflammation? - G.M. Sangiorgi

▸ Comparison of angiography and computer tomography-angiography (CTA)

with B-flow (BF) ultrasound (US) in carotid stenoses: improved pre-interventional

evaluation of carotid stenoses by B-flow ultrasound - R. Macharzina

▸ Carotid artery stenting improves neurocognitive function only in severe

internal carotid occlusive disease with objective cerebral ischemia - M.S. Lin

▸ Plaque analysis of femoral and carotid atherectomy samples - I. Ott

▸ Treatment stratification of carotid artery stenosis: novel duplex-

sonographic velocity cut-off values - R. Macharzina

▸ Carotid artery ultrasound findings can predict intermediate and high

SYNTAX score patients - N. Ikeda

▸ Take-home message - R. Vijayvergiya 187


14:30-16:30 Room Maillot How to...

Plenary session

How to do endovascular interventions: imaging, vascular access and

equipment selection

Chairpersons: M. Schillinger, M. Roffi

Objectives:

▸ To define what imaging equipment is required for endovascular

interventions

▸ To learn about wires, catheters, stents and other devices

▸ To promote a basis of reasoning for selecting appropriate devices and

techniques

▸ To acquire tips & tricks for vascular access

▸ Introduction and objectives - M. Schillinger

▸ Imaging: what is necessary, what is helpful - R. Dave

▸ What materials do I need for endovascular interventions? - A. Schmidt

▸ Cross-over: tips & tricks - H. Krankenberg

▸ When and how to do antegrade femoral puncture? - T. Zeller

▸ Brachial and radial approach for peripheral interventions - P. Pattynama

▸ Popliteal and pedal approach - D. Scheinert

▸ Discussion

▸ Take-home message - M. Roffi

15:00-16:30 Room 253 Clinic

Forum

Endovascular treatment for abdominal aortic aneurysm


submissions

Chairperson: P. Peeters

▸ Introduction - P. Peeters

▸ Challenging endovascular aneurysm repair case - E. Janakiraman

▸ Infra-renal abdominal aortic aneurysm with LT iliac occlusion in a

leukemic patient - modified aorto-uni-iliac stenting - R. Vijayvergiya

▸ Spondylodiscitis associated with paravertebral abscess complicated with

aortic rupture - F. Martino

▸ Endovascular treatment of ruptured abdominal aortic aneurysm

complicated with subacute graft thrombosis - J. Trebacz

▸ Take-home message - P. Peeters

Tuesday 17th

188


Tue

sday 1

7th

End

ova

scula

r

Endovascular


Plenary session

How to do endovascular interventions: carotid

and supra-aortic interventions

Chairpersons: N. Hopkins, M. van Sambeek


Germany

Objectives:

▸ To review the knowledge required to perform carotid and supra-aortic

interventions

▸ To demonstrate a step-by-step approach

▸ To learn how to avoid and manage complications

▸ Introduction and objectives - N. Hopkins

▸ What you need to know before you start - K. Mathias

▸ Carotid and supra-aortic interventions step-by-step - F. Castriota

▸ Supra-aortic interventions step-by-step - R. Dave

▸ How to avoid and manage complications - S. Myla

▸ Take-home message - M. van Sambeek


Forum

Femoral and below the knee interventions


Chairpersons: F. Ribichini, A. Sauguet

▸ Introduction - F. Ribichini

▸ Below the knee angioplasty in elderly patient with critical limb ischemia

A. Goldsmit

▸ Manual thrombectomy in acute limb ischemia - D. Dandrea

▸ Usefulness of trans-collateral method for chronic total occlusion of

superficial femoral artery - T. Suzuki

▸ Echo-guided treatment of a long superficial femoral artery chronic

total occlusion and sheathless stent delivery via below the knee vessel

H. Sakai

▸ Take-home message - A. Sauguet

189


17:00-18:30 Room 352AB

How should I treat?

Multivessel infrapopliteal occlusions in critical limb ischemia


Chairperson: T. Zeller

Objectives:

▸ To understand the most clinically meaningful treatment strategy in

presence of multiple vessel occlusion of infrapopliteal vessels in critical

limb ischemia

▸ To prioritise and decide which and how many vessels should be

recanalised and to which extent

▸ To discuss the best technique for recanalisation and for achieving and

maintaining vessel patency

▸ Introduction and objectives - T. Zeller

▸ Case 1 - Below the knee three vessel occlusion

- Case presentation - S. Bartus

- How would I treat? - R. Ferraresi

- How would I treat? - M. Fusaro

- How did I treat? - S. Bartus

- Discussion

- Consensus - T. Zeller

▸ Case 2 - Below the knee three vessel occlusion

- Case presentation - E. Blessing

- How would I treat? - D-D. Do

- How would I treat? - M. Brodmann

- How did I treat? - E. Blessing

- Discussion

- Consensus - T. Zeller

▸ Take-home message - T. Zeller

Tuesday 17th

190




Plenary session

How to do endovascular interventions: femoro-popliteal interventions

Chairpersons: R. Dave, M. Schillinger

With continuous live demonstration from Universität Leipzig Herzzentrum,

Leipzig - Germany

Objectives:

▸ To review the knowledge required to perform femoro-popliteal

interventions



▸ Introduction and objectives - R. Dave

▸ What you need to know before you start - I. Moussa

▸ Superficial femoral artery interventions step-by-step - H. Krankenberg

▸ How to avoid and manage complications - C. Schonholz

▸ Take-home message - M. Schillinger

08:30-10:00 Room 251 Break-out

Plenary session

Acute stroke interventions

Chairpersons: I. Grunwald, H. Sievert

Objectives:

▸ To learn about state-of-the-art acute medical treatment of stroke

▸ To understand how catheter interventions might improve outcome

▸ To understand how to establish a stroke centre

▸ Introduction and objectives - H. Sievert

▸ Epidemiology, pathophysiology and clinical presentation of acute stroke

I. Grunwald

▸ Best medical therapy and how to deliver it - K. Fassbender

▸ Techniques and devices for catheter based acute stroke interventions

G. Schroth

▸ How not to harm - N. Hopkins

▸ How to implement acute stroke intervention and how can cardiologists

become involved - M. Abelson

▸ Discussion

▸ Take-home message - I. Grunwald

Wednesday 18th

192




We

dn

esd

ay 1

8th

End

ova

scula

r

Endovascular

09:00-17:00 Near Theatre Bordeaux and TV studio

Innovation Incubator Space

On your way to or from a session, visit the Innovation Incubator Space and

learn about the latest technology from innovative companies. Grab a bite

from the buffet and talk with the representatives at each table. This space is

open to everyone, all day long.

▸ Cardiatis - Multilayer flow modulator for global aneurysm repair


▸ Avidal Vascular - Wombat drug reservoir technology

▸ Envision Scientific - Focusnp: sirolimus based nano carrier eluting-

coronary stent system


▸ Abbott Vascular - ABSORB bioresorbable vascular scaffold for peripheral

use


regurgitation




balloon catheter for treatment of coronary artery disease

▸ Valtech - Cardioband: transfemoral, surgical like, adjustable mitral

annuloplasty

09:00-10:30 Room 242A

How should I treat?

Critical decisions in critical limb ischemia

Under the auspices of the Belgian Society for Vascular Surgery (BSVS)

and the Vascular Surgery Society of Southern Africa (VASSA)

Chairpersons: P. Matley, P. Peeters

Objectives:

▸ To understand the interaction of disease at multiple levels on the

management and outcome of critical limb ischemia

▸ To teach a structured step-by-step approach to the management of critical

limb ischemia

▸ To introduce and review new endovascular techniques in below the knee

peripheral arterial disease

193


▸ Introduction and objectives - P. Peeters

▸ Critical limb ischemia: complex multilevel disease

- Case presentation - N. Naidoo

- How would I treat? - J. Pillai

- How would I treat? - M. Bosiers

- How did I treat? - N. Naidoo

- Discussion

- Consensus - P. Matley

▸ Critical limb ischemia: complex multilevel disease

- Case presentation - F. Vermassen

- How would I treat? - M. Bosiers

- How would I treat? - J. Pillai

- How did I treat? - F. Vermassen

- Discussion

- Consensus - P. Peeters

▸ Take-home message - P. Matley


All you need to know about carotid artery stenting

Chairpersons: M. Roffi, A. Cremonesi

Objective:

▸ At the end of this 90 minute ‘All you need to know about...’ session the





▸ Introduction and objectives - M. Roffi

▸ Background - Risk of stroke in carotid stenosis - M. Mazighi

▸ Clinical data - Updates on randomised trials and registries - F. Ribichini

▸ Issues in clinical practice - Technique and patient selection are equally

important - E. Minar

▸ Guidelines on carotid revascularisation - B. Reimers

▸ Unresolved issues and outlook in carotid artery stenting - S. MacDonald



Wednesday 18th

194


We

dn

esd

ay 1

8th

End

ova

scula

r

Endovascular

10:30-12:00 Room 341 Clinic

Abstract session

Endovascular management of lower limb ischemia


Chairpersons: D-D. Do, F. Castriota

▸ Introduction - D-D. Do

▸ The duplex sonography guided percutaneous peripheral intervention for

chronic total occlusion lesions in the superficial femoral arteries

K. Meguro

▸ EURO CANAL: study design of a prospective randomised trial investigating

Paclitaxel-coated balloons for infrapopliteal angioplasty in patients with

critical limb ischemia - N. Diehm

▸ Percutaneous management of lower limb ischemia following the use of

vascular closure devices - S. Rekik

▸ Bail-out stenting for treatment of below the knee arterial disease: acute

results and one-year clinical follow-up - A single centre experience

A. Cioppa

▸ Rheolytic thrombectomy for treatment of arterial limb ischemia: report of

a prospective multicentre registry - A. Amin

▸ Take-home message - F. Castriota

11:30-13:00 Room 251 Clinic

Forum

Occlusion after internal carotid stenting


submissions

Chairpersons: N. Hopkins, S. MacDonald

▸ Introduction - N. Hopkins

▸ Simultaneous intracranial and internal carotid angioplasty - D. Grinfeld

▸ No flow after carotid stenting - J.C. Londono

▸ Think, don't panic! Vanishing carotid artery flow before actual intervention

J.K. Lee

▸ Delayed shortening of carotid Wallstent with resultant restenosis, and its

treatment with additional stent deployment - K. Muramatsu

▸ How do we handle mud pie? Endovascular re-canalisation in patient with

carotid occlusion and repeated transient ischemic attack - J.K. Lee

▸ Take-home message - S. Macdonald

195



Plenary session

Cardiovascular Innovation Pipeline - Peripheral vascular disease and

structural heart disease

Chairpersons: P. Bonhoeffer, M.C. Morice, H. Sievert

▸ Overview of companies - E. Lehto


regurgitation - W. Schillinger


▸ Pi-R-Squared - Impacting valve repai - E. Golan


▸ Cardiatis - Multilayer flow modulator for global aneurysm repair - P. Gruffaz


▸ Avinger - Optical coherence tomography for peripheral intervention - B. Ford


▸ Odierna - Software for automatic IV-optical coherence tomography stent

analysis, image registration and 3D reconstruction - G. Ughi


▸ Avidal Vascular - Wombat drug reservoir technology - T. Heilmann


12:00-13:30 Room 343 Clinic

Abstract session

Stenting for complex lesions above and below the inguinal ligament


Chairpersons: A. Sauguet, F. Vermassen

▸ Introduction - A. Sauguet

▸ Mid-term outcome of endovascular treatment with primary self

expandable stent placement for chronic total occlusion of iliac artery

M. Araki

▸ Creation of a new aortic bifurcation with covered stent-grafts through a 9fr

access: a new technique to treat aorto-iliac occlusive disease - P. Goverde

▸ Role of endovascular therapy in the treatment of patients with Leriche

syndrome: initial and mid-term outcomes - O. Iida

▸ Mid-term results of iliac TASC C-D angioplasty in a single centre

experience - A. Liso

Wednesday 18th

196




We

dn

esd

ay 1

8th

End

ova

scula

r

Endovascular

▸ Procedural success and clinical follow-up in endovascular treatment for

TASC II C and D lesions in femoropopliteal arterial disease - A. Furgieri

▸ Results through 2-year follow-up from the reform clinical study

(evaluation of safety and effectiveness of the formula balloon-expandable

stent for renal artery stenosis) - R. Bersin

▸ Take-home message - F. Vermassen


Symposium

Titanium-nitride-oxide bioactive stent technology in acute coronary

syndrome patients: present and future

With an unrestricted educational grant from HEXACATH

Chairpersons: J. Fajadet, M. Sabate

Objectives:

▸ To review why acute coronary syndrome patients are a challenging

indication for PCI

▸ To understand the titanium-nitride-oxide coated stents potential interest

for acute coronary syndrome patients

▸ To describe the latest Titan2 bioactive stent clinical data and share the next

applications of this technology


▸ How the thrombogenic and inflammation context of acute coronary

syndrome patients must lead to a rationale stent choice - M. Sabate

▸ Perspective of optical coherence tomography findings after Titan2 stent

implantation in acute coronary syndrome patients - P. Karjalainen

▸ Optimal revascularisation in patients with acute myocardial infarction: the

CATS-AMI large scale registry - M. Angioi

▸ Randomised comparison between the bioactive stent Titan2 and the

Everolimus-eluting stent XienceV: the BASE-ACS trial - P. Karjalainen

▸ Introducing the future of bioactive stents - J. Fajadet

▸ Discussion


197


12:00-13:30 Room 353

How should I treat?

How should I treat challenging superficial femoral artery lesions?With an unrestricted educational grant from COOK MEDICALChairperson: M. Schillinger

Objectives:▸ To learn how to recanalise long superficial femoral artery occlusions

▸ To understand the impact of new treatment options to prevent recurrentstenoses


▸ Challenging superficial femoral artery lesions 1

- Case presentation - N. Diehm

- How would I treat? - D. Scheinert

- How would I treat? - T. Zeller

- How did I treat? - N. Diehm

- Discussion

- Consensus - M. Schillinger

▸ Challenging superficial femoral artery lesions 2

- Case presentation - F. Airoldi


- How would I treat? - T. Zeller

- How did I treat? - F. Airoldi

- Discussion

- Consensus - M. Schillinger

▸ Take-home message - M. Schillinger


Plenary session

How to do endovascular interventions: aorto-iliac interventionsChairpersons: I. Moussa, C. Schonholz

With continuous live demonstration from Universität Leipzig Herzzentrum,

Leipzig - Germany

Objectives:▸ To review the knowledge required to perform aorto-iliac interventions



▸ Introduction and objectives - I. Moussa

▸ What you need to know before you start - P. Pattynama

▸ Aorto-iliac interventions step-by-step - M. Schillinger

▸ How to avoid and manage complications - R. Dave

▸ Take-home message - C. Schonholz

Wednesday 18th

198


We

dn

esd

ay 1

8th

End

ova

scula

r

Endovascular


Plenary session

Critical limb ischemiaChairpersons: D. Scheinert, P. Peeters

Objectives:▸ To learn how to create and manage a wound care programme

▸ To define which arterial level to treat

▸ To select the appropriate therapy in patients with critical limb ischemia

▸ To present new therapeutic options

▸ Introduction and objectives - D. Scheinert

▸ How to create and manage a wound care programme - P. Leger

▸ Critical limb ischemia: endovascular and surgical options - M. Bosiers

▸ Advanced techniques for optimal interventional recanalisation in complexbelow the knee disease - R. Ferraresi

▸ Special considerations in diabetic patients - D-D. Do

▸ Critical limb ischemia: does long-term patency matter? - D. Scheinert

▸ End stage critical limb ischemia: bone marrow cell transplantation andmore? - M.A. Sevestre-Pietri

▸ Take-home message - P. Peeters

15:00-16:30 Room 342AB Break-out

Plenary session

Renal denervation therapyChairpersons: M. Roffi, E. Blessing

Objectives:▸ To understand the mechanisms of renal denervation therapy

▸ To learn how to select the patients and perform the procedure

▸ To review current results and limitations of the available data

▸ Introduction - M. Roffi

▸ There is a huge need for improved antihypertensive treatment! - H. Schunkert

▸ Pathophysiology of nerve-mediated blood pressure regulation and pre-clinical data of renal denervation - P. Sobotka

▸ Patient selection and technique of application - T. Zeller

▸ Clinical data of renal denervation - H. Sievert

▸ Open questions, other potential indications and future perspectives - T. Lüscher

▸ Discussion

▸ Take-home message - E. Blessing

199



Abstract session

Latest aspects on carotid artery stenting


Chairpersons: F. Castriota, I. Moussa

▸ Introduction - F. Castriota

▸ Carotid endarterectomy versus carotid stenting in symptomatic and

asymptomatic patients with carotid artery stenosis: a meta-analysis - P. Meier

▸ Early and long-term outcomes following combined percutaneous

revascularisation in patients with carotid and coronary artery stenoses

F. Tomai

▸ Transradial / transbrachial carotid stenting safety and feasibility trial

A. Youssef

▸ Carotid artery angioplasty in complex aortic arch anatomy - Predictors of

major and minor adverse events, including non-cardiovascular adverse

events - F. Damas De Los Santos

▸ Simultaneous hybrid revascularisation of carotid and coronary disease in

patients with acute coronary syndrome: initial results of a new therapeutic

approach - M. Ponte

▸ Proposal of an anatomical-procedural classification for evaluating carotid

angioplasty and stenting - E. Carvalho De Campos Martins

▸ Take-home message - I. Moussa


Symposium

Advancing the Paccocath technology and the future of drug-elutingballoon angioplastyWith an unrestricted educational grant from B. BRAUN and MEDRADINTERVENTIONAL/POSSISChairpersons: J.F. Granada, B. Scheller

Objectives:▸ To understand the concept and the basic principals of the Paccocath

balloon coating technology

▸ To get an overview/summary of the pre-clinical and clinical drug-elutingballoon evaluation for coronary and peripheral applications

▸ To learn about the possible coronary and peripheral indications of thePaccocath drug-eluting balloon technology

▸ To learn about procedural treatment recommendations and how the drug-eluting balloon should be used to achieve optimal long-term results

▸ To take home practical tips & tricks for the drug-eluting balloon usage

Wednesday 18th

200




We

dn

esd

ay 1

8th

End

ova

scula

r

Endovascular

▸ Introduction to the Paccocath technology - J.F. Granada

▸ Comprehensive review of clinical data with the Paccocath technologyB. Scheller

▸ Treatment recommendations of the German Consensus Group - D. Mathey

▸ Paccocath technology advances: insights into pre-clinical studies of thelatest generation Cotavance drug-eluting balloon - J.F. Granada

▸ A new look into Paccocath clinical data: THUNDER trial and beyond - G. Tepe

▸ Current Cotavance clinical trial status and future study designs - N. Diehm

▸ Discussion

▸ Take-home message - B. Scheller

16:30-18:00 Room 353

How should I treat?

Optimal revascularisation in patients with peripheral artery diseasetreated with titanium-nitride-oxide bioactive coated stentsWith an unrestricted educational grant from HEXACATHChairpersons: A. Cremonesi, H. Sievert

Objectives:▸ To understand what are the unresolved issues regarding percutaneous

transluminal angioplasty stenting both for superficial femoral artery andrenal indications

▸ To learn how the combination of a new design and titanium-nitride-oxidecoating can be a solution

▸ To discuss and compare superficial femoral artery and renal stentingstrategies from different countries


▸ Complex superfical femoral artery angioplasty

- Case presentation - A. Sauguet

- How would I treat? - M. Akesson

- How would I treat? - S. Saccà

- How did I treat? - A. Sauguet

- Discussion

- Consensus - A. Cremonesi

▸ Complex renal artery angioplasty

- Case presentation - P. Commeau

- How would I treat? - J.J. Munos

- How would I treat? - S. Sathe

- How did I treat? - P. Commeau

- Discussion

- Consensus - H. Sievert


201



Plenary session

How to do endovascular interventions: below the knee interventions

Chairpersons: M. Schillinger, H. Sievert

With continuous live demonstration from Villa Maria Cecilia Hospital,

Cotignola - Italy

Objectives:

▸ To review the knowledge required to perform below the knee interventions




▸ What you need to know before you start - G. Tepe

▸ Below the knee interventions step-by-step - T. Zeller

▸ How to avoid and manage complications - I. Moussa

▸ Take-home message - H. Sievert


Plenary session

Multilevel vascular disease: filling the gap between interventions and

medicine

Chairpersons: A. Cremonesi, F. Ribichini

Panellists: N. Diehm, D-D. Do, M. van Sambeek

Objectives:

▸ To understand the importance of clinical judgement in the vascular work-up

▸ To facilitate the creation of a local multidisciplinary team for evaluation

and decision-making

▸ To learn about the complexity of patients and risks associated with

multilevel vascular disease

▸ Introduction and objectives - A. Cremonesi

▸ Clinical case presentation: a patient admitted for transient ischemic

attack/minor stroke, with concomitant stable angina and uncontrolled

systemic hypertension (two drugs) - D. Capodanno

▸ Proposal of a complete vascular work-up: what really matters for the long-

term improvement of quality of life and survival - D-D. Do

▸ How to integrate the clinical findings and the technical challenges into a

coordinate vascular team - N. Diehm

▸ Multidisciplinary roundtable - N. Diehm, D-D. Do, M. van Sambeek

▸ What does evidence say on multilevel disease treatment strategy - F. Tomai

▸ Discussion

▸ Take-home message: the difference between "individual professional

opinions" and the opinion of a "cardiovascular team" - F. Ribichini

Thursday 19th

202


Thu

rsday 1

9th

End

ova

scula

r

Endovascular

10:00-11:30 Room 242A

How should I treat?

Challenging peripheral vessels intervention

Under the auspices of the Iranian Society of Interventional Cardiology

and the Turkish Working Group of Interventional Cardiology

Chairpersons: B.S. Cebeci, M. Hashemian

Objective:

▸ To learn how to treat patients with catheter-based technique of abdominal

aortic total occlusion when surgery cannot be done

▸ Introduction and objectives - B.S. Cebeci

▸ Hybrid approach to a patient with multiple coronary and aortic aneurysms

- Case presentation - E. Kardesoglu

- How would I treat? - O. Goktekin

- How would I treat? - A.M. Haj Zeinali

- How did I treat? - E. Kardesoglu

- Discussion

- Consensus - B.S. Cebeci

▸ Intervention of total occlusion of abdominal aorta

- Case presentation - A. Ghofraniha

- How would I treat? - A.M. Haj Zeinali

- How would I treat? - O. Goktekin

- How did I treat? - A. Ghofraniha

- Discussion

- Consensus - M. Hashemian

- Take-home message - M. Hashemian


Forum

Carotid intervention


submissions

Chairpersons: M. Roffi, E. Stabile

▸ Introduction - M. Roffi

▸ Recanalisation and balloon angioplasty of a symptomatic intracranial

symptomatic carotid stenosis in an 11 year-old child - I. Petrov

▸ Carotid stenting with protection - S. Singh

▸ A case of late carotid Wallstent migration leading to restenosis treated by

stent-in-stenting method with precise Pro RX - T. Umemoto

▸ Simultaneous brachiocephalic trunk and internal carotid angioplasty - D. Grinfeld

▸ Successful management of acute occlusion of internal carotid artery

during stenting procedure - C. Fantoni

▸ Take-home message - E. Stabile203


12:00-13:30 Room 251

How should I treat?

"Go distal": different approaches to infrainguinal challenges

With an unrestricted educational grant from BOSTON SCIENTIFIC

Chairperson: D. Scheinert

Objectives:

▸ To stress to the audience the importance of treating further and farther

infrainguinal disease

▸ To expose participants to various endovascular approaches, techniques

and options to treat lower limb disease

▸ To highlight some of the newest technologies on the market

▸ Introduction and objectives - D. Scheinert

▸ Crossing a challenging occluded superficial femoral artery

- Case presentation - A. Bolia

- How would I treat? - R. Langhoff


- How did I treat? - A. Bolia

- Discussion

- Consensus - D. Scheinert

▸ Extreme distal stenosis: how to restore flow to the foot?

- Case presentation - J. Clerissi

- How would I treat? - R. Langhoff


- How did I treat? - J. Clerissi

- Discussion

- Consensus - D. Scheinert

▸ Take-home message - D. Scheinert

12:00-13:30 Room 252AB

How should I treat?

Optimising treatment strategies for complex femoral and infrapopliteal

diseases

With an unrestricted educational grant from BIOTRONIK

Chairperson: O. d'Archambeau

Objectives:

▸ To discuss the role of long stenting in complex femoral and infrapopliteal

lesions

▸ To understand the emerging role and benefits of drug-coated balloons in

peripheral interventions

Thursday 19th

204


Thu

rsday 1

9th

End

ova

scula

r

Endovascular

▸ Introduction and objectives - O. d'Archambeau

▸ Emerging drug-coated balloon treatment options in femoral and

infrapopliteal lesion

- Case presentation - A. Schmidt

- How would I treat? - E. Calabrese

- How would I treat? - J. Van Den Berg

- How did I treat? - A. Schmidt

- Discussion

- Consensus - O. d'Archambeau

▸ Long stenting in complex lower limb interventions

- Case presentation - G. Pratesi

- How would I treat? - E. Calabrese

- How would I treat? - J. Van Den Berg

- How did I treat? - G. Pratesi

- Discussion

- Consensus - O. d'Archambeau

▸ Take-home message - O. d'Archambeau

12:00-13:30 Room 343 Clinic

Abstract session

Beyond the borders: new devices and indications for endovascular

treatment


Chairpersons: N. Hopkins, M.A. Ruffino

▸ Introduction - N. Hopkins

▸ Feasibility and safety of transradial arterial approach for simultaneous

right and left vertebral artery angiographic studies and stenting

A. Youssef

▸ Transluminal treatment of ischemic stroke with distal atherosclerotic

lesions of brain vessels - I. Maksimovich

▸ Transcatheter treatment of Alzheimer's disease - I. Maksimovich

▸ Catheter-based interventional therapy of acute ischemic stroke -

Experience from a single stroke centre, India - P. Veera Raghava Sarma

▸ Angiojet rheolytic thrombectomy in pulmonary embolism with cardiogenic

shock: a feasibility and safety pilot study - R. Bonvini

▸ Subclavian artery trauma: an endovascular approach - D. Benitti

▸ Take-home message - M.A. Ruffino

205



Plenary session

How to do endovascular interventions: renal and visceral interventions

Chairpersons: H. Sievert, P. Pattynama

With continuous live demonstration from Villa Maria Cecilia Hospital,

Cotignola - Italy

Objectives:

▸ To review the knowledge required to perform renal and visceral

interventions




▸ What you need to know before you start - C. Mialhe

▸ Renal interventions step-by-step - M. Schillinger

▸ Visceral interventions step-by-step - T. Zeller

▸ How to avoid and manage complications - B. Reimers

▸ Take-home message - P. Pattynama


Plenary session

Catheter-based management of massive intravascular thrombosis

Chairpersons: M. Roffi, A. Sauguet

Objectives:

▸ To learn about therapeutic options in patients presenting acute lower limb

occlusion

▸ To know how to deal with a patient presenting lower limb graft occlusion

▸ To select the appropriate therapy in patients with massive deep vein

thrombosis and/or pulmonary embolism

▸ Introduction and objectives - A. Sauguet

▸ Acute native lower limb occlusion: the endovascular options - A. Schmidt

▸ Discussion

▸ Management of graft occlusion in the lower limb - C. Schonholz

▸ Discussion

▸ Massive deep vein thrombosis: thrombolysis and mechanical thrombus

removal - N. Kucher

▸ Discussion

▸ Catheter-based options in massive pulmonary embolism - R. Bonvini

▸ Discussion

▸ Take-home message - M. Roffi

Thursday 19th

206


Thu

rsday 1

9th

End

ova

scula

r

Endovascular


Plenary session

Hybrid approach for the treatment of the thoracic aortic disease: casebased discussion Chairpersons: C. Setacci, M. van Sambeek

Objectives:▸ To learn about new therapeutic options and endovascular devices

▸ To learn about optimal pre-operative imaging

▸ To show the importance of multidisciplinary approach between surgicaland interventional team

▸ Introduction and objectives - C. Setacci

▸ Pathophysiology, definitions and medical treatment of complex thoracicaorta disease - C. Nienaber

▸ Indications, techniques and outcome of treatment of patients withcomplex thoracic aorta disease - R. Fattori

▸ Case presentation - F. Ribichini

▸ Expert opinion - G. Torsello

▸ How it was done - F. Ribichini

▸ Technical options for complex throracic aortic disease - M. van Sambeek

▸ Roundtable discussion

▸ Take-home message - M. van Sambeek

15:00-16:30 Room 353 Clinic

Abstract session

Cardiovascular impact of non coronary atherosclerosisSession comprising selected EuroPCR 2011 abstract submissionsChairpersons: M. Balghith, M. Haude

▸ Introduction - M. Balghith

▸ Three-year follow-up of patients with asymptomatic coronary arterydisease in the prevalence of asymptomatic coronary artery disease inischemic stroke patients (PRECORIS) trial - H. Aelion

▸ Renal artery stenosis increases overall mortality in patients with advancedchronic kidney disease - M. Hori

▸ Diseased arterial segment of lower extremity impact on adverse cardiacevents over combined coronary and peripheral artery disease patientsY. Sakamoto

▸ The necessity of myocardial revascularisation in patients with diabetesmellitus and critical limb ischemia - V. Kalashnikov

▸ Burden of coronary artery disease in severe limb ischemia patients is overhalf - C.W. Goh

▸ The 12-month prognosis of patients with critical limb ischemia andextensive gangrene after infrapopliteal endovascular therapy is extremelypoor - M. Nakano

▸ Take-home message - M. Haude207



Symposium

Drug-eluting balloons: current status and new perspectives


Chairpersons: G. Tepe, B. Scheller

Objectives:

▸ To provide a comprehensive overview of the span of potential clinical

indications for drug-eluting balloons in the coronary and peripheral areas

and understand where and why drug-eluting balloons should be

considered to address unmet needs

▸ To provide attendees with results of Medtronic drug-eluting balloons

(IN.PACT) within coronary and peripheral applications

▸ To share current limitations and future needs to further establish drug-

eluting balloon clinical evidence

▸ Introduction and objectives - G. Tepe

▸ Drug-eluting balloons in coronary in-stent restenosis: insights from

optical coherence tomography - P. Stella

▸ Discussion

▸ Drug-eluting balloons in very long and diffuse coronary lesions

G.M. Sangiorgi

▸ Discussion

▸ Drug-eluting balloons in peripheral haemodialysis fistulas - D. Patanè

▸ Discussion

▸ Drug-eluting balloons for lower limb arterial diseas - A. Schmidt

▸ Discussion

▸ Take-home message - G. Tepe

16:30-18:00 Room 352AB

Symposium

Catheter-based renal denervation treatment for hypertension

With an unrestricted educational grant from MEDTRONIC ARDIAN

Chairperson: K. Rocha-Singh

Objectives:

▸ To learn how affecting sympathetic nervous system activation may lower

blood pressure

▸ To consider recent data regarding renal denervation treatment in

hypertension

▸ To review information about the technology and procedure

▸ To understand how this physiology might affect other related areas (e.g.

insulin resistance, heart failure and other diseases)

Thursday 19th

208


Thu

rsday 1

9th

End

ova

scula

r

Endovascular

▸ Introduction and objectives - K. Rocha-Singh

▸ Background, physiology, and technique of catheter based renal

denervation - E. Blessing

▸ Results from the Symplicity HTN-1 and Symplicity HTN-2 trials - H. Sievert

▸ Impact of renal denervation on glucose metabolism, insulin resistance and

diabetes - F. Mahfoud

▸ Heart failure, sleep apnea and other areas of future research - A. Witkowski

▸ Discussion

▸ Take-home message - K. Rocha-Singh

17:00-18:00 Room 242B Clinic

Forum

Endovascular treatment for thoracic aorta aneurysm


submissions

Chairpersons: M. van Sambeek, C. Mialhe

▸ Introduction - M. van Sambeek

▸ Percutaneous transfemoral stent graft treatment of thoracic aortic

aneurysm of surgically repaired coarctation of aorta - S. Khogali

▸ Successful transluminal endoprosthetic correction of type A aortic

dissection after coronary artery bypass surgery - G. Pires De Morais

▸ The modified chimney technique with a thoracic aortic stent graft to

preserve the blood flow of the left common carotid artery for treating

descending thoracic aortic aneurysm and dissection - S.G. An

▸ Endovascular thoracic aortic aneurysm repair: impacted and partially

opened aortic stent - A. Abou Issa

▸ Take-home message - C. Mialhe

209


09:00-12:30 Room Maillot Break-out

Plenary session

Carotid revascularisation: Live it! Great news: carotid stenting is Class Irecommendation Chairpersons: A. Cremonesi, M. Roffi

Panellist: J.P. Becquemin

With continuous live demonstration from Hôpital Henri Mondor, Créteil -

France

Objectives:▸ To review the role of carotid artery stenting in the latest European Society

of Vascular Surgery (ESVS) and American Heart Asssociation (AHA) -American Stroke Association (ASA) guidelines

▸ To know the relationship between operator experience and outcomes in

carotid revascularisation

▸ To learn about advantages and limitations of carotid endarterectomy andcarotid artery stenting

▸ Introduction and objectives - M. Roffi

▸ Impact of learning curve in carotid endarterectomy and stenting - W. Gray

▸ Debate : is carotid artery stenting a Class I recommendation in

symptomatic patients ?

- Pro - N. Hopkins

- Against - D. Raithel

▸ Multidisciplinary roundtable discussion

▸ Advantages and limitations of carotid endarterectomy - C. Mialhe

▸ Advantages and limitations of carotid artery stenting - C. Schonholz

▸ Patient selection and operator experience are key for success - S. MacDonald


Friday 20th

210


Friday 2

0th

End

ova

scula

r

Endovascular

09:30-11:00 Room 241 Clinic

Abstract session

Endovascular treatment of thoracic and abdominal aortaSession comprising selected EuroPCR 2011 abstract submissionsChairperson: P. Pattynama

▸ Introduction - P. Pattynama

▸ New conformable stent graft devices - Can they solve the apposition

problems in the thoracic aorta near the arch? - M. Gawenda

▸ Endovascular peripheral and visceral aneurysms repair with Cardiatismultilayer stent: Italian multicentre registry results at 6- and 12-monthfollow-up - M.A. Ruffino

▸ Endovasvascular treatment of complicated aortic dissection: the use of anew device - R. Aun

▸ Endovascular repair of ruptured abdominal aortic aneurysms: University ofSao Paulo experience - D. Benitti

▸ Endovascular treatment of thoracic aortic disease: eleven year follow-up

A. Bortone

▸ Treatment of thoracic aortic disease using endovascular stent graft:

clinical outcomes and favorable effects on aortic remodeling - M. Ponte


09:30-12:30 Room 252AB How to...

Plenary session

How to do endovascular interventions: abdominal aortic aneurysm

treatment in the cathlab

Chairpersons: T. Zeller, H. Krankenberg

With continuous live demonstration from Catharina Ziekenhuis, Eindhoven -

The Netherlands

Objectives:

▸ To review the knowledge required to perform aortic endografting



▸ Introduction and objectives - T. Zeller

▸ What you need to know before you start - H. Sievert

▸ Aortic aneurysm interventions step-by-step - R. Dave

▸ How to avoid and manage acute and long-term complications - G. Torsello

▸ Take-home message - H. Krankenberg

211


11:00-12:30 Room 241 Clinic

Abstract session

Latest on femoro-popliteal interventions


Chairpersons: S.M. Hiremath, S. Duda

▸ Introduction - S.M. Hiremath

▸ Mid-term clinical outcomes and predictor of restenosis in self-expanding

Nitinol stent implantation for chronic total occlusion in femoropopliteal

artery - Multicentre registry in Japan - Y. Sakamoto

▸ Endovascular treatment of common femoral artery disease: medium-term

outcomes of 360 consecutive procedures - R. Bonvini

▸ Zilver PTX randomised trial of paclitaxel-eluting stents for femoropopliteal

artery disease: 24-month update - D. Scheinert

▸ Superficial femoral artery stenting: results from a 1,000-patient registry

T. Tuebler

▸ Acute and mid-term results of a new paclitaxel-eluting ballon use for

femoropopliteal obtructions angioplasty - A. Micari

▸ Should a stent be used to treat dissection when a paclitaxel-coated balloon

is used to treat lesions? - G. Tepe

▸ Take-home message - S. Duda


Forum

Aorto-iliac interventions


Chairpersons: P. Pattynama, A. Schmidt

▸ Introduction - A. Schmidt

▸ Percutaneous treatment of multifocal atherosclerosis: staged procedure?

How many stages? - A. Babunashvili

▸ Successful true-lumen stenting for the in-stent chronic total occlusion

occurred after pseudo-lumen stenting in the common iliac artery

T. Ishihara

▸ Endovascular treatment for high take-off Leriche syndrome - A. Nomura

▸ Dual route approach to right common illiac artery coronary chronic total

occlusion intervention using subintimal snare technique - S. Reddy

▸ Stenting of long total occlusion in the left iliac artery - W. Kadro


Friday 20th

212


Friday 2

0th

End

ova

scula

r

Endovascular


Main session




Panellists: J. Marco, P.W. Serruys, J. Fajadet, M.C. Morice, B. De Bruyne,

A. Vahanian, M. van Sambeek, E. Eeckhout, A. Cremonesi, H. Sievert,

D. Scheinert, C. Ruiz, P. Bonhoeffer, T.H. Koh, M. Thomas











213




Nurse and technician

programme

PART III

11T0768_PCRpocket_05_nurse 18/04/11 11:26 Page215


Main session



Panellists: A. Cremonesi, T. Lüscher, C. Rihal, C. Ruiz, P.W. Serruys,

R. Whitbourn


Germany



T. Lüscher


Main session



Panellists: E. Eeckhout, J.B. Ge, T.H. Koh, J. Marco, M.C. Morice, R. Ng,

P.W. Serruys, M. Thomas, A. Vahanian



PCR courses




PCR communications









Tuesday 17th

216



Tue

sday 1

7th

Nu

rses a

nd

tech

nicia

ns

Nurses and technicians

13:30-15:30 Room 241

Nurse and technician session

Nurse research from daily cathlab practice

Chairpersons: L. Kløvgaard, R. Vermeulen

Objectives:

▸ To be able to identify different types of studies we meet in our daily

practice

▸ To learn about specific nurse-driven clinical studies

▸ To understand the impact of research in the cathlab on patient care

▸ Introduction and objectives - L. Kløvgaard

▸ Different study designs - An overview - N. Aerts

▸ Transradial hemostasis with the Dorchester protocol - J. Wheelband

▸ Quality of life before and after PCI - D. Zughaft

▸ Anxiety as a risk factor in patients undergoing PCI - T. Wagenaar-Streefkerk

▸ TAVI treated patients: What kind of specialised nursing do they need?

K.H. Lisby

▸ Take-home message - L. Kløvgaard

217


09:30-11:30 Room 241


Structural heart disease interventionsChairpersons: M. Leahy, S. Buendia

Objectives:▸ To present the benefits of inter-institutional nurse collaborations

▸ To know how to deal with complications during structural heart diseaseinterventions

▸ To better understand the practical steps involved in preparing valves for TAVI

▸ Introduction and objectives - M. Leahy

▸ Percutaneous mitral valve repair using MitraClip - The benefit of inter-institutional nurse collaboration - B. Wulff

▸ The Geneva experience on melody valve implementation - X. Jacottin

▸ Nursing management: TAVI acute complications and comorbid conditionsin the cathlab - M. Ghorbati

▸ The Edwards experience - A practical step-by-step approach to devicepreparation - V. Rodriguez Garcia-Abad

▸ The CoreValve experience - A practical step-by-step approach to devicepreparation - M. De Ronde

▸ Take-home message - M. Leahy

11:30-13:00 Room 241


Coronary clinical cases from a nursing perspectiveChaipersons: R. Vermeulen, S. Buendia

Objectives:▸ To recognise some of the complications that happen during standardprocedures and how to treat them

▸ To better understand the underlying principles of cardiac catheterisationrelated complications

▸ To present the nursing perspective in anticipating, observing and treatingcardiac catheterisation related complications

▸ Introduction and objectives - R. Vermeulen

▸ Dissection of the aorta after failed PCI: case - R. Vermeulen

▸ Coronary artery perforation: a nursing perspective - M. Van Der Heijden

▸ Microcirculation evaluation in the cathlab - R. Esteves

▸ How to retrieve a lost stent - B. Finn

▸ Take-home message - R. Vermeulen

Wednesday 18th

218




We

dn

esd

ay 1

8th

Nu

rses a

nd

tech

nicia

ns



LTT - Scrubbing-in for bifurcation PCI

Facilitators: S. Buendia, M. Leahy, M. Oberhoff

Panellist: M. Simon


Live in-a-box® from Institut Cardiovasculaire Paris Sud, Massy - France

219

We hope to see you in other sessionsboth coronary/structural heart disease and endovascular

the Course is open to everybody!

The LTT sessions are highly educative and interactive.

Don’t miss them!!


09:30-11:00 Room 241


New developments in the modern cathlab

Chairpersons: R. Vermeulen, M. Leahy

Objectives:

▸ To learn about some of the new developments in the modern cathlab, in

medicine, equipment and staffing

▸ To better understand the impact of new developments on daily practice

▸ To present the most recent innovative ideas for potential future

applications

▸ Introduction and objectives - R. Vermeulen

▸ New antithrombotic medicines in the cathlab - M. Pascual

▸ Percutaneous repair of mitral regurgitation - M. Van Der Heijden

▸ Post-nursing careers in the cathlab - Working with nurse practitioners and

physician assistants - H. Deuling

▸ Experiences with 3D roadmapping in cardiovascular imaging - S. Van Weenen

▸ Take-home message - R. Vermeulen

11:00-12:30 Room 241


The miscellaneous abstract session

Chairpersons: L. Kløvgaard, M. Leahy

Objectives:

▸ To learn about the safety and feasibility using manual aspiration during

primary PCI for STEMI

▸ To understand the value of information pathways between units attending

to the care of patients

▸ To learn about a simple no-instruction compression to be used after radial

access

▸ Introduction and objectives - L. Kløvgaard

▸ Proximal aspiration in acute myocardial infarction - J.A. Fernandez Rodriguez

▸ Minimising complications by improving communication - M. Holton

▸ New innovations, new ways to work: multi-skilling in the cardiac cathlab

C. Loder

▸ Radial access compression devices: complication can develop - What our

team developed to prevent this - L. Hinterbuchner

▸ Take-home message - L. Kløvgaard

Thursday 19th

220



Thu

rsday 1

9th

Nu

rses a

nd

tech

nicia

ns


14:00-16:00 Room 241


The treatment of STEMI from a cathlab management perspective

Chairpersons: M. Leahy, R. Vermeulen

Objectives:

▸ To present how primary PCI services are delivered across differing

geographies

▸ To better understand how optimal management practices can improve the

patient pathway

▸ To identify and overcome common barriers in implementing optimal

patient care in STEMI

▸ Introduction and objectives - M. Leahy

▸ The treatment of STEMI from a cathlab management perspective

- The Polish experience - M. Wizimirski

- The Spanish experience - E. Sanchez Hernandez

- The German experience - M. Jacobs

- The English experience - V. Oriolo

- The Danish experience - M. Christensen

▸ Panel discussion/Open forum

▸ Take-home message - M. Leahy

STENT

FOR LIFE

221



Main session




Panellists: J. Marco, P.W. Serruys, J. Fajadet, M.C. Morice,

B. De Bruyne, A. Vahanian, M. van Sambeek, E. Eeckhout, A. Cremonesi,

H. Sievert, D. Scheinert, C. Ruiz, P. Bonhoeffer, T.H. Koh, M. Thomas











Friday 20th

222



Training

villag

e - Level 3

Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

s

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Vascular

closu

rep. 173

Bifu

rcat

ion

lesion

sp. 173

Tues

day 17

th

CORD

IS CA

RDIA

C &

VASC

ULAR

INST

ITUTE

CROS

SROA

DS, T

he A

bbot

t Va

scular

Educ

ation

Netw

ork

EDWA

RDS L

IFESC

IENCE

S

MEDT

RONI

C ACA

DEMI

A

ST. J

UDE M

EDICA

L

Radial app

roac

hp. 173

AMI f

or n

urse

sp. 227

Bifu

rcat

ion

lesion

sp. 174

Tran

scat

hete

r hea

rt valve

sp. 174

Tran

scat

hete

r hea

rt valve

sp. 174

MVD

p. 174

Hem

osta

sis

man

agem

ent

p. 175

Hem

osta

sis

man

agem

ent f

ornu

rses

p. 227

Hem

osta

sis

man

agem

ent

for n

urse

sp. 227

Hem

osta

sis

man

agem

ent f

ornu

rses

p. 227

Training

villag

e - Level 3


Nu

rses a

nd

tech

nicia

ns

Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

sTraining

villag

e - Level 3

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Vascular

closu

rep. 175

Radial app

roac

hp. 175

Wed

nesd

ay 18th

CORD

IS CA

RDIA

C &

VASC

ULAR

INST

ITUTE

CROS

SROA

DS, T

he A

bbot

t Va

scular

Educ

ation

Netw

ork

EDWA

RDS L

IFESC

IENCE

S

MEDT

RONI

C ACA

DEMI

A

ST. J

UDE M

EDICA

L

Bifu

rcat

ion

lesion

sp. 176

Intra

card

iac ec

hoca

rdiogr

aphy

in TAV

Ip. 176

Vascular

closu

rep. 175

AMI f

or n

urse

sp. 228

CTO

p. 177

Tran

scat

hete

r hea

rt valve

sp. 177

Tran

scat

hete

r hea

rt valve

sp. 177

MVD

p. 178

FFR

for p

hysician

sp. 178

STEM

Ip. 176

Tran

scat

hete

r hea

rt valve

sp. 177

Tran

scat

hete

r hea

rt valve

sp. 177

Tran

scat

hete

r hea

rt valve

sp. 177

Bifu

rcat

ion

lesion

sp. 177

MVD

p. 178

MVD

for n

urse

sp. 228

AMI f

or n

urse

sp. 228

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

FFR

for p

hysician

sp. 178

FFR

for p

hysician

sp. 178

FFR

for p

hysician

sp. 178

FFR

for p

hysician

sp. 178


9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

TAVI

p. 183

Friday

20th

MEDT

RONI

C ACA

DEMI

A

9h

10h

11h

12h

13h

14h

15h

16h

17h

18h

19h

8h30

Radial app

roac

hp. 179

FFR

for n

urse

sp. 229

AMI

p. 180

CORD

IS CA

RDIA

C &

VASC

ULAR

INST

ITUTE

CROS

SROA

DS, T

he A

bbot

t Va

scular

Educ

ation

Netw

ork

EDWA

RDS L

IFESC

IENCE

S

MEDT

RONI

C ACA

DEMI

A

ST. J

UDE M

EDICA

L

Vascular

closu

rep. 179

Intra

card

iac ec

hoca

rdiogr

aphy

in TAV

Ip. 179

Radial app

roac

hp. 180

CTO

p. 180

Bifu

rcat

ion

lesion

sp. 181

AMI

p. 180

Tran

scat

hete

r hea

rt valve

sp. 181

Tran

scat

hete

r hea

rt valve

sp. 181

Tran

scat

hete

r hea

rt valve

sp. 181

Tran

scat

hete

r hea

rt valve

sp. 181

TAVI

p. 182

TAVI

p. 182

TAVI

p. 182

TAVI

p. 182

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

FFR

for n

urse

sp. 229

OCT fo

r phy

sician

sp. 182

OCT fo

r phy

sician

sp. 182

OCT fo

r phy

sician

sp. 182

OCT fo

r phy

sician

sp. 182

OCT fo

r phy

sician

sp. 182

Training

villag

e - Level 3

Thur

sday

19th

Corona

ry and

stru

ctural hea

rt disease

Nurses & te

chnician

s


Nu

rses a

nd

tech

nicia

ns

227

Tuesday 17th May



Acute myocardial infarction patient management from

a cathlab nurse perspective



Trainers: J. Hunter, J. Spratt

Objectives:

▸ To give an update on acute myocardial infarction management from a

cathlab nurse perspective (pre-, per- and post-procedure management

aspects, patient preparation and monitoring, patient preparation for

emergency strategies)

▸ To provide hands-on exercise on virtual reality monitor



15:15-16:15

16:30-17:30

Hemostasis management for nurses - Practical hands-on session on

usage of passive and active closure devices


Trainers: H. Curling Gustafsson, P. Vanloock

Objectives:

▸ To discuss active and passive closure devices

▸ To understand how to reduce complication risk following vessel closure

▸ To practice deployment techniques and application of active and passive

closure devices

STENT

FOR LIFE

Train

ing

village


Wednesday 18th May



Acute myocardial infarction patient management from

a cathlab nurse perspective



Trainers: D. Hildick-Smith, J. Hunter

Objectives:

▸ To give an update on acute myocardial infarction management from a

cathlab nurse perspective (pre-, per- and post-procedure management

aspects, patient preparation and monitoring, patient preparation for

emergency strategies)

▸ To provide hands-on exercise on virtual reality simulator



Multivessel disease


Trainers: N. Aerts, A. Alonso, L. Jones, B. O'Meara

Objectives:


score/Euroscore/Fractional flow reserve




Acute myocardial infarction


MEDTRONIC ACADEMIA

Trainers: A. Alonso, S. Buendia, L. Jones, L. Lamerichs

Objective:

▸ To achieve better angiographic outcomes due to the

hands-on training using the thrombo-aspiration (Export) and a focused

simulation session for cathlab teams

STENT

FOR LIFE

STENT

FOR LIFE

228

Training village


Train

ing

village

Nu

rses a

nd

tech

nicia

ns


229



10:00-11:00

11:00-12:00

14:00-15:00

15:00-16:00

16:00-17:00

Functional coronary lesion assessment - Cathlab efficiency for nurses

and technicians - Practical hands-on session: fractional flow reserve set

up from A-Z



Objectives:

▸ To practice accurate fractional flow reserve set up

▸ To understand the different steps during coronary flow measurement

▸ To improve daily clinical practice through an accurate fractional flow

reserve approach

Thursday 19th May

Training VillageRoom ST JUDE MEDICAL


10:00-11:00

11:00-12:00

14:00-15:00

15:00-16:00

16:00-17:00

Functional coronary lesion assessment - Cathlab efficiency for nurses

and technicians - Practical hands-on session: fractional flow reserve set

up from A-Z



Objectives:

▸ To practice accurate fractional flow reserve set up

▸ To understand the different steps during coronary flow measurement

▸ To improve daily clinical practice through an accurate fractional flow

reserve approach


PCR Family

230

EuroPCREuroPCR, our flagship, is the leading

interventional cardiovascular Course, and the

official annual meeting of the European

Association for Percutaneous Cardiovascular

Interventions.

Next edition: 15th-18th May, 2012.

www.europcr.com

AsiaPCR/SingLiveBased on a strong and respectful collaboration

with prominent PCR family members, this

Course is built by and for the Asia-Pacific

cardiovascular community.

It reaches out to a wider international

audience, to share and learn from the expertise

in Asia-Pacific, and stimulate regional projects.

Join us from 12th - 14th January, 2012.

www.asiapcr.com

PCR London ValvesA meeting centered on the “Heart-team”

approach, fully dedicated to the new

modalities of valves treatment.

Next edition: 16th-18th October, 2011.

www.pcrlondonvalves.com

Booth M20 - Level 2!

11T0768_PCRpocket_06_Fin 18/04/11 11:25 Page230

231

PCR Family - Innovation in education at workPatient-centred, innovative session formats, open-mindedness,

interactivity, continuous evaluation and improvement are the

fundamental building-blocks of the PCR Courses. In 2010, more than

15,000 participants from all over the world attended the PCR courses.

PCRonlineAn online reference platform to inform and

impulse the new formats of education to

the whole cardiovascular interventional

community.

www.pcronline.com

PCR PublishingEdits scientific publications.

EuroIntervention Journal, the monthly official

journal of the EAPCI, now PubMed / Medline

referenced. The first 2 textbooks are available,

another is in progress.

www.pcrpublishing.com

www.eurointervention.com

Educative solutionsThe mission is to implement the Participatory

learning group development concept.

Acting as an R&D cell, this branch has created

the LTT sessions and PCR Seminars.

TrialsThe mission is to federate and stimulate new

clinical trials within our interventional

cardiovascular field and to inform the

community. The trials with the PCR label will

benefit from the PCR communication arsenal.



Your A-Z for EuroPCR

233

Airport shuttleFree shuttles will take you from Charles de Gaulle airport to thePalais des Congrès and back.

From CDG airport to Palais des Congrès

c Tuesday 17th: Every 30 min from 8:00 am to 11:00 am

cWednesday 18th: Every 30 min from 8:30 to 11:00 am

c Departure points- Terminal 1: departure level, gate 8- Terminal 2A: gate 8- Terminal 2D: gate 8- Terminal 2F: gallery 6

From Palais des Congrès to CDG airport

c Thursday 19th: Every 30 min from 17:00 to 18:30

c Friday 20th: Every 30 min from 12:30 to 14:30

c Departure point: Parking Pershing - Boulevard Pershing

AndroïdThe application dedicated to EuroPCR is available and includes:breaking news, the scientific programme, all exhibitors, maps andmore. Download it now at europcr.com!

Bag pick-upLocated on Level 1.

BlackBerryThe application dedicated to EuroPCR is available and includes:breaking news, the scientific programme, all exhibitors, maps andmore. Download it now at europcr.com!

BusBus lines for the Palais des Congrès: 82, 73, 43, 244, PC 1, PC 2 or PC 3.Ask at the Concierge "counter" on Level 0 for more information.

Case cornerLocated on Level 3 it gives you the opportunity to review the com-plication and clinical cases submitted for EuroPCR. See page 8 formore information.

CateringSee "Lunch".


234


234

ConciergeOpen 8:00 to 18:00 Monday to Friday. Located on Level 0. This servicecan help you with daily needs: courier services, dry-cleaning, restaurantreservations, flower delivery, train tickets, taxis…

CloakroomLocated in the main arena foyer (Level 0,5). It's free of charge and openthe same hours as the registration.

Convention centreThe Palais des Congrès de Paris is located at 2, place de la Porte Maillot,75017 Paris. See "Airport shuttle", "Bus", "Metro", or "Train station shuttle".

Cyber spaceThe Cyber space provides free access to computers connected to the Internet.Located on Level 1. See also "WiFi".

Daily newsHot off the press, distributed every morning at Level 0 escalators and atself-serve points throughout the Palais des Congrès.

E-badgeTo pick up your E-badge, go to the E-badge desk with the barcode youprinted when you pre-registered online.

EuroIntervention JournalOfficial journal of the EAPCI. Pick-up your copies at the distributionpoints situated throughout the Palais des Congrès. The May issue plus3 supplements are available free!

ExhibitorsSee page 244 for the exhibition map.Consult the Exhibit Guide to find more information about the companies.Information also available in the smartphone applications (iPhone, Androïd and Blackberry). Download them now from europcr.com!See also “Opening hours” for Exhibit hall information.

Exhibitor support centre For exhibitors only - office located on Level 1.

FoodSee "Lunch".


235235

FreeYour badge* includes access to all scientific sessions, the exhibition area,the Materials Catalogue, the Randomised Trials Book, EuroPCR &AsiaPCR/SingLIVE Abstracts Book, the EuroIntervention supplement andMay Issues.

A one-year subscription to EuroIntervention Journal from 17th May, 2011to 15th May, 2012 is also included, except for exhibitor and press badges.

Guest loungeAccess to the Guest Lounge is reserved for Guest Faculty only.

Badges will be checked at the entrance. Located on Level 2.

HotelsSee page 240 to find the complete list.Information also available in the smartphone applications (iPhone, Androïd and Blackberry). Download them now from europcr.com!

HoursFor onsite registration, scientific sessions, and exhibition area: see "Opening hours".

Interactive case cornerRendez-vous at the interactive case corner to discuss the cases submittedfor EuroPCR 2011. Participants will exchange on their experience in afriendly environment, without time constraints.

Innovation incubatorGrab a bite to eat at the buffet and chat with representatives from companies who bring you the latest innovations.Wednesday only, open to all, Level 3.

InternetFree WiFi is available in selected areas. If you need a computer, visit the Cyber space, located on Level 1.

IPhoneThe application dedicated to EuroPCR is available and includes: breakingnews, the scientific programme, all exhibitors, maps and more.

Download it now at europcr.com!

LanguageEnglish is the official language of EuroPCR.



236

LinkedInLinkedIn account holders can join the LinkedIn PCRonline group to conti-nue to share their EuroPCR visit online and stay up-to-date with all thelatest news.

Live messagesWrite and send instant messages published on PCRonline during theCourse! Tell us about your EuroPCR experience and post your text at thePCR Family stand M20, Level 2.

Lost and FoundLost property can be found at the Exhibitor support centre. Located on Level 1.

LunchLunch buffets open at 12:00 at the cafés situated Level 1 and Level 2: Bistrot Montmartre, London Pub, Singapore Food Court, Café de Paris. Lunch bags distributed at 13:00. As a reminder, eating is not allowed insession rooms.

Meeting roomsLocated on the mezzanines, Levels 1, 2, 3.Access via the stairs on the leftand right of the building. See maps page 2.

MetroLine 1 direction Porte Maillot - Palais des Congrès stop.

NewsStay updated with all EuroPCR events. Read the Daily, consult the brea-king news on the EuroPCR smartphone applications, or consult PCRon-line.com at the Cyber space.

Opening hours

Scientific sessions

Tuesday 17th May 10:00 - 19:00

Wednesday 18th May 08:00 - 18:30

Thursday 19th May 08:00 - 19:00

Friday 20th May 09:00 - 14:00

Exhibition area




Friday 20th May 08:30 - 13:00


Onsite registration

Sunday 15th May 14:00 - 18:00

Monday 16th May 08:00 - 18:00




Friday 20th May 08:00 - 13:00

Preview room:

Monday 16th May 09:00 - 18:00




Friday 20th May 08:00 - 13:00

PharmacyThe nearest pharmacy is on Level 0 of the Palais des Congrès shoppingcentre.

PhotographyPhotography and filming are strictly prohibited.

Poster areaVisit the poster area on Level 1.Poster presentations with authors: Wednesday 18th: 12:00 - 13:30 Thursday 19th: 12:00 - 13:30

PCR family boothVisit us at booth M20 – Level 2 and find out more about the PCR family:EuroPCR, AsiaPCR/SingLIVE, PCR London Valves, EuroIntervention,PCRonline, PCR publishing, PCR seminars and PCR trials.

PCRonlineA trusted online reference source for the entire cardiovascular community,offering you free access all year round to the scientific content from EuroPCR, reviews, comments and much more. A place for the wholecommunity to stay in touch, to share and exchange.Visit us at the PCR family booth M20, Level 2.

PressThe Press office and the Press conference room are located on Level 3 -rooms 301/302/303.

237



238

Preview roomFor speakers only. All speakers must upload their slides at least 3hours before the start of the session. Located on Level 2, open from9:00 am Monday 16th.

ShuttlesSee “Airport shuttle” or “Train station shuttle”.

SmokingThe Palais des Congrès is a non-smoking building.

TourismFor tours of Paris or other tourist information, go to the Conciergedesk. Located on Level 0.

Train station shuttleFree shuttles will take you from the Gare du Nord train station tothe Palais des Congrès and back.

From Gare du Nord train station to Palais des Congrès

Tuesday 17th 9:30, 10:30, 11:30, 12:30, 13:30

Wednesday 18th 9:30, 10:30, 11:30, 12:30, 13:30

Departure points: Bus station Level 1 - Gare routière

From Palais des Congrès to Gare du Nord train station

Thursday 19th 16:30, 17:30, 18:30

Friday 20th 11:00, 12;00, 13:00

Departure points: Parking Pershing - Boulevard Pershing

VisitsSee "Tourism".

WaterSelf-service fountains are provided on Level 1,2 & 3.

WiFiFree WiFi connection is available in selected areas.



Paris hotels

240

ALL SEASONS LAFAYETTE** 25 rue Vernet, 75008 PARISTel: +33 1 48 01 09 82 [email protected] www.accorhotels.com

APARTHOTEL ADAGIO HASSMAN*** 129 - 131 boulevard Haussmann 75008 PARISTel: +33 1 56 88 61 00 [email protected] www.accorhotels.com

APARTHOTEL ADAGIO TOUR EIFFEL*** 14 rue du Théatre 75015 PARISTel: +33 1 45 71 88 88 [email protected] www.accorhotels.com

APARTHOTEL ADAGIO OPÉRA*** 43 rue Caumartin 75009 PARISTel: +33 1 58 18 08 20 [email protected] www.accorhotels.com

APARTHOTEL ADAGIO PARC COURBEVOIE*** 1 rue des Lilas d’Espagne 92400 COURBEVOIETel: +33 1 55 70 79 79 [email protected] www.accorhotels.com

HOTEL ASTRID*** 27 avenue Carnot 75017 PARISTel: +33 1 44 09 26 00 [email protected] www.hotelastridparis.fr

HOTEL BASSANO**** 15 rue Bassano 75016 PARISTel: +33 1 47 23 78 23 [email protected] www.hotel-bassano.com

HOTEL BEST WESTERN DUCS DE BOURGOGNE 19 rue du Pont Neuf, 75001 PARISTel: +33 1 42 33 95 64 [email protected] paris-hotel-bourgogne.com

HOTEL BEST WESTERN MATHIS ELYSÉES MATIGNON 3 rue de Ponthieu, 75008 PARISTel: +33 1 42 25 73 01 [email protected] paris-hotel-mathis.com

HOTEL BEST WESTERN REGENTS GARDEN**** 6 rue Pierre Demours 75017 PARISTel: +33 1 45 74 07 30 [email protected] www.hotel-regents-paris.com

HOTEL BEST WESTERN STAR CHAMPS ELYSÉES*** 18 rue de l'Arc de Triomphe 75017 PARISTel: +33 1 43 80 27 69 [email protected] www.paris-hotel-staretoile.com

HOTEL BEST LOUVRE WESTERN ST HONORE**** 141 rue Saint Honoré 75001 PARISTel: +33 1 42 96 23 23 [email protected] www.bestwestern.fr

HOTEL CECILIA*** 11 avenue Mac Mahon 75017 PARISTel: +33 1 43 80 32 10 [email protected] www.hotelceciliaparis.mobi

HOTEL CHÂTEAU FRONTENAC**** 54 rue Pierre Charbon 75008 PARISTel: +33 1 53 23 13 13 [email protected] www.hfrontenac.com

HOTEL CONCORDE LAFAYETTE**** 3 place du Général Koenig 75017 PARISTel: +33 1 40 68 50 68 [email protected] www.concorde-lafayette.com

HOTEL CONCORDE MONTPARNASSE**** 40 rue du Commandant Mouchotte 75014 PARISTel: +33 1 56 54 84 00 [email protected] www.montparnasse.concorde-hotels.fr

HOTEL CONCORDE OPERA**** 108 rue Saint-Lazare 75008 PARISTel: +33 1 40 08 44 44 [email protected] www.operaparis.concorde-hotels.fr

HOTEL COURCELLES ETOILE*** 184 rue de Courcelles 75017 PARISTel: +33 1 47 63 65 30 [email protected] www.hotel-ce.com

HOTEL COURTYARD NEUILLY**** 58 boulevard Victor-Hugo 92200 NEUILLY-SUR-SEINETel: +33 1 55 63 64 65 [email protected] www.marriott.fr

HOTEL DU BOIS*** 11 rue du Dôme 75116 PARISTel: +33 1 45 00 31 96 [email protected] www.hoteldubois.com

HOTEL ELYSEES REGENCIA**** 41 avenue Marceau 75016 PARISTel: +33 1 47 20 42 65 [email protected] www.regencia.com

HOTEL ETOILE PARK*** 10 avenue Mac Mahon 75017 PARISTel: +33 1 42 67 69 63 [email protected] www.etoileparkhotel.com

HOTEL EVERGREEN**** 8 place Georges Pompidou 92300 LEVALLOIS-PERRETTel: + 33 1 47 58 88 99 [email protected] www.evergreenhotel-paris.com

HOTEL FRANCOIS ITel: +33 1 47 23 44 04

HOTEL FRANKLIN ROOSEVELT****Tel: +33 1 53 57 49 50

FRASER SUITES HARMONIE LA DEFENSE****Tel: +33 1 55 23 26 26

FRASER SUITES CHAMPS ÉLYSÉES****Tel: +33 1 44 13 33 33

HOLIDAY INN PORTE DE CLICHY***Tel: +33 1 76 68 77 00

HOTEL HILTON ARC DE TRIOMPHE****Tel: +33 1 58 36 67 00

HOTEL HILTON DEFENSE****Tel: +33 1 46 92 10 10

HOTEL HIDDEN HOTEL****Tel: +33 1 40 55 03 57

HOTEL IBIS DEFENSE**Tel: +33 1 41 97 40 40

HOTEL JARDIN DE NEUILLY****Tel: +33 1 46 24 22 77

HOTEL KEPPLER****Tel: +33 1 47 20 65 05

HOTEL LE LUMEN****Tel: +33 1 44 50 77 00

HOTEL LE LUTETIA****Tel: +33 1 49 54 46 46

HOTEL LOUVRE CONCORDE****Tel: +33 1 44 58 38 38

HOTEL MAGELLAN***Tel: +33 1 45 72 44 51

HOTEL MERCURE DEFENSE 5***Tel: +33 1 49 04 75 00

HOTEL MERCURE LAFAYETTE***Tel: +33 1 47 70 26 75

HOTEL MERCURE MONTMARTRE****Tel: +33 1 44 69 70 70

HOTEL MERCURE MONTY OPÉRA***Tel: +33 1 47 70 26 10

HOTEL MERCURE OPERA CUSSET***Tel: +33 1 42 97 48 90

HOTEL PARIS NEUILLY***Tel: +33 1 47 47 14 67

HOTEL MERCURE ROYAL MADELEINE***Tel: +33 1 42 66 13 81

HOTEL MERCURE TOUR EIFFEL SUFFREN****Tel: +33 1 45 78 50 00


241

HOTEL FRANCOIS Ier**** 7 rue Magellan 75008 PARIS Tel: +33 1 47 23 44 04 [email protected] www.the-paris-hotel.com

HOTEL FRANKLIN ROOSEVELT**** 18 rue Clément Marot 75008 PARISTel: +33 1 53 57 49 50 [email protected] www.hroosevelt.com

FRASER SUITES HARMONIE LA DEFENSE**** 6 boulevard de Neuilly 92400 COURBEVOIETel: +33 1 55 23 26 26 [email protected] paris.frasershospitality.com

FRASER SUITES CHAMPS ÉLYSÉES**** 74 avenue des Champs-Elysées 75008 PARISTel: +33 1 44 13 33 33 [email protected] paris.frasershospitality.com

HOLIDAY INN PORTE DE CLICHY*** 2 rue du 8 Mai 1945 92110 CLICHYTel: +33 1 76 68 77 00 [email protected] www.holidayinn.com

HOTEL HILTON ARC DE TRIOMPHE**** 57 rue de Courcelles 75008 PARISTel: +33 1 58 36 67 00 [email protected] www1.hilton.com

HOTEL HILTON DEFENSE**** 2 place de la Défense CNIT 92053 PARISTel: +33 1 46 92 10 10 [email protected] www1.hilton.com

HOTEL HIDDEN HOTEL**** 28 rue de l'Arc de Triomphe 75017 PARISTel: +33 1 40 55 03 57 [email protected] hidden-hotel.com

HOTEL IBIS DEFENSE** 4 boulevard de Neuilly La Défense 1 Pont de Neuilly 92081 LA DEFENSETel: +33 1 41 97 40 40 [email protected] www.ibishotel.com

HOTEL JARDIN DE NEUILLY**** 5 rue Paul Déroulède 92200 NEUILLY-SUR-SEINETel: +33 1 46 24 22 77 [email protected] www.hoteljardindeneuilly.com

HOTEL KEPPLER**** 10 rue Keppler 75016 PARISTel: +33 1 47 20 65 05 [email protected] www.keppler.fr

HOTEL LE LUMEN**** 15 rue des Pyramides 75001 PARISTel: +33 1 44 50 77 00 [email protected] www.hotel-lumenparis.com

HOTEL LE LUTETIA**** 45 boulevard Raspail 75006 PARISTel: +33 1 49 54 46 46 [email protected] www.lutetia-paris.com

HOTEL LOUVRE CONCORDE**** Place André Malraux 75001 PARISTel: +33 1 44 58 38 38 [email protected] www.louvre.concorde-hotels.fr

HOTEL MAGELLAN*** 17-19 rue Jean-Baptiste Dumas 75017 PARISTel: +33 1 45 72 44 51 [email protected] www.hotelmagellan.com

HOTEL MERCURE DEFENSE 5*** 18-30 rue Baudin Place Charras 92400 COURBEVOIETel: +33 1 49 04 75 00 [email protected] www.mercure.com

HOTEL MERCURE LAFAYETTE*** 7 rue de Trevise 75009 PARISTel: +33 1 47 70 26 75 [email protected] www.mercure.com

HOTEL MERCURE MONTMARTRE**** 3 rue Caulaincourt 75018 PARISTel: +33 1 44 69 70 70 [email protected] www.mercure.com

HOTEL MERCURE MONTY OPÉRA*** 5 rue de Montyon 75009 PARISTel: +33 1 47 70 26 10 [email protected] www.mercure.com

HOTEL MERCURE OPERA CUSSET*** 95 rue de Richelieu 75002 PARISTel: +33 1 42 97 48 90 [email protected] www.accorhotels.com

HOTEL PARIS NEUILLY*** 199 avenue Charles de Gaulle 92200 NEUILLY-SUR-SEINE Tel: +33 1 47 47 14 67 [email protected] www.accorhotels.com

HOTEL MERCURE ROYAL MADELEINE*** 29 rue de l'arcade 75008 PARISTel: +33 1 42 66 13 81 [email protected] www.accorhotels.com

HOTEL MERCURE TOUR EIFFEL SUFFREN**** 20 rue Jean-Rey 75015 PARISTel: +33 1 45 78 50 00 [email protected] www.mercure.com


Paris hotels

242

HOTEL MERIDIEN ETOILE**** 81 boulevard Gouvion St-Cyr 75017 PARISTel: +33 1 40 68 34 34 [email protected] www.lemeridienetoile.com

HOTEL MERIDIEN MONTPARNASSE**** 19 rue du Commandant Mouchotte 75014 PARISTel: +33 1 44 36 44 36 [email protected] www.lemeridien-montparnasse.com

HOTEL MON HOTEL**** 1 rue d'Argentine 75116 PARISTel: +33 1 45 02 76 76 monhotel.fr

HOTEL MONTFLEURI**** 21 avenue de la Grande Armée 75116 PARISTel: +33 1 45 00 33 65 [email protected] www.paris-hotel-montfleuri.com

HOTEL NAPOLEON**** 40 avenue de Frieldalnd 75008 PARISTel: +33 1 56 68 43 21 [email protected] www.hotelnapoleonparis.com

HOTEL NOVOTEL MONTPARNASSE**** 17 rue du Cotentin 75015 PARISTel: +33 1 53 91 23 75 [email protected] www.novotel.com

HOTEL NOVOTEL PARIS LA DEFENSE*** 2 boulevard de Neuilly 92081 LA DEFENSETel: +33 1 41 45 23 23 [email protected] www.novotel.com

HOTEL NOVOTEL PARIS LES HALLES**** 8 place Marguerite de Navarre 75001 PARISTel: +33 1 42 21 31 31 [email protected] www.accorhotels.com

HOTEL NOVOTEL PORTE D ASNIERES*** 34 avenue Porte d'Asnières 75017 PARISTel: +33 1 44 40 52 52 [email protected] www.accorhotels.com

HOTEL NOVOTEL TOUR EIFFEL**** 61 quai de Grenelle 75015 PARISTel: +33 1 40 58 20 00 [email protected] www.novotel.com

HOTEL NOVOTEL VAUGIRARD*** 257 rue de Vaugirard 75015 PARISTel: +33 1 40 45 10 00 [email protected] www.novotel.com

HOTEL PULLMAN LA DEFENSE**** 11 avenue de l'Arche 92081 PARIS LA DEFENSETel: +33 1 47 17 50 00 [email protected] www.accorhotels.com

HOTEL PULLMAN RIVE GAUCHE**** 8-12 rue Louis Armand 75015 PARISTel: +33 1 40 60 30 30 [email protected] www.accorhotels.com

HOTEL PULLMAN TOUR EIFFEL**** 18 avenue de Suffren 75015 PARISTel: +33 1 44 38 56 00 [email protected] www.accorhotels.com

HOTEL RADISSON BLU BOULOGNE**** 33 Avenue Edouard Vaillant - 92100 ParisTel: +33 1 46 08 85 00 [email protected] www.radissonblu.com

HOTEL RADISSON BLU LE DOKHAN'S**** 117 rue Lauriston 75016 PARISTel: +33 1 53 65 66 99 [email protected] www.radissonblu.fr

HOTEL RADISSON BLU METROPOLITAN**** 10 place de Mexico 75116 PARISTel: +33 1 56 90 40 04 [email protected] www.radissonblu.com

HOTEL RADISSON CHAMPS ELYSEES**** 78 bis avenue Marceau 75008 PARISTel: +33 1 53 234343 [email protected] www.radissonblu.com

HOTEL REGINA**** 2 places des Pyramides 75001 PARISTel: +33 1 42 60 31 10 [email protected] www.regina-hotel.com

HOTEL RENAISSANCE ARC DE TRIOMPHE**** 39 avenue de Wagram 75017 PARISTel: +33 1 55 37 55 37 [email protected] www.marriott.com

HOTEL RENAISSANCE LA DEFENSE**** 60 jardin de Valmy, boulevard Circulaire 92918 PARIS LA DEFENSETel: +33 1 41 97 50 50 [email protected] www.marriott.fr

HOTEL ROCHESTER CHAMPS ELYSEES**** 92 rue de la Boétie 75008 PARISTel: +33 1 56 69 69 00 [email protected] www.hrochester.com

HOTEL ST JAMES & ALBANY**** 202 rue de Rivoli 75001 PARISTel: + +33 1 44 58 43 21 [email protected] www.hotels-francepatrimoine.com

HOTEL SCRIBE BY SOFITEL*****Tel: +33 1 44 71 24 24

HOTEL SEZZ****Tel: +33 1 56 75 26 26

HOTEL SPLENDID ETOILE****Tel: +33 1 45 72 72 00

HOTEL SOFITEL ARC DE TRIOMPHE****Tel: +33 1 53 89 50 50

HOTEL SOFITEL LE BALTIMORE****Tel: +33 1 44 34 54 54

HOTEL SOFITEL DEFENSE CENTRE*****Tel: +33 1 47 76 44 43

HOTEL SOFITEL LE FAUBOURG*****Tel: +33 1 44 94 14 14

HOTEL VILLA DES TERNES***Tel: +33 1 53 81 94 94

HOTEL VERNET****Tel: +33 1 44 31 98 00

HOTEL WALDORF ARC DE TRIOMPHE****Tel: +33 1 47 64 67 67

HOTEL WALDORF TROCADERO****Tel: + 33 1 45 53 83 30

HOTEL WARWICK****Tel: +33 1 45 63 14 11

HOTEL WESTIN****Tel: +33 1 44 77 11 11


243

HOTEL SCRIBE BY SOFITEL***** 1 rue Scribe 75009 PARISTel: +33 1 44 71 24 24 [email protected] www.sofitel.com

HOTEL SEZZ**** 6 avenue Fremiet, 75016 PARISTel: +33 1 56 75 26 26 hotelsezz-paris.com

HOTEL SPLENDID ETOILE**** 1 avenue Carnot 75017 PARISTel: +33 1 45 72 72 00 [email protected] www.hsplendid.com

HOTEL SOFITEL ARC DE TRIOMPHE**** 14 rue Beaujon 75008 PARISTel: +33 1 53 89 50 50 [email protected] www.accorhotels.com

HOTEL SOFITEL LE BALTIMORE**** 88 bis avenue Kléber 75016 PARISTel: +33 1 44 34 54 54 [email protected] www.accorhotels.com

HOTEL SOFITEL DEFENSE CENTRE***** 33 voie des Sculpteurs 92800 PUTEAUXTel: +33 1 47 76 44 43 [email protected] www.sofitel.com

HOTEL SOFITEL LE FAUBOURG***** 15 rue Boissy d'Anglas 75008 PARISTel: +33 1 44 94 14 14 [email protected] www.sofitel.com

HOTEL VILLA DES TERNES*** 97 avenue des Ternes 75017 PARISTel: +33 1 53 81 94 94 [email protected] www.paris-hotel-ternes.com

HOTEL VERNET**** 25 rue Vernet, 75008 PARISTel: +33 1 44 31 98 00 [email protected] hotelvernet.com

HOTEL WALDORF ARC DE TRIOMPHE**** 36 rue Pierre Demours 75017 PARISTel: +33 1 47 64 67 67 [email protected] www.hotelswaldorfparis.com

HOTEL WALDORF TROCADERO**** 97 rue Lauriston 75016 PARISTel: + 33 1 45 53 83 30 [email protected] www.hotelswaldorfparis.com

HOTEL WARWICK**** 5 rue de Berri 75008 PARISTel: +33 1 45 63 14 11 [email protected] www.warwickparis.com

HOTEL WESTIN**** 3 rue de Castiglione 75001 PARISTel: +33 1 44 77 11 11 [email protected] www.starwoodhotels.com


Exhibition halls

244

Asahi Intecc Co., Ltd. P12

AstraZeneca M74

Atrium Europe BV F05

B. Braun Melsungen AG P01

BALTON M69

Biosensors International F30 + F31

Bioteque Corporation M85

BIOTRONIK F16

Boston Scientific F17 + F18

Cambus Medical M23

Cappella Medical Devices M01

COMPANY STAND Nr

Aachen Resonance GmbH N13-1

Abbott Vascular International

BVBA F11 + F12 + F13

Abiomed Europe GmbH M72

Accumetrics N13

Acist Medical Systems N19

ACROSTAK M02

Alvimedica Medical Technologies P10

amg International GmbH M41

Andramed GmbH N09

Angioplasty Summit-TCTAP T11

COMPANY STAND Nr

N19

N17

N14N16

N13

N13-1

N11

N09

N07

N05

N18

N15

N12

N08

N06

N04

N02

N03

N01

P16

P14

P12

P10

P07

P05

P04

P02P01

P03

P06

P08

P09

P11

P13

P15

F19F14

F10

F29

F20

F17 F15

F16

F12F11

F09

F08

F06F07

F04

F05F28

F30

F31

F27 F21

F22

F18

F26 F25 F24 F23

LONDON PUB

ABSTRACT

POSTERS

MAIN ARENA

SINGAPOREFOOD COURT

BAG PICK-UP

CYBER SPACE

T24 T23T22 T21 T20

T01 T02 T03-04-05

T18 T17T16 T15 T14

T07 T08 T09 T10 T11 T12T13

BOOTHS P01 TO P16

BOOTHSN01 TO

N19

BOOTHS FO4 TO F31

BOOTHS TO1 TO T24

F13

MONTMARTRE

Level 1

M18

M20

M12

M15

M07M09


245

F04

F05

FOOD COURT

BOOTHS P01 TO P16

M11

M14

M17

M64

M01

M65

M66

M67

M68

M73M74

M69M69-1

M70

M71M72

M02 M03 M04 M05

M06

M19M18

M85

M84

M83

M23M22

M56

M57

M54M55

M78M82

M77

M76

M81

M79M80

M75

M31M32

M34M35

M33

M36M37

M38

M39

M43M44

M42

M41

M45M46

M47

M49M50

M48M51M52

M53

M40

M20

M12 M13

M16M15

M07M09

M08M10

BOOTHS M01 TO M85

BISTROT MONTMARTRE

ROOMMAILLOT

PREVIEWROOM

GUEST LOUNGE

Level 2

GE HEALTHCARE M68

HEXACATH F09 + F10

HRA RESEARCH P09

IHT - Cordynamic N03 + N04

InspireMD P14

INVENT BIO-MED PVT.LTD. M49 + M50

IROKO CARDIO N12

ITGI Medical F24

Japan Stent Technology M11

JenaValve Technology M17

JIM 2012 T07

JOLIFE AB M47

KIMAL PLC M36 + M37

Lake Region Medical M31 + M32

Lancer Medical Technology

Pvt Ltd M78 + M82

Lepu Medical Technology

(Beijing) Co., Ltd M45 + M46

Liaoning Biomedical Center M83

Lifetech Scientific Co.,Ltd M42

Lumenous Device Technologies, Inc M18

CARDIOREPORT M13

Celonova Biosciences N07

Charing Cross / BIBA Medical T09

CID Srl N01 + N02

CIT T01

Comed BV N15

Cook Medical P16

Cordis, Johnson & Johnson F15

Creganna-Tactx Medical P08

CRF & ACC T03 + T04 + T05

CRTonline.org T08

Daiichi Sankyo Europe GmbH/Eli Lilly

International F04

Demax Medical Technology M76

DISA Vascular M04

EBIT AET (a business unit of ESAOTESpA) M03

Edwards Lifesciences F27

ESC / EAPCI M07 + M09

eucatech AG P15

Eurocor F28

EUROPEAN CARDIOVASCULAR

RESEARCH CENTER - CERC M06

COMPANY STAND Nr COMPANY STAND Nr


Exhibition halls

246

MINVASYS P04

Multiplate M22

NATEC MEDICAL LTD. P13

Occlutech M71

Onset Medical Corporation M39

OptiMed Medizinische Instrumente

GmbH F25

OrbusNeich N06

Ostial Corp. M38

Paieon Inc. M77

PAN MEDICAL LTD. M08 + M10

COMPANY STAND Nr

MAQUET Cardiovascular P05

Medis Medical Imaging Systems BV P11

MEDRAD Interventional / Bayer

Healthcare Pharmaceuticals N18

Medtronic International

Trading Sarl F19 + F20 + F21

Mentice AB N08

MERIL LIFE SCIENCES PVT. LTD. F22 + F23

Merit Medical M64

MicroPort Medical (Shanghai) Co., Ltd. M66

MINITUBES / QUALIMED / MEKO N17

COMPANY STAND Nr

Level 1

M18

M20

M12

M15

M07M09

N19

N17

N14N16

N13

N13-1

N11

N09

N07

N05

N18

N15

N12

N08

N06

N04

N02

N03

N01

P16

P14

P12

P10

P07

P05

P04

P02P01

P03

P06

P08

P09

P11

P13

P15

F19F14

F10

F29

F20

F17 F15

F16

F12F11

F09

F08

F06F07

F04

F05F28

F30

F31

F27 F21

F22

F18

F26 F25 F24 F23

LONDON PUB

ABSTRACT

POSTERS

MAIN ARENA

SINGAPOREFOOD COURT

BAG PICK-UP

CYBER SPACE

T24 T23T22 T21 T20

T01 T02 T03-04-05

T18 T17T16 T15 T14

T07 T08 T09 T10 T11 T12T13

BOOTHS P01 TO P16

BOOTHSN01 TO

N19

BOOTHS FO4 TO F31

BOOTHS TO1 TO T24

F13

MONTMARTRE


247

Level 2

STENTYS N05

Svelte Medical Systems, Inc. M57

Symetis SA M53

Synexmed (Shenzhen) Company Limited M81

Teleflex F26

Terumo Europe F14

The Medicines Company M70

theheart.org M19

TOBI & EVACS T02

TORAY M40

Toshiba Medical Systems M84

translumina GmbH M51 + M52

TriReme Medical M16

Tryton Medical, Inc. P03

Vascular Concepts Ltd M65

Vascular Solutions, Inc. P06

Vasmed Technologies Ltd. N14 + N16

VOLCANO F29

Wisepress T12 + T13

Ziehm Imaging M54 + M55

ZOLL Medical Corporations M15

PCR Family M20

PendraCare P07

PEROUSE MEDICAL M05

pfm medical ag M14

PHILIPS HEALTHCARE M73

Pie Medical Imaging M48

PLC Medical Systems, Inc. M12

PRECISION WIRE COMPONENTS M75

Promed Medical Tech. (Suzhou) Co., Ltd M33

QuikClot® M69-1

Rontis AG P02

Sahajanand Medical

Technologies Private Limited M34 + M35

Scientific Village T14 to T23

SCITECH MED M43 + M44

Siemens AG Healthcare Sector M67

Silicon Valley Medical Instruments, Inc M56

Simbionix USA Corp. N11

SIS MEDICAL AG M79 + M80

SOLACI T10

St Jude Medical F06 + F07 + F08

COMPANY STAND Nr COMPANY STAND Nr

M11

M14

M17

M64

M01

M65

M66

M67

M68

M73M74

M69M69-1

M70

M71M72

M02 M03 M04 M05

M06

M19M18

M85

M84

M83

M23M22

M56

M57

M54M55

M78M82

M77

M76

M81

M79M80

M75

M31M32

M34M35

M33

M36M37

M38

M39

M43M44

M42

M41

M45M46

M47

M49M50

M48M51M52

M53

M40

M20

M12 M13

M16M15

M07M09

M08M10

BOOTHS M01 TO M85

BISTROT MONTMARTRE

ROOMMAILLOT

PREVIEWROOM

GUEST LOUNGE

F04

F05

FOOD COURT

BOOTHS P01 TO P16


Palais des Congrès plan

248

133M 132M 131M

138M

137M

136M

135M

134M

128M

127M

126M

125M

124M

121M 122M 123M

EXHIBITION HALL

LONDON PUB

CYBER SPACE ABSTRACTPOSTERS

SINGAPOREFOOD COURT

BAG PICK-UP

MAIN ARENA

EX

HI

BI

TI

ON

EX

HI

BI

TI

ON

103102101

104

111112113

EXHIBITOR SUPPORT CENTRE

MEET WITHTHE TRIALISTS

WC

WC WC

WCWC

WC WC

WC

MEZZANINE MEZZANINE

ENTRANCE

REGISTRATION AREA

TO LEVEL 1 TO LEVEL 1

CONCIERGE,HOTEL

FACULTYDESKS

TO LEVEL 0,5:

COMPANIES DESK, CLOAKROOM

Level 0

Level 1


MEZZANINE MEZZANINEPRESS

342AB

341351

353

THEATREBORDEAUX

THEATREHAVANE

TRAININGVILLAGE

INNOVATION INCUBATORWEDNESDAY

303

304

305

302313 301

329M

328M

327M

326M

325M

227M320M

227M321M

227M322M

324M

323M

339M

338M

337M

336M

335M

CASE CORNER

WC

WC WC

WCWC

WC WC

WC

PCRTV

352AB

343

334M

333M 332M

331M

330M

312

314 311

INTERACTIVECASE CORNER

233M 232M 231M

237M

236M

235M

234M

227M

226M

225M

224M

221M 222M 223M

EXHIBITION HALL

243

241251

253

BISTROT MONTMARTRE

PCR FAMILY STAND

PREVIEW

THEATREBLEU

ROOMMAILLOT

MAIN ARENA

204

211213 203202201212

WC

WC WC

WCWC

WC WC

WC

MEZZANINE MEZZANINE

242A

242B

GUESTLOUNGE

252AB

Level 2

Level 3



Documents

¼š议日程... · 2017-05-02 · Palais des Congrès plan 133M132M131M 138M 137M 136M 135M 134M 128M 127M 126M 125M 124M 121M122M123M EXHIBITION HALL LONDON PUB CYBER SPACE ABSTRACT